[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 59 of about 59
1. Gérard P, Lepercq P, Leclerc M, Gavini F, Raibaud P, Juste C: Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol; 2007 Sep;73(18):5742-9
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces.
  • We describe here the first isolation and characterization of a cholesterol-reducing bacterium of human intestinal origin.
  • Strain D8 was a gram-negative, non-spore-forming, rod-shaped organism identified as a member of the genus Bacteroides closely related to Bacteroides vulgatus, based on its morphological and biochemical characteristics.

  • MedlinePlus Health Information. consumer health - Bowel Movement.
  • MedlinePlus Health Information. consumer health - Cholesterol.
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lipids. 1993 Mar;28(3):181-8 [8464348.001]
  • [Cites] J Bacteriol. 1991 Jan;173(2):697-703 [1987160.001]
  • [Cites] Steroids. 1996 Jan;61(1):33-40 [8789734.001]
  • [Cites] Appl Environ Microbiol. 1996 Apr;62(4):1434-6 [8919807.001]
  • [Cites] Appl Environ Microbiol. 1997 Jul;63(7):2802-13 [9212428.001]
  • [Cites] Syst Appl Microbiol. 1998 Mar;21(1):65-71 [9741111.001]
  • [Cites] Appl Environ Microbiol. 1998 Oct;64(10):3854-9 [9758810.001]
  • [Cites] Br J Cancer. 1999 Jun;80(8):1132-6 [10376962.001]
  • [Cites] Can J Biochem Physiol. 1959 Aug;37(8):911-7 [13671378.001]
  • [Cites] J Mol Biol. 1962 Jul;5:109-18 [14470099.001]
  • [Cites] FEMS Microbiol Lett. 2005 Jan 1;242(1):81-6 [15621423.001]
  • [Cites] Inflamm Bowel Dis. 2005 May;11(5):473-80 [15867587.001]
  • [Cites] Science. 2005 Jun 10;308(5728):1635-8 [15831718.001]
  • [Cites] Int J Syst Evol Microbiol. 2005 Sep;55(Pt 5):2143-7 [16166722.001]
  • [Cites] FEMS Microbiol Ecol. 2005 Sep 1;54(1):77-85 [16329974.001]
  • [Cites] Int J Syst Evol Microbiol. 2006 Jan;56(Pt 1):151-4 [16403880.001]
  • [Cites] Int J Syst Evol Microbiol. 2006 May;56(Pt 5):931-5 [16627634.001]
  • [Cites] Int J Syst Evol Microbiol. 2006 Jul;56(Pt 7):1639-43 [16825642.001]
  • [Cites] FEMS Microbiol Ecol. 2004 Mar 1;47(3):337-43 [19712322.001]
  • [Cites] Appl Environ Microbiol. 1999 Nov;65(11):4799-807 [10543789.001]
  • [Cites] Science. 2001 Feb 2;291(5505):881-4 [11157169.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1363-71 [14985472.001]
  • [Cites] Eur J Biochem. 1970 Jan;12(1):133-42 [4984993.001]
  • [Cites] Eur J Biochem. 1971 Aug 16;21(3):428-32 [5569608.001]
  • [Cites] Eur J Biochem. 1973 Jul 16;36(2):411-21 [4730962.001]
  • [Cites] Cancer Res. 1974 Sep;34(9):2250-4 [4843533.001]
  • [Cites] Appl Environ Microbiol. 1980 Dec;40(6):1130-2 [7458310.001]
  • [Cites] Appl Environ Microbiol. 1982 Jan;43(1):86-9 [6798934.001]
  • [Cites] Jpn J Med. 1983 Jan;22(1):14-20 [6302358.001]
  • [Cites] J Lipid Res. 1983 Jun;24(6):675-700 [6350517.001]
  • [Cites] Annu Rev Microbiol. 1984;38:293-313 [6388494.001]
  • [Cites] Scand J Gastroenterol. 1985 Dec;20(10):1180-4 [4095491.001]
  • [Cites] Cancer. 1987 Sep 1;60(5):994-9 [3111679.001]
  • [Cites] Ann Med. 1990 Feb;22(1):49-52 [2184845.001]
  • [Cites] APMIS. 1990 Sep;98(9):839-44 [2223037.001]
  • [Cites] Int J Syst Bacteriol. 1994 Jan;44(1):137-42 [8123557.001]
  • (PMID = 17616613.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ217839
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S; 97C5T2UQ7J / Cholesterol
  • [Other-IDs] NLM/ PMC2074900
  •  go-up   go-down


2. Sangnoi Y, Sakulkeo O, Yuenyongsawad S, Kanjana-opas A, Ingkaninan K, Plubrukarn A, Suwanborirux K: Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica. Mar Drugs; 2008;6(4):578-86

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica.
  • Acetylcholinesterase-inhibiting activity of marinoquinoline A (1), a new pyrroloquinoline from a novel species of a marine gliding bacterium Rapidithrix thailandica, was assessed (IC(50) 4.9 microM).
  • Two related pyrrole derivatives, 3-(2'-aminophenyl)-pyrrole (3) and 2,2-dimethyl-pyrrolo-1,2-dihydroquinoline (4), were also isolated from two other strains of R. thailandica.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Microbiol Methods. 2003 Jul;54(1):21-7 [12732418.001]
  • [Cites] Int J Syst Evol Microbiol. 2007 Oct;57(Pt 10):2275-9 [17911296.001]
  • [Cites] J Antibiot (Tokyo). 1981 May;34(5):555-66 [7275838.001]
  • [Cites] J Antibiot (Tokyo). 1982 Aug;35(8):1101-3 [6815147.001]
  • [Cites] J Antibiot (Tokyo). 1983 Dec;36(12):1735-42 [6662814.001]
  • [Cites] J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 [2359136.001]
  • [Cites] J Basic Microbiol. 1992;32(3):209-14 [1512712.001]
  • [Cites] J Bacteriol. 1998 Apr;180(7):1939-43 [9537395.001]
  • [Cites] J Antibiot (Tokyo). 1998 Mar;51(3):275-81 [9589062.001]
  • [Cites] J Appl Microbiol. 1998 Jul;85(1):69-78 [9721657.001]
  • [Cites] Biochem Pharmacol. 1961 Jul;7:88-95 [13726518.001]
  • [Cites] J Nat Prod. 2005 Sep;68(9):1380-5 [16180818.001]
  • [Cites] J Med Chem. 2005 Nov 17;48(23):7223-33 [16279781.001]
  • [Cites] Mech Ageing Dev. 2006 Feb;127(2):158-65 [16297434.001]
  • [Cites] J Pharm Pharmacol. 2006 Jun;58(6):847-52 [16734986.001]
  • [Cites] J Mol Graph Model. 2006 Oct;25(2):169-75 [16413803.001]
  • [Cites] Int J Syst Evol Microbiol. 2006 Dec;56(Pt 12):2931-5 [17159001.001]
  • [Cites] Pharmacol Res. 2004 Oct;50(4):441-51 [15304241.001]
  • (PMID = 19172195.001).
  • [ISSN] 1660-3397
  • [Journal-full-title] Marine drugs
  • [ISO-abbreviation] Mar Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Cholinesterase Inhibitors; 0 / Pyrroles; 0 / Quinolines; EC 3.1.1.7 / Acetylcholinesterase
  • [Other-IDs] NLM/ PMC2630848
  • [Keywords] NOTNLM ; Rapidithrix thailandica / acetylcholinesterase inhibitors / gliding bacteria / phenylpyrroles / pyrroloquinolines
  •  go-up   go-down


3. Nam SJ, Gaudêncio SP, Kauffman CA, Jensen PR, Kondratyuk TP, Marler LE, Pezzuto JM, Fenical W: Fijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus Nocardiopsis. J Nat Prod; 2010 Jun 25;73(6):1080-6
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus Nocardiopsis.
  • Fijiolide A, a potent inhibitor of TNF-alpha-induced NFkappaB activation, along with fijiolide B, were isolated from a marine-derived bacterium of the genus Nocardiopsis.
  • Fijiolides A and B are related to several recently isolated chloroaromatic compounds, which appear to be the Bergman cyclization products of enediyne precursors.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Org Lett. 2005 Jun 23;7(13):2731-4 [15957933.001]
  • [Cites] J Antibiot (Tokyo). 2005 Jan;58(1):1-26 [15813176.001]
  • [Cites] Org Lett. 2006 Mar 16;8(6):1021-4 [16524258.001]
  • [Cites] J Nat Prod. 2006 Mar;69(3):421-4 [16562850.001]
  • [Cites] J Nat Prod. 2006 Mar;69(3):460-3 [16562858.001]
  • [Cites] Eur J Cancer. 2006 Apr;42(6):779-84 [16530406.001]
  • [Cites] Cell Death Differ. 2006 May;13(5):738-47 [16485028.001]
  • [Cites] Mini Rev Med Chem. 2006 Aug;6(8):945-51 [16918500.001]
  • [Cites] Int J Biochem Cell Biol. 2006;38(10):1647-53 [16766221.001]
  • [Cites] Nat Chem Biol. 2006 Dec;2(12):666-73 [17108984.001]
  • [Cites] Expert Opin Ther Targets. 2007 Feb;11(2):133-44 [17227230.001]
  • [Cites] Cancer Sci. 2007 Mar;98(3):268-74 [17270016.001]
  • [Cites] Org Lett. 2007 Apr 12;9(8):1525-8 [17373804.001]
  • [Cites] J Am Chem Soc. 2007 Apr 18;129(15):4795-9 [17378569.001]
  • [Cites] J Nat Prod. 2007 Aug;70(8):1321-8 [17630797.001]
  • [Cites] Org Lett. 2008 Feb 21;10(4):629-31 [18205372.001]
  • [Cites] Angew Chem Int Ed Engl. 2008;47(17):3258-61 [18348121.001]
  • [Cites] Org Lett. 2008 Dec 18;10(24):5505-8 [19007176.001]
  • [Cites] Angew Chem Int Ed Engl. 2009;48(4):725-7 [19090514.001]
  • [Cites] Angew Chem Int Ed Engl. 2009;48(4):728-32 [19097126.001]
  • [Cites] Apoptosis. 2009 Apr;14(4):348-63 [19212815.001]
  • [Cites] Org Lett. 2009 Mar 19;11(6):1353-6 [19228040.001]
  • [Cites] Cell. 2002 Apr;109 Suppl:S81-96 [11983155.001]
  • [Cites] Angew Chem Int Ed Engl. 2003 Jan 20;42(3):355-7 [12548698.001]
  • [Cites] Biochem Pharmacol. 2003 Jul 1;66(1):15-23 [12818361.001]
  • [Cites] J Biol Chem. 2004 Jun 18;279(25):26019-27 [15047705.001]
  • [Cites] Mutat Res. 2004 Nov 2;555(1-2):33-51 [15476850.001]
  • [Cites] Org Lett. 2009 Sep 3;11(17):3862-5 [19655766.001]
  • [Cites] J Org Chem. 2009 Aug 7;74(15):5502-9 [19572603.001]
  • [Cites] J Antibiot (Tokyo). 1988 Nov;41(11):1575-9 [3198491.001]
  • [Cites] J Antibiot (Tokyo). 1988 Nov;41(11):1580-5 [3198492.001]
  • [Cites] Cancer Res. 1997 Jan 15;57(2):272-8 [9000567.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):578-85 [9973203.001]
  • [Cites] J Am Chem Soc. 2006 Feb 8;128(5):1622-32 [16448135.001]
  • (PMID = 20481500.001).
  • [ISSN] 1520-6025
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / U19 CA067775-100002; United States / NCI NIH HHS / CA / CA067775-100002; United States / NCI NIH HHS / CA / CA048112-170007; United States / NCI NIH HHS / CA / P01 CA048112; United States / NCI NIH HHS / CA / P01 CA048112-170007; United States / NCI NIH HHS / CA / U19 CA067775; United States / FIC NIH HHS / TW / U01 TW007401; United States / FIC NIH HHS / TW / U19 TW007401; United States / FIC NIH HHS / TW / U01-TW007401-O1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glycosides; 0 / NF-kappa B; 0 / Tumor Necrosis Factor-alpha; 0 / fijiolide A; 0 / fijiolide B; EC 1.6.5.2 / NAD(P)H Dehydrogenase (Quinone)
  • [Other-IDs] NLM/ NIHMS207343; NLM/ PMC2901511
  •  go-up   go-down


Advertisement
4. Tepes B: Can gastric cancer be prevented? J Physiol Pharmacol; 2009 Dec;60 Suppl 7:71-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can gastric cancer be prevented?
  • Gastric adenocarcinoma is the fourth most common malignancy worldwide and is globally the second leading cause of cancer-related deaths each year.
  • Among the risk factors are genetic factors (genetic diffuse gastric cancer - E-cadherin mutation (CDH1), pro- and anti-inflammatory cytokine genes and innate immune response gene polymorphisms), environmental factors (infection with the bacterium Helicobacter pylori (H. pylori), Epstein-Barr virus, nutrition: nitroso compounds, salt and antioxidants intake) and other factors (pernicious anemia, gastric polyps, gastric surgery, reproductive hormones, smoking).
  • The bacterium H. pylori has been found to be the major carcinogen in gastric cancer development.
  • One percent of patients infected with H. pylori will develop gastric cancer.
  • American and European guidelines on the management of H. pylori infection recommend H. pylori eradication in all patients with atrophy and/or intestinal metaplasia and in all first-degree relatives of gastric cancer patients.
  • In the Asian Pacific Gastric Cancer Consensus, it was suggested for the first time that it is time for population-based screening and treatment of H. pylori infection in regions with gastric cancer incidence above 20/100000 per year.
  • Population screen and treat of H. pylori infection should be recommended in regions with gastric cancer incidence above 20/100000 per year.
  • [MeSH-minor] Animals. Early Detection of Cancer. Helicobacter Infections / complications. Helicobacter Infections / drug therapy. Helicobacter Infections / physiopathology. Helicobacter pylori. Humans. Mass Screening. Patient Education as Topic. Risk Factors. Stomach Diseases / physiopathology. Stomach Diseases / prevention & control. Stomach Diseases / therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20388948.001).
  • [ISSN] 1899-1505
  • [Journal-full-title] Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • [ISO-abbreviation] J. Physiol. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 74
  •  go-up   go-down


5. Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, Tiwari BK: Helicobacter pylori and gastric cancer. Asian Pac J Cancer Prev; 2010;11(3):583-8
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Helicobacter pylori and gastric cancer.
  • From the beginning, this gram-negative bacterium has provoked the interest of bacteriologists, gastroenterologists, infectious disease specialists, cancer biologists, epidemiologists, pathologists, and pharmaceutical scientists.
  • Chronic inflammation elicited by the bacterium provided the missing link in the progression to gastric carcinoma; accordingly, H. pylori was named as a class 1 carcinogen by the World Health Organization.
  • Two key papers published in 1991 in the Journal of the National Cancer Institute reported a positive association between gastric cancer and H. pylori infection.
  • Host related factors for the development of disease can indicate genetic susceptibility (or resistance) or acquired influences, which may stimulate defenses of the host against environmental carcinogens like H.pylori.
  • The present article is a mini-review of the history and epidemiology of the bacterium and its suggested association with the development and progression of gastric cancer.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21039020.001).
  • [ISSN] 2476-762X
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Thailand
  •  go-up   go-down


6. Mishra RR, Tewari M, Shukla HS: Helicobacter species and pathogenesis of gallbladder cancer. Hepatobiliary Pancreat Dis Int; 2010 Apr;9(2):129-34
MedlinePlus Health Information. consumer health - Gallbladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Helicobacter species and pathogenesis of gallbladder cancer.
  • BACKGROUND: Gallbladder cancer (GBC) is a rare disease but a leading cause of cancer-related death worldwide.
  • DATA SOURCES: A PubMed search on "helicobacter", "gallbladder cancer", and "biliary tract malignancies" was done on the topic, and the relevant data were collected, reviewed, and analyzed.
  • Infection with helicobacter is an important risk factor for the development of cancer and the bacterium has been categorized as a group-I carcinogen by the International Agency for Research on Cancer (IARC).
  • Thereby they invade the tissues and produce chemical carcinogens that lead to DNA damage and subsequently a series of gene mutations transform normal cells into cancer cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20382581.001).
  • [ISSN] 1499-3872
  • [Journal-full-title] Hepatobiliary & pancreatic diseases international : HBPD INT
  • [ISO-abbreviation] HBPD INT
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / DNA, Bacterial
  • [Number-of-references] 55
  •  go-up   go-down


7. Wroblewski LE, Peek RM Jr, Wilson KT: Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev; 2010 Oct;23(4):713-39
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Helicobacter pylori and gastric cancer: factors that modulate disease risk.
  • Infection with H. pylori causes chronic inflammation and significantly increases the risk of developing duodenal and gastric ulcer disease and gastric cancer.
  • Infection with H. pylori is the strongest known risk factor for gastric cancer, which is the second leading cause of cancer-related deaths worldwide.
  • Once H. pylori colonizes the gastric environment, it persists for the lifetime of the host, suggesting that the host immune response is ineffective in clearing this bacterium.
  • In this review, we discuss the host immune response and examine other host factors that increase the pathogenic potential of this bacterium, including host polymorphisms, alterations to the apical-junctional complex, and the effects of environmental factors.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gut. 2005 Nov;54(11):1536-40 [15985559.001]
  • [Cites] Nat Immunol. 2005 Nov;6(11):1123-32 [16200070.001]
  • [Cites] J Surg Oncol. 2005 Nov 1;92(2):116-23 [16231374.001]
  • [Cites] Transgenic Res. 2005 Oct;14(5):655-63 [16245156.001]
  • [Cites] J Exp Med. 2005 Nov 7;202(9):1235-47 [16275761.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16339-44 [16258069.001]
  • [Cites] Infect Immun. 2005 Dec;73(12):7844-52 [16299274.001]
  • [Cites] Cancer Res. 2005 Dec 1;65(23):10709-15 [16322215.001]
  • [Cites] J Immunol. 2005 Dec 15;175(12):8200-8 [16339559.001]
  • [Cites] Mol Cell Biol. 2006 Jan;26(1):261-76 [16354697.001]
  • [Cites] Infect Immun. 2006 Jan;74(1):248-56 [16368978.001]
  • [Cites] J Pathol. 2006 Jan;208(2):233-48 [16362989.001]
  • [Cites] Am J Gastroenterol. 2006 Jan;101(1):29-35 [16405530.001]
  • [Cites] Microbes Infect. 2006 Jan;8(1):52-60 [16260169.001]
  • [Cites] Gut. 2006 Apr;55(4):463-8 [16428266.001]
  • [Cites] J Clin Invest. 2006 Apr;116(4):1092-101 [16543949.001]
  • [Cites] Anticancer Res. 1999 Sep-Oct;19(5C):4401-5 [10650783.001]
  • [Cites] J Clin Pathol. 1999 Sep;52(9):658-64 [10655986.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1263-8 [10655519.001]
  • [Cites] Infect Immun. 2000 Mar;68(3):1189-95 [10678925.001]
  • [Cites] J Exp Med. 2000 Feb 21;191(4):587-92 [10684850.001]
  • [Cites] J Exp Med. 2000 Feb 21;191(4):593-602 [10684851.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1497-500 [10688800.001]
  • [Cites] Nature. 2000 Mar 23;404(6776):398-402 [10746728.001]
  • [Cites] Nat Med. 2000 May;6(5):536-42 [10802709.001]
  • [Cites] Carcinogenesis. 2000 Jun;21(6):1111-5 [10836997.001]
  • [Cites] Annu Rev Immunol. 2000;18:767-811 [10837075.001]
  • [Cites] Infect Immun. 2000 Jul;68(7):4303-11 [10858249.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7533-8 [10852959.001]
  • [Cites] Int J Cancer. 2000 Jul 1;87(1):133-40 [10861464.001]
  • [Cites] Int J Cancer. 2000 Aug 1;87(3):322-7 [10897035.001]
  • [Cites] J Immunol. 2000 Aug 15;165(4):1918-24 [10925273.001]
  • [Cites] J Cell Biol. 2000 Aug 7;150(3):567-80 [10931868.001]
  • [Cites] Am J Pathol. 2000 Sep;157(3):729-35 [10980112.001]
  • [Cites] Annu Rev Microbiol. 2000;54:615-40 [11018139.001]
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):559-78 [11030073.001]
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):579-92, v-vi [11030074.001]
  • [Cites] Infect Immun. 2000 Nov;68(11):6265-72 [11035734.001]
  • [Cites] J Immunol. 2000 Nov 1;165(9):5332-7 [11046068.001]
  • [Cites] EMBO J. 2000 Dec 1;19(23):6361-70 [11101509.001]
  • [Cites] J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8 [11106679.001]
  • [Cites] Clin Cancer Res. 2006 May 15;12(10):3216-21 [16707623.001]
  • [Cites] Infect Immun. 2006 Jun;74(6):3519-29 [16714584.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G73-81 [16469828.001]
  • [Cites] Cancer Res. 2006 Jul 1;66(13):6834-42 [16818661.001]
  • [Cites] Infect Immun. 2006 Aug;74(8):4673-84 [16861655.001]
  • [Cites] Hum Pathol. 2006 Aug;37(8):1042-9 [16867867.001]
  • [Cites] Gastroenterology. 2006 Aug;131(2):525-37 [16890606.001]
  • [Cites] Gut. 2006 Sep;55(9):1360-1; author reply 1361 [16905702.001]
  • [Cites] Int J Cancer. 2006 Oct 1;119(7):1558-66 [16646055.001]
  • [Cites] Br J Cancer. 2006 Sep 18;95(6):744-51 [16940985.001]
  • [Cites] J Biol Chem. 2006 Oct 27;281(43):32344-52 [16954210.001]
  • [Cites] Carcinogenesis. 2006 Nov;27(11):2250-7 [16774936.001]
  • [Cites] J Immunol. 2006 Dec 1;177(11):7950-8 [17114467.001]
  • [Cites] PLoS Pathog. 2006 Oct;2(10):e110 [17121461.001]
  • [Cites] Am J Pathol. 2006 Dec;169(6):1901-9 [17148655.001]
  • [Cites] J Exp Med. 2006 Dec 25;203(13):2841-52 [17145958.001]
  • [Cites] Infect Immun. 2007 Feb;75(2):810-9 [17101659.001]
  • [Cites] Acta Trop. 2006 Dec;100(3):232-40 [17181989.001]
  • [Cites] Infect Immun. 2007 Mar;75(3):1203-13 [17194805.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12778-83 [10535999.001]
  • [Cites] J Pathol. 1999 Oct;189(2):180-5 [10547572.001]
  • [Cites] J Bacteriol. 1999 Nov;181(22):6969-76 [10559162.001]
  • [Cites] J Biol Chem. 1999 Dec 3;274(49):35179-85 [10575001.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14559-64 [10588744.001]
  • [Cites] Curr Biol. 1999 Dec 16-30;9(24):1441-7 [10607586.001]
  • [Cites] J Exp Med. 2000 Jan 3;191(1):115-28 [10620610.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6124-31 [10626802.001]
  • [Cites] Science. 2000 Jan 21;287(5452):482-5 [10642549.001]
  • [Cites] Cell Host Microbe. 2009 Jan 22;5(1):23-34 [19154985.001]
  • [Cites] Gastroenterology. 2009 Jan;136(1):247-56 [18948106.001]
  • [Cites] Gastroenterology. 2009 Jan;136(1):236-46 [18996125.001]
  • [Cites] J Infect Dis. 2009 Mar 1;199(5):641-51 [19199544.001]
  • [Cites] Cell Microbiol. 2009 Mar;11(3):488-505 [19046339.001]
  • [Cites] Infect Immun. 2009 Apr;77(4):1337-48 [19179414.001]
  • [Cites] PLoS Pathog. 2009 May;5(5):e1000407 [19412339.001]
  • [Cites] J Infect Dis. 2009 Sep 1;200(5):745-55 [19604117.001]
  • [Cites] J Biol Chem. 2009 Aug 14;284(33):22166-72 [19546211.001]
  • [Cites] Mol Cell Proteomics. 2009 Aug;8(8):1947-58 [19470446.001]
  • [Cites] J Biol Chem. 2009 Aug 21;284(34):23024-36 [19553659.001]
  • [Cites] Mucosal Immunol. 2009 Sep;2(5):403-11 [19587639.001]
  • [Cites] Nat Med. 2009 Sep;15(9):1016-22 [19701202.001]
  • [Cites] PLoS Pathog. 2009 Oct;5(10):e1000603 [19798427.001]
  • [Cites] Digestion. 2009;80(3):200-7 [19752557.001]
  • [Cites] Cancer Sci. 2009 Nov;100(11):2152-9 [19694753.001]
  • [Cites] J Clin Microbiol. 2009 Nov;47(11):3493-500 [19726606.001]
  • [Cites] J Exp Med. 2009 Dec 21;206(13):3061-72 [20008521.001]
  • [Cites] Nat Struct Mol Biol. 2010 Jan;17(1):130-2 [19966800.001]
  • [Cites] Gastroenterology. 2010 Feb;138(2):562-72, 572.e1-2 [19883649.001]
  • [Cites] J Immunol. 2010 Mar 1;184(5):2572-82 [20097867.001]
  • [Cites] Gastroenterology. 2010 Mar;138(3):1046-54 [19931266.001]
  • [Cites] J Clin Invest. 2010 May;120(5):1645-62 [20389019.001]
  • [Cites] Cell Host Microbe. 2010 May 20;7(5):399-411 [20478541.001]
  • [Cites] Clin Microbiol Infect. 2010 Aug;16(8):1264-9 [19832706.001]
  • [Cites] J Immunol. 2004 Apr 15;172(8):5024-33 [15067084.001]
  • [Cites] Infect Immun. 1994 May;62(5):1557-65 [8168917.001]
  • [Cites] Scand J Gastroenterol. 1994 May;29(5):425-9 [8036458.001]
  • [Cites] Mol Microbiol. 1994 Apr;12(2):307-19 [8057855.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1464-9 [15941957.001]
  • [Cites] J Immunol. 2005 Jun 15;174(12):8144-53 [15944323.001]
  • [Cites] J Biol Chem. 2005 Jun 17;280(24):23130-7 [15831497.001]
  • [Cites] Infect Immun. 2005 Jul;73(7):4180-9 [15972508.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9247-52 [15956202.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51 [16027366.001]
  • [Cites] Microbiology. 2005 Oct;151(Pt 10):3267-76 [16207910.001]
  • [Cites] Gut. 2004 Sep;53(9):1217-9 [15306570.001]
  • [Cites] Infect Immun. 2004 Sep;72(9):5181-92 [15322013.001]
  • [Cites] Nat Rev Cancer. 2004 Sep;4(9):688-94 [15343275.001]
  • [Cites] J Biol Chem. 2004 Sep 17;279(38):40161-73 [15247269.001]
  • [Cites] Proteomics. 2004 Oct;4(10):2961-8 [15378755.001]
  • [Cites] Cancer Cell. 2004 Oct;6(4):409-21 [15488763.001]
  • [Cites] Nat Immunol. 2004 Nov;5(11):1166-74 [15489856.001]
  • [Cites] J Biol Chem. 1976 May 10;251(9):2629-36 [816795.001]
  • [Cites] Lancet. 1984 Jun 16;1(8390):1311-5 [6145023.001]
  • [Cites] J Infect Dis. 1986 Apr;153(4):658-63 [3950447.001]
  • [Cites] J Clin Pathol. 1986 Apr;39(4):353-65 [3517070.001]
  • [Cites] Gut. 1986 Jun;27(6):642-7 [3721286.001]
  • [Cites] J Clin Pathol. 1986 Aug;39(8):863-70 [3528230.001]
  • [Cites] J Med Microbiol. 1988 Jun;26(2):93-9 [3385767.001]
  • [Cites] J Clin Microbiol. 1989 Mar;27(3):436-41 [2715319.001]
  • [Cites] Infect Immun. 1990 Mar;58(3):603-10 [2307514.001]
  • [Cites] J Clin Invest. 1991 Mar;87(3):894-900 [1847939.001]
  • [Cites] Lancet. 1991 Aug 10;338(8763):332-5 [1677696.001]
  • [Cites] J Exp Med. 1992 Feb 1;175(2):517-25 [1732414.001]
  • [Cites] Gut. 1991 Dec;32(12):1473-7 [1773951.001]
  • [Cites] Mol Carcinog. 1991;4(6):527-33 [1793490.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10570-5 [1587837.001]
  • [Cites] Mol Microbiol. 1992 Oct;6(19):2863-74 [1435261.001]
  • [Cites] Cancer Res. 1992 Dec 15;52(24):6735-40 [1458460.001]
  • [Cites] J Bacteriol. 1993 Jun;175(11):3278-88 [8501031.001]
  • [Cites] Gut. 1993 Oct;34(10):1339-43 [8244098.001]
  • [Cites] Science. 1993 Dec 17;262(5141):1892-5 [8018146.001]
  • [Cites] J Biol Chem. 1994 Apr 8;269(14):10566-73 [8144644.001]
  • [Cites] Laryngoscope. 2003 May;113(5):815-20 [12792316.001]
  • [Cites] Infect Immun. 2003 Jul;71(7):3837-43 [12819067.001]
  • [Cites] Infect Immun. 2003 Jul;71(7):4163-6 [12819109.001]
  • [Cites] Science. 2003 Aug 22;301(5636):1099-102 [12934009.001]
  • [Cites] Gastroenterology. 2003 Oct;125(4):1125-36 [14517796.001]
  • [Cites] J Immunol. 2003 Oct 15;171(8):3913-7 [14530307.001]
  • [Cites] Cell Microbiol. 2003 Nov;5(11):821-34 [14531897.001]
  • [Cites] J Biol Chem. 2003 Nov 28;278(48):48204-9 [13129933.001]
  • [Cites] Microbes Infect. 2003 Dec;5(15):1345-56 [14670447.001]
  • [Cites] J Exp Med. 2003 Dec 15;198(12):1887-97 [14676300.001]
  • [Cites] J Biol Chem. 2004 Jan 2;279(1):245-50 [14573621.001]
  • [Cites] JAMA. 2004 Jan 14;291(2):187-94 [14722144.001]
  • [Cites] Trends Genet. 2004 Apr;20(4):177-81 [15041171.001]
  • [Cites] Gastric Cancer. 2004;7(1):46-53 [15052440.001]
  • [Cites] Gastroenterology. 2004 Apr;126(4):1030-43 [15057743.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):915-8 [17287725.001]
  • [Cites] Gastroenterology. 2007 Mar;132(3):1009-23 [17383424.001]
  • [Cites] Cell Microbiol. 2007 May;9(5):1148-61 [17217431.001]
  • [Cites] Dig Dis Sci. 2007 Jun;52(6):1517-26 [17404882.001]
  • [Cites] Nature. 2007 May 17;447(7142):330-3 [17507984.001]
  • [Cites] Cancer Res. 2007 May 15;67(10):4709-15 [17510398.001]
  • [Cites] Pathol Res Pract. 2007;203(6):433-44 [17509776.001]
  • [Cites] Am J Gastroenterol. 2007 Jul;102(7):1361-71 [17509026.001]
  • [Cites] Oncogene. 2007 Jul 12;26(32):4617-26 [17237808.001]
  • [Cites] Infect Immun. 2007 Aug;75(8):4030-9 [17562777.001]
  • [Cites] Gastroenterology. 2007 Aug;133(2):659-72 [17681184.001]
  • [Cites] World J Gastroenterol. 2006 Apr 14;12(14):2174-80 [16610017.001]
  • [Cites] Gastroenterology. 2006 Apr;130(4):1181-90 [16618412.001]
  • [Cites] J Immunol. 2006 May 1;176(9):5306-13 [16621997.001]
  • [Cites] Int J Cancer. 2006 Jul 1;119(1):196-201 [16450397.001]
  • [Cites] J Biol Chem. 2006 Apr 28;281(17):11637-48 [16513653.001]
  • [Cites] J Gastroenterol Hepatol. 2006 Apr;21(4):759-66 [16677166.001]
  • [Cites] Nature. 2006 May 11;441(7090):231-4 [16648837.001]
  • [Cites] Gastroenterology. 2006 May;130(6):1754-63 [16697739.001]
  • [Cites] Gut. 2006 Jun;55(6):775-81 [16322107.001]
  • [Cites] Cancer Res. 2006 May 15;66(10):5111-20 [16707434.001]
  • [Cites] J Cell Physiol. 2008 Mar;214(3):582-7 [17786942.001]
  • [Cites] Int J Infect Dis. 2008 Jan;12(1):30-6 [17548220.001]
  • [Cites] Cancer Cell. 2008 Jan;13(1):23-35 [18167337.001]
  • [Cites] Cell Host Microbe. 2008 Jan 17;3(1):20-9 [18191791.001]
  • [Cites] Cancer Res. 2008 Jan 15;68(2):379-87 [18199531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8 [18192401.001]
  • [Cites] Cell Microbiol. 2008 Mar;10(3):781-94 [18005242.001]
  • [Cites] Lab Invest. 2008 Mar;88(3):328-36 [18180700.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G795-807 [18202112.001]
  • [Cites] Gastroenterology. 2008 Apr;134(4):1267; author reply 1268 [18395110.001]
  • [Cites] J Clin Microbiol. 2008 May;46(5):1774-9 [18353934.001]
  • [Cites] J Bacteriol. 2008 Jun;190(11):4100-5 [18375562.001]
  • [Cites] Lab Invest. 2008 Jun;88(6):664-81 [18475258.001]
  • [Cites] J Clin Invest. 2008 Jun;118(6):2325-36 [18483624.001]
  • [Cites] J Pathol. 2008 Jul;215(3):308-16 [18498114.001]
  • [Cites] Gastroenterology. 2008 Jun;134(7):1842-60 [18474247.001]
  • [Cites] EMBO J. 2008 Jun 18;27(12):1671-81 [18511911.001]
  • [Cites] Gastroenterology. 2008 Jul;135(1):91-9 [18474244.001]
  • [Cites] J Med Microbiol. 2008 Sep;57(Pt 9):1062-7 [18719174.001]
  • [Cites] Cancer Causes Control. 2008 Oct;19(8):869-77 [18369531.001]
  • [Cites] J Biol Chem. 2008 Sep 26;283(39):26714-25 [18625712.001]
  • [Cites] J Gastroenterol. 2008;43(9):705-10 [18807132.001]
  • [Cites] Mol Biol Cell. 2008 Oct;19(10):4110-21 [18653469.001]
  • [Cites] Cancer Cell. 2008 Nov 4;14(5):408-19 [18977329.001]
  • [Cites] Cancer Sci. 2008 Oct;99(10):2004-11 [19016760.001]
  • [Cites] Am J Epidemiol. 2008 Dec 15;168(12):1409-15 [18945691.001]
  • [Cites] Cell Microbiol. 2009 Jan;11(1):70-82 [18782353.001]
  • [Cites] J Biol Chem. 2009 Jan 16;284(3):1612-9 [18996844.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102 [9488582.001]
  • [Cites] Gastroenterology. 1998 Mar;114(3):482-92 [9496938.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1998 Jan;10(1):41-6 [9512952.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3925-30 [9520469.001]
  • [Cites] J Clin Invest. 1998 Apr 15;101(8):1604-13 [9541490.001]
  • [Cites] Gut. 1998 Mar;42(3):351-6 [9577340.001]
  • [Cites] Int J Cancer. 1998 Apr 17;79(2):187-94 [9583735.001]
  • [Cites] Mol Microbiol. 1998 Apr;28(1):37-53 [9593295.001]
  • [Cites] Clin Exp Metastasis. 1998 May;16(4):313-21 [9626810.001]
  • [Cites] J Clin Pathol. 1998 Mar;51(3):225-8 [9659265.001]
  • [Cites] J Clin Invest. 1998 Aug 15;102(4):813-20 [9710450.001]
  • [Cites] Int J Cancer. 1998 Oct 5;78(2):135-9 [9754640.001]
  • [Cites] Int J Cancer. 1998 Oct 29;78(3):298-300 [9766561.001]
  • [Cites] Int J Oncol. 1998 Nov;13(5):1031-5 [9772296.001]
  • [Cites] J Infect Dis. 1998 Nov;178(5):1516-20 [9780278.001]
  • [Cites] J Biol Chem. 1998 Oct 30;273(44):28560-3 [9786845.001]
  • [Cites] J Clin Invest. 1998 Oct 15;102(8):1506-14 [9788963.001]
  • [Cites] J Biol Chem. 1998 Nov 6;273(45):29745-53 [9792688.001]
  • [Cites] Cancer Res. 1998 Dec 1;58(23):5500-6 [9850086.001]
  • [Cites] Prostaglandins Leukot Essent Fatty Acids. 1998 Nov;59(5):313-6 [9888205.001]
  • [Cites] Nature. 1999 Jan 14;397(6715):176-80 [9923682.001]
  • [Cites] J Exp Med. 1999 Feb 15;189(4):611-4 [9989975.001]
  • [Cites] Dig Dis Sci. 1999 Mar;44(3):465-78 [10080136.001]
  • [Cites] Gastroenterology. 1999 Apr;116(4):823-30 [10092304.001]
  • [Cites] Gastroenterology. 1999 Jun;116(6):1319-29 [10348815.001]
  • [Cites] Infect Immun. 1999 Aug;67(8):4237-42 [10417197.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17205-16 [14963045.001]
  • [Cites] J Infect Dis. 2004 May 15;189(10):1914-20 [15122529.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 18;101(20):7727-32 [15128946.001]
  • [Cites] Public Health Nutr. 2004 May;7(3):407-22 [15153272.001]
  • [Cites] Infect Immun. 2004 Jun;72(6):3646-9 [15155677.001]
  • [Cites] Helicobacter. 2004 Jun;9(3):217-27 [15165257.001]
  • [Cites] J Immunol. 2004 Jul 15;173(2):1249-57 [15240717.001]
  • [Cites] J Hypertens. 2004 Aug;22(8):1475-7 [15257168.001]
  • [Cites] Infect Immun. 2004 Aug;72(8):4416-23 [15271898.001]
  • [Cites] Science. 2004 Jul 23;305(5683):519-22 [15273394.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5186-91 [15795379.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):833-48 [15825067.001]
  • [Cites] J Biol Chem. 2005 Jun 10;280(23):22492-6 [15843384.001]
  • [Cites] Jpn J Cancer Res. 2002 Oct;93(10):1083-9 [12417037.001]
  • [Cites] Mol Cell. 2002 Oct;10(4):745-55 [12419219.001]
  • [Cites] J Natl Cancer Inst. 2002 Nov 20;94(22):1680-7 [12441323.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1793-803 [12454835.001]
  • [Cites] Nat Rev Immunol. 2002 Dec;2(12):933-44 [12461566.001]
  • [Cites] J Immunol. 2002 Dec 15;169(12):6977-84 [12471132.001]
  • [Cites] Cell Microbiol. 2003 Jan;5(1):25-40 [12542468.001]
  • [Cites] EMBO J. 2003 Feb 3;22(3):515-28 [12554652.001]
  • [Cites] J Biol Chem. 2003 Feb 7;278(6):3664-70 [12446738.001]
  • [Cites] J Immunol. 2003 Feb 15;170(4):1635-9 [12574325.001]
  • [Cites] Nat Genet. 2003 Mar;33(3):375-81 [12598897.001]
  • [Cites] Cancer Res. 2003 Mar 1;63(5):951-7 [12615708.001]
  • [Cites] Gut. 2003 Apr;52(4):502-6 [12631658.001]
  • [Cites] Int J Exp Pathol. 2002 Oct;83(5):257-63 [12641822.001]
  • [Cites] Infect Immun. 2003 Apr;71(4):1755-62 [12654789.001]
  • [Cites] Gastroenterology. 2003 Apr;124(4):949-60 [12671892.001]
  • [Cites] J Exp Med. 2003 Apr 7;197(7):813-22 [12668646.001]
  • [Cites] J Infect Dis. 2003 Apr 15;187(8):1165-77 [12695995.001]
  • [Cites] Oncology. 2003;64(3):251-8 [12697966.001]
  • [Cites] J Cell Biol. 2003 Apr 28;161(2):249-55 [12719469.001]
  • [Cites] Gastroenterology. 2003 May;124(5):1193-201 [12730860.001]
  • [Cites] Gastroenterology. 2003 May;124(5):1408-19 [12730880.001]
  • [Cites] J Epidemiol. 2003 May;13(3):162-8 [12749604.001]
  • [Cites] Science. 2003 May 30;300(5624):1430-4 [12775840.001]
  • [Cites] Clin Exp Immunol. 2003 Jun;132(3):393-400 [12780684.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Sep;15(9):1459-65 [11552919.001]
  • [Cites] Gastroenterology. 2001 Oct;121(4):823-9 [11606496.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13844-9 [11717441.001]
  • [Cites] J Biol Chem. 2001 Dec 21;276(51):48127-34 [11604402.001]
  • [Cites] Neoplasia. 2001 Nov-Dec;3(6):459-68 [11774028.001]
  • [Cites] Cancer Res. 2002 Jan 1;62(1):233-40 [11782383.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] Genes Dev. 2002 Feb 1;16(3):307-23 [11825873.001]
  • [Cites] J Clin Invest. 2002 Feb;109(4):431-5 [11854312.001]
  • [Cites] Virchows Arch. 2002 Mar;440(3):318-24 [11889604.001]
  • [Cites] Infect Immun. 2002 Apr;70(4):1984-90 [11895962.001]
  • [Cites] Nat Rev Cancer. 2001 Oct;1(1):11-21 [11900248.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):28-37 [11902583.001]
  • [Cites] Int J Cancer. 2002 Mar 20;98(3):446-9 [11920598.001]
  • [Cites] Mol Microbiol. 2002 Feb;43(4):971-80 [11929545.001]
  • [Cites] Gut. 2002 May;50 Suppl 3:III19-24 [11953328.001]
  • [Cites] Infect Immun. 2002 May;70(5):2630-9 [11953405.001]
  • [Cites] Helicobacter. 2002 Apr;7(2):139-40; author reply 140-1 [11966874.001]
  • [Cites] J Immunol. 2002 May 1;168(9):4692-700 [11971019.001]
  • [Cites] J Immunol. 2002 Jun 15;168(12):6002-6 [12055207.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jul 19;295(3):695-701 [12099696.001]
  • [Cites] Gastroenterology. 2002 Jul;123(1):92-105 [12105837.001]
  • [Cites] Science. 2002 Jul 26;297(5581):573-8 [12142529.001]
  • [Cites] Cell Microbiol. 2002 Oct;4(10):677-90 [12366404.001]
  • [Cites] Di Yi Jun Yi Da Xue Xue Bao. 2002 Apr;22(4):348-50, 365 [12390744.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4805-12 [8062282.001]
  • [Cites] Infect Immun. 2007 Sep;75(9):4305-15 [17562760.001]
  • [Cites] Gastroenterology. 2007 Sep;133(3):926-36 [17854597.001]
  • [Cites] Exp Cell Res. 2007 Oct 1;313(16):3459-71 [17692843.001]
  • [Cites] Clin Infect Dis. 2007 Nov 1;45(9):1204-6 [17918084.001]
  • [Cites] Cancer Res. 2007 Oct 15;67(20):10019-26 [17942936.001]
  • [Cites] FEMS Immunol Med Microbiol. 2007 Dec;51(3):577-86 [17919297.001]
  • [Cites] Cell Host Microbe. 2007 Oct 11;2(4):209-11 [18005737.001]
  • [Cites] Cell Host Microbe. 2007 Oct 11;2(4):250-63 [18005743.001]
  • [Cites] Annu Rev Pathol. 2006;1:63-96 [18039108.001]
  • [Cites] Int J Cancer. 2008 Feb 15;122(4):823-31 [17960618.001]
  • [Cites] J Biol Chem. 2001 Jan 5;276(1):804-10 [11034994.001]
  • [Cites] Infect Immun. 2001 Feb;69(2):1025-31 [11159999.001]
  • [Cites] J Cell Sci. 2001 Feb;114(Pt 4):695-707 [11171375.001]
  • [Cites] Scand J Gastroenterol. 2001 Feb;36(2):208-13 [11252415.001]
  • [Cites] Nat Immunol. 2001 Apr;2(4):361-7 [11276208.001]
  • [Cites] J Clin Invest. 2001 Apr;107(7):767-73 [11285290.001]
  • [Cites] Br J Cancer. 2001 Apr 6;84(7):965-8 [11286478.001]
  • [Cites] Gut. 2001 Jun;48(6):743-7 [11358884.001]
  • [Cites] Gut. 2001 Jun;48(6):765-73 [11358893.001]
  • [Cites] J Immunol. 2001 Jun 15;166(12):7456-61 [11390498.001]
  • [Cites] Infect Immun. 2001 Aug;69(8):5080-7 [11447189.001]
  • [Cites] Science. 2001 Jul 13;293(5528):253-6 [11452116.001]
  • [Cites] Nat Immunol. 2001 Aug;2(8):675-80 [11477402.001]
  • [Cites] Infect Immun. 2001 Sep;69(9):5857-63 [11500464.001]
  • [Cites] N Engl J Med. 2001 Sep 13;345(11):784-9 [11556297.001]
  • [Cites] Curr Opin Cell Biol. 2001 Oct;13(5):604-10 [11544030.001]
  • [Cites] J Clin Invest. 1994 Sep;94(3):1328-32 [8083373.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9720-4 [7937879.001]
  • [Cites] Cancer Res. 1995 Feb 1;55(3):562-5 [7834625.001]
  • [Cites] Science. 1995 Mar 17;267(5204):1655-8 [7886456.001]
  • [Cites] Mol Microbiol. 1994 Nov;14(4):691-703 [7891557.001]
  • [Cites] Gut. 1995 Mar;36(3):341-5 [7698689.001]
  • [Cites] J Clin Microbiol. 1995 Jan;33(1):28-32 [7699060.001]
  • [Cites] J Bacteriol. 1995 Jun;177(11):3010-20 [7768796.001]
  • [Cites] N Engl J Med. 1995 Jul 6;333(1):32-41 [7776992.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):17771-7 [7629077.001]
  • [Cites] J Theor Biol. 1995 Sep 21;176(2):281-90 [7475116.001]
  • [Cites] J Natl Cancer Inst. 1995 Dec 6;87(23):1777-80 [7473834.001]
  • [Cites] Am J Pathol. 1996 Feb;148(2):519-26 [8579114.001]
  • [Cites] Cancer Res. 1996 Mar 15;56(6):1279-82 [8640814.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2239-44 [8637856.001]
  • [Cites] J Exp Med. 1996 Jun 1;183(6):2593-603 [8676080.001]
  • [Cites] Infect Immun. 1996 Jul;64(7):2445-8 [8698465.001]
  • [Cites] Cancer Res. 1996 Jul 15;56(14):3238-43 [8764115.001]
  • [Cites] Gut. 1996 Apr;38(4):498-501 [8707076.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):477-81 [8781746.001]
  • [Cites] Nature. 1996 Oct 31;383(6603):787-93 [8893001.001]
  • [Cites] Gastroenterology. 1996 Dec;111(6):1524-33 [8942731.001]
  • [Cites] Gut. 1996 Sep;39(3):444-8 [8949652.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53 [8962108.001]
  • [Cites] Gastroenterology. 1997 Jan;112(1):92-9 [8978347.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1402-7 [9037065.001]
  • [Cites] Cancer Res. 1997 Apr 1;57(7):1276-80 [9102213.001]
  • [Cites] J Clin Invest. 1997 Apr 1;99(7):1628-36 [9120006.001]
  • [Cites] Gut. 1997 Mar;40(3):297-301 [9135515.001]
  • [Cites] Eur J Immunol. 1997 Jul;27(7):1751-5 [9247587.001]
  • [Cites] Nature. 1997 Aug 7;388(6642):539-47 [9252185.001]
  • [Cites] J Cell Biol. 1997 Aug 25;138(4):891-9 [9265654.001]
  • [Cites] Dig Dis Sci. 1997 Aug;42(8):1652-9 [9286230.001]
  • [Cites] J Clin Invest. 1997 Sep 15;100(6):1325-9 [9294096.001]
  • [Cites] Infect Immun. 1997 Oct;65(10):4229-35 [9317031.001]
  • [Cites] Gastroenterology. 1997 Dec;113(6):1836-47 [9394723.001]
  • [Cites] Am J Pathol. 1997 Dec;151(6):1695-703 [9403720.001]
  • [Cites] Science. 1998 Jan 16;279(5349):373-7 [9430586.001]
  • [Cites] Am J Gastroenterol. 1999 Sep;94(9):2398-402 [10483998.001]
  • [Cites] Cancer Res. 1999 Oct 1;59(19):4823-8 [10519391.001]
  • [Cites] Semin Cell Dev Biol. 2004 Dec;15(6):657-63 [15561585.001]
  • [Cites] Science. 2004 Nov 26;306(5701):1568-71 [15567866.001]
  • [Cites] Cancer Res. 2004 Dec 1;64(23):8521-5 [15574757.001]
  • [Cites] Infect Immun. 2005 Jan;73(1):523-31 [15618192.001]
  • [Cites] Cancer Sci. 2005 Jan;96(1):1-6 [15649247.001]
  • [Cites] Science. 2005 Jan 14;307(5707):254-8 [15653504.001]
  • [Cites] J Biol Chem. 2005 Jan 28;280(4):2409-12 [15548540.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • (PMID = 20930071.001).
  • [ISSN] 1098-6618
  • [Journal-full-title] Clinical microbiology reviews
  • [ISO-abbreviation] Clin. Microbiol. Rev.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA028842; United States / NIDDK NIH HHS / DK / R01 DK053620; United States / NCI NIH HHS / CA / P01 CA028842; United States / NIDDK NIH HHS / DK / P30 DK058404; United States / NCCIH NIH HHS / AT / R01 AT004821; United States / NCCIH NIH HHS / AT / AT004821; United States / NIDDK NIH HHS / DK / DK053620; United States / NCI NIH HHS / CA / P01 CA116087; United States / NCI NIH HHS / CA / CA116087; United States / NIDDK NIH HHS / DK / DK058405; United States / NIDDK NIH HHS / DK / DK77955; United States / NIDDK NIH HHS / DK / R01 DK058587; United States / NIDDK NIH HHS / DK / K01 DK077955; United States / NIDDK NIH HHS / DK / DK058404; United States / NIDDK NIH HHS / DK / DK58587
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Virulence Factors; 0 / cagA protein, Helicobacter pylori
  • [Other-IDs] NLM/ PMC2952980
  •  go-up   go-down


8. Bouché O, Lagarde S: [Stomach cancer]. Rev Prat; 2005 Jan 31;55(2):123-30
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Stomach cancer].
  • [Transliterated title] Cancer de l'estomac.
  • Despite its decline in incidence in developed countries, gastric cancer is the second digestive cancer in France and remains the second most cause of cancer-related deaths in the world.
  • However there is no definite clinical evidence of the benefit of eradication on cancer risk.
  • By waiting for effective anti-H. pylorivaccine, H. pylori should be only eradicated in selected patients at the highest risk of cancer.
  • The stake is to develop inexpensive tests for identification of individuals at high risk, depending on genotypic polymorphisms of both the bacterium and the host.
  • The endoscopic diagnosis is currently made at an advanced stage, related to non-specific and late symptoms.
  • Gastric cancer is considered to be a chemotherapy sensitive disease, but polychemotherapy regimens (fluorouraci +/- cisplatin +/- epirubicin) result in modest increased survival (median 9 months); yet, the promising effectiveness of new drugs (irinotecan, docetaxel, oxaliplatin, capecitabin, targeted biotherapies) makes us hope an improvement of results.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15825991.001).
  • [ISSN] 0035-2640
  • [Journal-full-title] La Revue du praticien
  • [ISO-abbreviation] Rev Prat
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 34
  •  go-up   go-down


9. Izzotti A, Durando P, Ansaldi F, Gianiorio F, Pulliero A: Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases. Mutat Res; 2009 Jul 10;667(1-2):142-57
MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases.
  • Helicobacter pylori is a Gram-negative bacterium that infects the stomach of more than half of the world's population. H. pylori infection is an established risk factor for gastric cancer, although it is not sufficient cause for the appearance of cancer, per se.
  • Several studies have investigated the role of this bacterium in non-cancer diseases, including gastritis ulcer, duodenal ulcer, gastroesophageal reflux, cardiovascular diseases, neurodegenerative diseases, ocular diseases, and dermatological disorders.
  • Among non-cancer diseases, idiopathic thrombocytopenic purpura appears to show the strongest link with H. pylori.
  • On the whole, the major factors playing a pathogenic role in H. pylori-related non-cancer diseases are: (a) host polymorphisms in genes involved in inflammation and protection against oxidative damage, (b) host exposure to dietary genotoxic agents, and (c) bacterial genetic polymorphisms.
  • In conclusion, there is an evidence that mutagenesis-related mechanisms play a pathogenic role in the appearance of non-cancer diseases following H. pylori infection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19563929.001).
  • [ISSN] 0027-5107
  • [Journal-full-title] Mutation research
  • [ISO-abbreviation] Mutat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Environmental Pollutants
  • [Number-of-references] 152
  •  go-up   go-down


10. Pinkerton DM, Banwell MG, Garson MJ, Kumar N, de Moraes MO, Cavalcanti BC, Barros FW, Pessoa C: Antimicrobial and cytotoxic activities of synthetically derived tambjamines C and E - J, BE-18591, and a related alkaloid from the marine bacterium Pseudoalteromonas tunicata. Chem Biodivers; 2010 May;7(5):1311-24
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antimicrobial and cytotoxic activities of synthetically derived tambjamines C and E - J, BE-18591, and a related alkaloid from the marine bacterium Pseudoalteromonas tunicata.
  • In the first comprehensive biological assessment of the tambjamine class of marine alkaloids, synthetically derived samples of compounds 1-9 have been subjected to evaluation as antimicrobial agents and screened for their cytotoxic effects on various human cancer cell lines.
  • Most were strongly active against the fungus Malassezia furfur (>amphotericin B) and showed considerable, but non-selective, antiproliferative activity against both human cancer and normal cell lines.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20491087.001).
  • [ISSN] 1612-1880
  • [Journal-full-title] Chemistry & biodiversity
  • [ISO-abbreviation] Chem. Biodivers.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Alkaloids; 0 / Anti-Infective Agents; 0 / Cytotoxins; 0 / Pyrroles; 147138-01-0 / BE 18591
  •  go-up   go-down


11. Lahner E, Bernardini G, Santucci A, Annibale B: Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics; 2010 Apr;7(2):239-48
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype.
  • Helicobacter pylori infection is linked to the development of gastric cancer.
  • Atrophic body gastritis is considered the first important step in the histogenesis of such neoplasia. H. pylori infection is involved in the induction of atrophic body gastritis, but documentation of H. pylori infection is difficult because of the progressive disappearance of the bacterium.
  • In the present review, we describe how several research groups used H. pylori immunoproteomics to investigate highly immunoreactive bacterial antigens related to the development of gastric cancer.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20377390.001).
  • [ISSN] 1744-8387
  • [Journal-full-title] Expert review of proteomics
  • [ISO-abbreviation] Expert Rev Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Number-of-references] 90
  •  go-up   go-down


12. Yan ZY, Ding ZH: [Genome-wide identification of exported proteins of the novel bacterium Phenylobacterium zucineum HLK1(T) using a consensus computational strategy]. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Mar;38(2):174-80

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Genome-wide identification of exported proteins of the novel bacterium Phenylobacterium zucineum HLK1(T) using a consensus computational strategy].
  • OBJECTIVE: To predict the exported proteins of the novel bacterium Phenylobacterium zucineum HLK1(T) using genome-wide computational identification by searching the export signals including N-terminal signal peptides and alpha-transmembrane helices.
  • According to the COG classification standard, most of these exported proteins were P proteins related to inorganic ion transport and metabolism and S proteins whose functions were unknown.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19363826.001).
  • [ISSN] 1008-9292
  • [Journal-full-title] Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
  • [ISO-abbreviation] Zhejiang Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Protein Sorting Signals; 0 / Proteome
  •  go-up   go-down


13. Kato I, Canzian F, Plummer M, Franceschi S, van Doorn LJ, Vivas J, Lopez G, Lu Y, Gioia-Patricola L, Severson RK, Schwartz AG, Muñoz N: Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci; 2007 Jan;52(1):254-61
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer.
  • As Helicobacter pylori (HP) is a Gram-negative bacterium, we investigated the associations between several functional polymorphisms in genes involved in lipopolysaccharide (LPS) signaling and the prevalence of various stages of gastric premalignant lesions in a Venezuelan population.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17171451.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 98309
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD14; 0 / Lipopolysaccharides; 0 / NOD2 protein, human; 0 / Nod2 Signaling Adaptor Protein; 0 / Peptidoglycan; 0 / TLR4 protein, human; 0 / Toll-Like Receptor 4
  •  go-up   go-down


14. Correa P: New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol; 2005 Jun 1;90(3):134-8; discussion 138
Hazardous Substances Data Bank. SELENIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility.
  • Recently acquired knowledge points to the potential of markedly improved strategies for the prevention of gastric cancer.
  • The International Agency for Cancer Research has reached the conclusion that infection with Helicobacter pylori (H. pylori) is carcinogenic to humans (Group I).
  • The bacterium displays marked genetic heterogeneity.
  • Virulence related genes, especially cag A and vac A s1 m1 are associated with an increased cancer risk.
  • Genetic susceptibility, especially polymorphisms of the cytokine genes may increase cancer risk.
  • Highly susceptible individuals infected with high virulence bacterial genotypes have a markedly increased gastric cancer risk.

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc
  • (PMID = 15895454.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Cytokines; 0 / VacA protein, Helicobacter pylori; 0 / cagA protein, Helicobacter pylori; 1406-18-4 / Vitamin E; H6241UJ22B / Selenium
  • [Number-of-references] 22
  •  go-up   go-down


15. Shin KS, Hong SB, Son BR: [A Case of Catheter-Related Bacteremia by Arthrobacter woluwensis.]. Korean J Lab Med; 2006 Apr;26(2):103-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A Case of Catheter-Related Bacteremia by Arthrobacter woluwensis.].
  • Arthrobacter woluwensis, a catalase-positive coryneform bacterium recognized as an opportunistic pathogen, was repeatedly isolated from the blood of a 56-year-old male patient with metastatic colon cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156709.001).
  • [ISSN] 1598-6535
  • [Journal-full-title] The Korean journal of laboratory medicine
  • [ISO-abbreviation] Korean J Lab Med
  • [Language] kor
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


16. Tjalsma H, Schöller-Guinard M, Lasonder E, Ruers TJ, Willems HL, Swinkels DW: Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer; 2006 Nov 1;119(9):2127-35
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis.
  • The human bowel contains a large and dynamic bacterial population that is not only essential for intestinal health, but also critical for the development of diseases such as cancer.
  • In this respect, the Gram-positive bacterium Streptococcus bovis has been associated with colon cancer for many years.
  • To investigate the clinical importance of this association, an immunocapture mass spectrometry assay was developed that can generate infection-related protein profiles.
  • The composition of these profiles is governed by the capture of specific antigens by serum antibodies from colon cancer patients.
  • This assay showed that S. bovis antigen profiles could distinguish 11 out of 12 colon cancer patients from 8 control subjects, whereas antigen profiles derived from the gut bacterium Escherichia coli were not diagnostic for colon cancer.
  • Moreover, S. bovis antigen profiles were also detected in polyp patients, indicating that infection with this bacterium does occur early during carcinogenesis.
  • These infections, however, only become apparent in colon cancer patients with a compromised immune system (bacteremia) or coincidental cardiac valve lesions (endocarditis).
  • This makes profiling of the humoral immune response against "silent" S. bovis infections a promising diagnostic tool for the early detection of human colon cancer, which is crucial for the effective treatment of this disease.
  • [MeSH-minor] Humans. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Cancer. 2006 Nov 1;119(9):xi-xii [16947772.001]
  • (PMID = 16841330.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial
  •  go-up   go-down


17. Dasanu CA, Rathmann J, Alexandrescu DT: H. pylori-associated gastric cancer in a husband-wife pair: a veritable family affair. South Med J; 2009 Nov;102(11):1158-60
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] H. pylori-associated gastric cancer in a husband-wife pair: a veritable family affair.
  • Family environment probably represents a high route of transmission for H. pylori, a bacterium associated with gastric cancer (GC).
  • Both patients had active H. pylori-related inflammation.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] South Med J. 2009 Nov;102(11):1104-5 [19864976.001]
  • (PMID = 19864985.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Yu WJ, Wang YW, You JF, Wang JL, Cui XL, Pei F, Zheng J: [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro]. Zhonghua Bing Li Xue Za Zhi; 2010 Sep;39(9):615-20
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro].
  • OBJECTIVE: To investigate the mechanism of influence of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) on the biological behavior of human prostatic cancer cell line PC-3M-1E8.
  • METHODS: The expression of GST-Raf1-RBD recombinant protein, a specific binding domain of active Ras (GTP-Ras), was induced by IPTG in JM109 bacterium.
  • SDS-PAGE and coomassie brilliant blue staining were performed using cleaved product of the bacterium to determine the expression of the fusion protein.
  • Western blotting was used to detect the expression levels of downstream proteins of Ras signal pathway which may be related to the function of PAG1.
  • RESULTS: After IPTG induction, the GST-Raf1-RBD recombinant protein, with a molecular weight of 33 000, was noticed to be highly expressed in JM109 bacterium.
  • In human prostate and prostatic adenocarcinoma tissues, the expression of PAG1 is related to the cellular differentiation and malignancy.
  • [MeSH-minor] Actins / metabolism. Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Cell Cycle. Cell Line, Tumor. Cyclin D1 / metabolism. Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Extracellular Signal-Regulated MAP Kinases / metabolism. Humans. Male. Neoplasm Invasiveness. Prostate / metabolism. Proto-Oncogene Proteins c-akt / metabolism. Transfection. ras Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21092590.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Actins; 0 / Adaptor Proteins, Signal Transducing; 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Membrane Proteins; 0 / PAG1 protein, human; 136601-57-5 / Cyclin D1; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


19. Wolf P, Elsässer-Beile U: Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. Int J Med Microbiol; 2009 Mar;299(3):161-76
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
  • The pathogenic bacterium Pseudomonas aeruginosa has the ability to cause severe acute and chronic infections in humans.
  • Pseudomonas exotoxin A (PE) is the most toxic virulence factor of this bacterium.
  • In these molecules, the enzymatic active domain of PE is specifically targeted to tumor-related antigens.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18948059.001).
  • [ISSN] 1618-0607
  • [Journal-full-title] International journal of medical microbiology : IJMM
  • [ISO-abbreviation] Int. J. Med. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Bacterial Toxins; 0 / Exotoxins; 0 / Immunotoxins; 0 / Virulence Factors; EC 2.4.2.- / ADP Ribose Transferases; EC 2.4.2.31 / toxA protein, Pseudomonas aeruginosa
  • [Number-of-references] 131
  •  go-up   go-down


20. Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer; 2006 Jun 15;118(12):3030-44
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Several infectious agents are considered to be causes of cancer in humans.
  • The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
  • The estimated total of infection-attributable cancer in the year 2002 is 1.9 million cases, or 17.8% of the global cancer burden.
  • The principal agents are the bacterium Helicobacter pylori (5.5% of all cancer), the human papilloma viruses (5.2%), the hepatitis B and C viruses (4.9%), Epstein-Barr virus (1%), human immunodeficiency virus (HIV) together with the human herpes virus 8 (0.9%).
  • Relatively less important causes of cancer are the schistosomes (0.1%), human T-cell lymphotropic virus type I (0.03%) and the liver flukes (0.02%).
  • [MeSH-minor] AIDS-Related Opportunistic Infections / epidemiology. Africa / epidemiology. Americas / epidemiology. Animals. Asia / epidemiology. Cholangiocarcinoma / epidemiology. Cholangiocarcinoma / parasitology. Epstein-Barr Virus Infections / complications. Helicobacter Infections / complications. Helicobacter pylori. Hepatitis B / complications. Hepatitis B / epidemiology. Hepatitis C / complications. Hepatitis C / epidemiology. Humans. Lymphoma / epidemiology. Lymphoma / virology. Opisthorchiasis / complications. Opisthorchis. Papillomaviridae. Papillomavirus Infections / complications. Prevalence. Sarcoma, Kaposi / epidemiology. Schistosoma haematobium. Schistosomiasis / complications. Stomach Neoplasms / epidemiology. Stomach Neoplasms / microbiology. Tumor Virus Infections / complications

  • MedlinePlus Health Information. consumer health - International Health.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16404738.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Han XY, Tarrand JJ, Dickey BF, Esteva FJ: Helicobacter pylori bacteremia with sepsis syndrome. J Clin Microbiol; 2010 Dec;48(12):4661-3
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 65-year-old woman with a history of gastric bleeding, breast cancer, antineoplastic chemotherapy, and prednisone use presented with a fever, chest pain, a dry cough, hypotension, and prominent pulmonary bronchovascular markings.
  • The bacterium eventually grew on brucella agar upon extended incubation.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Pathol. 2002 Nov;118(5):796-801 [12428802.001]
  • [Cites] Lancet. 1983 Jun 4;1(8336):1273-5 [6134060.001]
  • [Cites] J Clin Microbiol. 2005 May;43(5):2513-5 [15872299.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):621 [7805696.001]
  • [Cites] J Am Osteopath Assoc. 1993 Jan;93(1):87-91 [8423130.001]
  • (PMID = 20861342.001).
  • [ISSN] 1098-660X
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ HQ266659
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016672; United States / NCI NIH HHS / CA / CA16672
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / DNA, Bacterial; 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC3008481
  •  go-up   go-down


22. Vogiatzi P, Cassone M, Luzzi I, Lucchetti C, Otvos L Jr, Giordano A: Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. J Cell Biochem; 2007 Oct 1;102(2):264-73
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The gram-negative bacterium Helicobacter pylori is known as a persistent colonizer of the human stomach, and probably less known is that it is also involved in extraintestinal diseases.
  • Public awareness of its contribution in the development of gastric cancer is less than 15 years old.
  • This keynote presentation is to provide a bird's eye view of H. pylori-related gastric diseases, including gastric cancer, with a synthesis of the molecular mechanisms involved, and an exhaustive presentation and discussion of the current therapeutic guidelines and future strategies for prevention or therapy.
  • [MeSH-minor] Anti-Ulcer Agents / therapeutic use. Bacterial Vaccines. Cancer Vaccines / therapeutic use. Drug Resistance, Bacterial. Humans

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Peptic Ulcer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17486575.001).
  • [ISSN] 0730-2312
  • [Journal-full-title] Journal of cellular biochemistry
  • [ISO-abbreviation] J. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anti-Ulcer Agents; 0 / Bacterial Vaccines; 0 / Cancer Vaccines
  • [Number-of-references] 49
  •  go-up   go-down


23. Pérez-Tomás R, Viñas M: New insights on the antitumoral properties of prodiginines. Curr Med Chem; 2010;17(21):2222-31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Apoptosis is involved in the action of several (and perhaps all) cancer-chemotherapeutic agents.
  • The biosynthesis of prodigiosin and derivatives has been extensively studied in Serratia marcescens. S. marcescens is a Gramnegative bacterium belonging to Enterobacteriaceae.
  • Here we review the main characteristics of prodigiosin and their derivatives as well as the most prominent pharmacological activity of prodiginines and related compounds, including novel synthetic PG-derivatives with lower toxicity like GX15-070 (Obatoclax).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20459382.001).
  • [ISSN] 1875-533X
  • [Journal-full-title] Current medicinal chemistry
  • [ISO-abbreviation] Curr. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Pyrroles; 0 / obatoclax; 24311-00-0 / prodiginine; OL369FU7CJ / Prodigiosin
  •  go-up   go-down


24. Xuan SY, Li N, Qiang X, Zhou RR, Shi YX, Jiang WJ: Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol; 2006 Apr 21;12(15):2335-40
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-two patients with other liver diseases (5 with liver trauma, 7 with cavernous liver hemangioma, 6 with liver cyst and 4 with hepatolithiasis), 25 patients with gastric cancer, 15 with colonic cancer and 15 with myoma of uterus served as controls.
  • RESULTS: The positive rate of Helicobacter cultured in HCC and gastric cancer tissue was 10.7% (3/28) and 24% (6/25), respectively.
  • The bacterium was observed in adjacent hepatocytes of the two HCC samples by SEM.
  • The bacterium was also found in four gastric cancer samples.
  • PCR showed that the positive rate of HCC and gastric cancer samples was 60.7% and 72% respectively, while the controls were negative (P<0.01).
  • There was no statistical significance between HCC and gastric cancer (P>0.05), but the positive rate of HCC and controls had statistical significance (P<0.01).
  • Only 3 HCC samples and 2 gastric cancer samples of the cagA genes were detected.
  • Helicobacter spp. infection is related with HCC, which needs further research.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 1996 May;64(5):1548-58 [8613359.001]
  • [Cites] J Clin Pathol. 2004 Aug;57(8):822-8 [15280402.001]
  • [Cites] Br J Biomed Sci. 1998 Sep;55(3):176-8 [10367401.001]
  • [Cites] J Clin Pathol. 2004 Dec;57(12):1273-7 [15563667.001]
  • [Cites] Gut. 2005 Mar;54(3):396-401 [15710989.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):391-5 [15854528.001]
  • [Cites] J Clin Microbiol. 2000 Mar;38(3):1072-6 [10698999.001]
  • [Cites] Med Hypotheses. 2000 Feb;54(2):275-7 [10790764.001]
  • [Cites] Cancer. 2000 Oct 1;89(7):1431-9 [11013355.001]
  • [Cites] Lancet. 1993 Sep 4;342(8871):575-7 [8102719.001]
  • [Cites] J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7 [8040890.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):17771-7 [7629077.001]
  • [Cites] Annu Rev Microbiol. 2000;54:615-40 [11018139.001]
  • [Cites] Gastroenterology. 2001 Oct;121(4):1023-4 [11665691.001]
  • [Cites] Panminerva Med. 2002 Mar;44(1):19-22 [11887086.001]
  • [Cites] Aliment Pharmacol Ther. 2002 Jun;16(6):1037-45 [12030944.001]
  • [Cites] Panminerva Med. 2002 Jun;44(2):145-7 [12032434.001]
  • [Cites] World J Gastroenterol. 2003 Jan;9(1):5-8 [12508341.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):635-40 [12679900.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):755-8 [12679926.001]
  • [Cites] BMJ. 2003 May 10;326(7397):994-5 [12742895.001]
  • [Cites] World J Gastroenterol. 2003 Jul;9(7):1580-3 [12854168.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1171-4 [14560149.001]
  • [Cites] World J Gastroenterol. 2003 Oct;9(10):2137-9 [14562364.001]
  • [Cites] Infect Immun. 2003 Nov;71(11):6573-81 [14573679.001]
  • [Cites] Panminerva Med. 2003 Sep;45(3):183-8 [14618116.001]
  • [Cites] World J Gastroenterol. 2004 Feb 15;10(4):598-601 [14966925.001]
  • [Cites] Am J Gastroenterol. 1996 Jul;91(7):1322-5 [8677987.001]
  • (PMID = 16688821.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC4088066
  •  go-up   go-down


25. Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, Sasakawa C, Ropeleski MJ, Peek RM Jr, Jones NL: Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res; 2009 Jan 15;69(2):632-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Persistent infection with Helicobacter pylori confers an increased risk for the development of gastric cancer.
  • However, the exact mechanisms whereby this bacterium causes carcinogenesis have not been completely elucidated.
  • Therefore, we hypothesized that H. pylori infection modulates STAT3 signaling, favoring gastric cancer development.
  • However, activation was not related to autocrine activation by IL-6 or IL-11.
  • Collectively, these results indicate that H. pylori CagA activates the STAT3 signaling pathway in vitro and in vivo, providing a potential mechanism by which chronic H. pylori infection promotes the development of gastric cancer.

  • Hazardous Substances Data Bank. L-TYROSINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2003 May 30;300(5624):1430-4 [12775840.001]
  • [Cites] J Cell Biol. 2003 Apr 28;161(2):249-55 [12719469.001]
  • [Cites] Infect Immun. 2004 Jan;72(1):537-45 [14688135.001]
  • [Cites] Gastroenterology. 2004 Jan;126(1):196-207 [14699500.001]
  • [Cites] JAMA. 2004 Jan 14;291(2):187-94 [14722144.001]
  • [Cites] Nat Rev Cancer. 2004 Feb;4(2):97-105 [14964307.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8 [14982987.001]
  • [Cites] Oncogene. 2004 Jun 17;23(28):4921-9 [15077160.001]
  • [Cites] J Immunol. 1998 Jun 15;160(12):6056-61 [9637522.001]
  • [Cites] Mol Cell Biol. 1999 Jul;19(7):4643-52 [10373513.001]
  • [Cites] Cell. 1999 Aug 6;98(3):295-303 [10458605.001]
  • [Cites] Infect Immun. 2005 Jan;73(1):523-31 [15618192.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51 [16027366.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16339-44 [16258069.001]
  • [Cites] J Pathol. 2006 Jan;208(2):233-48 [16362989.001]
  • [Cites] J Infect Dis. 2006 Feb 1;193(3):360-9 [16388483.001]
  • [Cites] J Biol Chem. 2006 Mar 17;281(11):7302-8 [16407171.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G73-81 [16469828.001]
  • [Cites] Mol Biol Cell. 2006 Jul;17(7):2986-95 [16624864.001]
  • [Cites] Clin Microbiol Rev. 2006 Jul;19(3):449-90 [16847081.001]
  • [Cites] Gastroenterology. 2006 Aug;131(2):525-37 [16890606.001]
  • [Cites] Gastroenterology. 2006 Oct;131(4):1073-85 [17030178.001]
  • [Cites] Nat Rev Immunol. 2007 Jan;7(1):41-51 [17186030.001]
  • [Cites] J Pathol. 2007 Oct;213(2):140-51 [17724739.001]
  • [Cites] Cancer Res. 2008 Jan 15;68(2):379-87 [18199531.001]
  • [Cites] Semin Cell Dev Biol. 2008 Aug;19(4):351-9 [18620071.001]
  • [Cites] J Immunol. 2003 Aug 15;171(4):2035-41 [12902508.001]
  • [Cites] Nat Rev Cancer. 2004 Sep;4(9):688-94 [15343275.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Sep 3;321(4):828-34 [15358102.001]
  • [Cites] Mol Microbiol. 2002 Feb;43(4):971-80 [11929545.001]
  • [Cites] Nat Med. 2002 Oct;8(10):1089-97 [12219085.001]
  • [Cites] Blood. 2002 Nov 1;100(9):3311-8 [12384432.001]
  • [Cites] Mol Cell. 2002 Oct;10(4):745-55 [12419219.001]
  • [ErratumIn] Cancer Res. 2013 Jul 1;73(13):4170
  • (PMID = 19147578.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / DK 58587; United States / NCI NIH HHS / CA / R01 CA077955; United States / NIDDK NIH HHS / DK / R01 DK058587-01A1; United States / NCI NIH HHS / CA / R29 CA077955; United States / NCI NIH HHS / CA / R01 CA077955-06; United States / NIDDK NIH HHS / DK / R01 DK073902; United States / NIDDK NIH HHS / DK / R01 DK073902-01; United States / NIDDK NIH HHS / DK / DK073902-01; United States / NIDDK NIH HHS / DK / R01 DK058587; United States / NCI NIH HHS / CA / CA 77955; United States / NIDDK NIH HHS / DK / DK 73902
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Receptors, Interleukin-6; 0 / STAT3 Transcription Factor; 0 / STAT3 protein, human; 0 / cagA protein, Helicobacter pylori; 133483-10-0 / Cytokine Receptor gp130; 42HK56048U / Tyrosine
  • [Other-IDs] NLM/ NIHMS79347; NLM/ PMC3418672
  •  go-up   go-down


26. Yamaoka Y: Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol; 2010 Nov;7(11):629-41
MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Some populations that have a high prevalence of H. pylori infection also have a high incidence of gastric cancer (for example, in East Asia), whereas others do not (for example, in Africa and South Asia).
  • Even within East Asia, the incidence of gastric cancer varies (decreasing in the south). H. pylori is a highly heterogeneous bacterium and its virulence varies geographically.
  • Geographic differences in the incidence of gastric cancer can be explained, at least in part, by the presence of different types of H. pylori virulence factor, especially CagA, VacA and OipA.
  • However, it is still unclear why the pathogenicity of H. pylori increased as it migrated from Africa to East Asia during the course of evolution. H. pylori infection is also thought to be involved in the development of duodenal ulcer, which is at the opposite end of the disease spectrum to gastric cancer.
  • Despite advances in our understanding of the development of H. pylori-related diseases, further work is required to clarify the roles of H. pylori virulence factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Epidemiol Infect. 2000 Feb;124(1):91-6 [10722135.001]
  • [Cites] J Bacteriol. 2000 Jun;182(11):3210-8 [10809702.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7533-8 [10852959.001]
  • [Cites] Helicobacter. 2001 Jun;6(2):116-24 [11422466.001]
  • [Cites] J Clin Microbiol. 2002 Jan;40(1):239-46 [11773122.001]
  • [Cites] J Infect Dis. 2002 Feb 1;185(3):341-7 [11807716.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] J Biol Chem. 2002 Mar 1;277(9):6775-8 [11788577.001]
  • [Cites] Mol Microbiol. 2001 Dec;42(5):1337-48 [11886563.001]
  • [Cites] Mol Microbiol. 2002 Feb;43(4):971-80 [11929545.001]
  • [Cites] FEBS Lett. 2002 Apr 24;517(1-3):180-4 [12062433.001]
  • [Cites] Gastroenterology. 2002 Aug;123(2):414-24 [12145793.001]
  • [Cites] Int J Med Microbiol. 2002 Sep;292(3-4):257-66 [12398216.001]
  • [Cites] J Infect Dis. 2002 Dec 1;186(11):1621-30 [12447739.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1992-2004 [12454856.001]
  • [Cites] J Biol Chem. 2003 Feb 7;278(6):3664-70 [12446738.001]
  • [Cites] Science. 2003 Mar 7;299(5612):1582-5 [12624269.001]
  • [Cites] J Cell Biol. 2003 Apr 28;161(2):249-55 [12719469.001]
  • [Cites] J Bacteriol. 2003 Jul;185(13):3764-72 [12813069.001]
  • [Cites] Science. 2003 Aug 22;301(5636):1099-102 [12934009.001]
  • [Cites] J Exp Med. 2003 Dec 15;198(12):1887-97 [14676300.001]
  • [Cites] Gastroenterology. 2004 Apr;126(4):1030-43 [15057743.001]
  • [Cites] J Clin Microbiol. 2004 Apr;42(4):1648-51 [15071020.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 18;101(20):7727-32 [15128946.001]
  • [Cites] Gastroenterology. 2004 Aug;127(2):514-23 [15300584.001]
  • [Cites] Nature. 2007 May 17;447(7142):330-3 [17507984.001]
  • [Cites] Oncogene. 2007 May 24;26(24):3462-72 [17160020.001]
  • [Cites] Microbiology. 2007 Sep;153(Pt 9):2896-909 [17768234.001]
  • [Cites] Cell Microbiol. 2007 Oct;9(10):2457-69 [17517062.001]
  • [Cites] Gastroenterology. 2007 Sep;133(3):926-36 [17854597.001]
  • [Cites] Clin Infect Dis. 2007 Nov 1;45(9):1204-6 [17918084.001]
  • [Cites] Nature. 2007 Oct 18;449(7164):862-6 [17943123.001]
  • [Cites] Helicobacter. 2007 Dec;12(6):591-7 [18001398.001]
  • [Cites] Cell Host Microbe. 2007 Oct 11;2(4):250-63 [18005743.001]
  • [Cites] Annu Rev Pathol. 2006;1:63-96 [18039108.001]
  • [Cites] Cancer Res. 2008 Jan 15;68(2):379-87 [18199531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8 [18192401.001]
  • [Cites] Int J Med Microbiol. 2008 Apr;298(3-4):223-30 [17897881.001]
  • [Cites] Cell Microbiol. 2008 Apr;10(4):1008-20 [18067607.001]
  • [Cites] Gastroenterology. 2008 Apr;134(4):1267; author reply 1268 [18395110.001]
  • [Cites] J Med Microbiol. 2008 May;57(Pt 5):545-53 [18436586.001]
  • [Cites] J Med Microbiol. 2008 May;57(Pt 5):554-62 [18436587.001]
  • [Cites] J Clin Microbiol. 2008 May;46(5):1774-9 [18353934.001]
  • [Cites] Gastroenterology. 2008 Jul;135(1):91-9 [18474244.001]
  • [Cites] World J Gastroenterol. 2008 Jul 21;14(27):4265-72 [18666312.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1053-9 [18560912.001]
  • [Cites] BMC Gastroenterol. 2008;8:49 [18950522.001]
  • [Cites] Cell Microbiol. 2009 Jan;11(1):70-82 [18782353.001]
  • [Cites] Cell Host Microbe. 2009 Jan 22;5(1):23-34 [19154985.001]
  • [Cites] Science. 2009 Jan 23;323(5913):527-30 [19164753.001]
  • [Cites] Gut. 1999 Dec;45(6):804-11 [10562576.001]
  • [Cites] Cell Microbiol. 2009 Mar;11(3):488-505 [19046339.001]
  • [Cites] Cell Host Microbe. 2009 Apr 23;5(4):397-403 [19380118.001]
  • [Cites] J Dig Dis. 2009 May;10(2):77-84 [19426388.001]
  • [Cites] J Biol Chem. 2009 Aug 14;284(33):22166-72 [19546211.001]
  • [Cites] Clin Microbiol Infect. 2009 Sep;15(9):835-42 [19392900.001]
  • [Cites] Clin Microbiol Infect. 2009 Sep;15(9):829-34 [19702588.001]
  • [Cites] PLoS One. 2009;4(9):e6859 [19727398.001]
  • [Cites] BMC Microbiol. 2009;9:175 [19698173.001]
  • [Cites] J Infect Dev Ctries. 2008;2(3):174-81 [19738347.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1227-36 [19551413.001]
  • [Cites] PLoS Pathog. 2009 Oct;5(10):e1000603 [19798427.001]
  • [Cites] Int J Cancer. 2009 Dec 1;125(11):2497-504 [19588494.001]
  • [Cites] J Clin Microbiol. 2009 Nov;47(11):3493-500 [19726606.001]
  • [Cites] PLoS One. 2009;4(11):e7736 [19893742.001]
  • [Cites] J Clin Microbiol. 2009 Dec;47(12):4021-8 [19846630.001]
  • [Cites] PLoS Pathog. 2009 Dec;5(12):e1000684 [19997503.001]
  • [Cites] Nat Struct Mol Biol. 2010 Jan;17(1):130-2 [19966800.001]
  • [Cites] J Gastroenterol Hepatol. 2010 Jan;25(1):172-7 [19793167.001]
  • [Cites] Helicobacter. 2010 Jun;15(3):163-76 [20557357.001]
  • [Cites] J Infect Dis. 2010 Jul 15;202(2):261-9 [20533870.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):817-21 [20419465.001]
  • [Cites] Clin Microbiol Infect. 2010 Aug;16(8):1264-9 [19832706.001]
  • [Cites] CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 [20610543.001]
  • [Cites] Nucleic Acids Res. 2010 Oct;38(18):6089-101 [20478826.001]
  • [Cites] J Clin Microbiol. 1999 Jul;37(7):2274-9 [10364597.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Sep 24;322(3):860-6 [15336542.001]
  • [Cites] Nat Rev Cancer. 2004 Sep;4(9):688-94 [15343275.001]
  • [Cites] Helicobacter. 2004 Oct;9(5):453-9 [15361085.001]
  • [Cites] Rev Infect Dis. 1991 Jul-Aug;13 Suppl 8:S686-9 [1925309.001]
  • [Cites] Gut. 1992 Apr;33(4):429-31 [1582581.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10570-5 [1587837.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):17771-7 [7629077.001]
  • [Cites] Gastroenterology. 1996 Jun;110(6):1744-52 [8964399.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53 [8962108.001]
  • [Cites] Gastroenterology. 1997 Dec;113(6):1983-91 [9394739.001]
  • [Cites] Gut. 1998 May;42(5):609-17 [9659152.001]
  • [Cites] Gastroenterology. 1998 Jul;115(1):58-66 [9649459.001]
  • [Cites] J Clin Microbiol. 1998 Aug;36(8):2258-63 [9666002.001]
  • [Cites] J Clin Microbiol. 1999 Apr;37(4):1203-5 [10074554.001]
  • [Cites] Gastroenterology. 1999 Aug;117(2):342-9 [10419915.001]
  • [Cites] Gene. 2004 Dec 8;343(1):165-72 [15563842.001]
  • [Cites] Nat Rev Microbiol. 2005 Apr;3(4):320-32 [15759043.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):833-48 [15825067.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9300-5 [15972330.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9661-6 [15980153.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51 [16027366.001]
  • [Cites] Helicobacter. 2005;10 Suppl 1:14-20 [16178966.001]
  • [Cites] Mol Biol Cell. 2005 Oct;16(10):4954-66 [16030249.001]
  • [Cites] Curr Opin Gastroenterol. 2005 Nov;21(6):653-9 [16220040.001]
  • [Cites] Cell Microbiol. 2006 Jan;8(1):97-106 [16367869.001]
  • [Cites] Infect Immun. 2006 Jan;74(1):273-81 [16368981.001]
  • [Cites] Gut. 2006 Jun;55(6):775-81 [16322107.001]
  • [Cites] Cancer Res. 2006 May 15;66(10):5111-20 [16707434.001]
  • [Cites] Clin Microbiol Rev. 2006 Jul;19(3):449-90 [16847081.001]
  • [Cites] Gut. 2006 Sep;55(9):1360-1; author reply 1361 [16905702.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2006;20(4):675-86 [16997152.001]
  • [Cites] J Infect Dis. 2006 Nov 15;194(10):1346-55 [17054063.001]
  • [Cites] J Biol Chem. 2006 Oct 27;281(43):32344-52 [16954210.001]
  • [Cites] Clin Gastroenterol Hepatol. 2007 Jan;5(1):49-58 [17157077.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):915-8 [17287725.001]
  • [Cites] J Biol Chem. 2007 Mar 2;282(9):6242-54 [17202133.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2007;21(2):205-14 [17382273.001]
  • [Cites] Gastroenterology. 2007 Mar;132(3):1024-38 [17383425.001]
  • [Cites] Gastroenterology. 2007 Apr;132(4):1309-19 [17408661.001]
  • (PMID = 20938460.001).
  • [ISSN] 1759-5053
  • [Journal-full-title] Nature reviews. Gastroenterology & hepatology
  • [ISO-abbreviation] Nat Rev Gastroenterol Hepatol
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / DK062813-08; United States / NIDDK NIH HHS / DK / R01 DK062813; United States / NIDDK NIH HHS / DK / DK62813; United States / NIDDK NIH HHS / DK / R01 DK062813-08
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Virulence Factors; 0 / cagA protein, Helicobacter pylori
  • [Other-IDs] NLM/ NIHMS305196; NLM/ PMC3137895
  •  go-up   go-down


27. Chen X, Xu C, Wang F, Shen S, Jia Y: [Prokaryotic expression and antigenicity of the CagA gene in Helicobacter pylori]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug;35(8):847-53

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To synthesize the specific CagA gene segment of the gastric cancer idiotype Helicobacter pylori (H. pylori), establish the prokaryotic expression system and identify the antigenicity sequence of recombination signals.
  • METHODS: We selected the CagA fragment which was related to gastric cancer in our earlier research.
  • The synthesized CagA gene was cut from the pUC57-CagA plasmid and then was carried by expression vector pET32a to be transformed into the host bacterium BL21 (DE3).
  • The host bacterium with pET32a-CagA was induced by IPTG to express fusion protein.
  • The host bacterium BL21 (DE3) containing pET32a-CagA could express CagA fusion protein after the IPTG induction.
  • Western blot showed that the fusion protein could be combined with the antibody of the whole bacterium of anti-H. pylori.
  • We hope to set the foundation for selecting the strain in H. pylori correlated to gastric cancer and corresponding therapy in clinical practice.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20818078.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Recombinant Fusion Proteins; 0 / cagA protein, Helicobacter pylori
  •  go-up   go-down


28. Suzuki H, Hibi T, Marshall BJ: Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol; 2007 Jan;42(1):1-15
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Similarly, the incidence of gastric cancer and other diseases related to H. pylori are likely to be greatly reduced in the near future.
  • Isolation of the spiral intragastric bacterium H. pylori totally reversed the false dogma that the stomach was sterile, and it taught us that chronic infectious disease can still exist in modern society.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2000 Mar 23;404(6776):398-402 [10746728.001]
  • [Cites] Gut. 2000 May;46(5):615-21 [10764703.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):52-6 [10896071.001]
  • [Cites] Lancet. 2000 May 13;355(9216):1665-9 [10905240.001]
  • [Cites] Gastroenterology. 2000 Nov;119(5):1191-202 [11054376.001]
  • [Cites] J Exp Med. 2000 Dec 4;192(11):1601-10 [11104802.001]
  • [Cites] J Clin Invest. 2001 Mar;107(5):611-20 [11238562.001]
  • [Cites] N Engl J Med. 2001 Mar 29;344(13):967-73 [11274623.001]
  • [Cites] Aliment Pharmacol Ther. 2001 May;15(5):699-702 [11328264.001]
  • [Cites] Helicobacter. 2001 Mar;6(1):60-5 [11328367.001]
  • [Cites] Lancet. 2001 Jun 2;357(9270):1738-42 [11403809.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2001 Jun;13(6):673-6 [11434593.001]
  • [Cites] J Microbiol Methods. 2001 Sep;46(3):235-40 [11438188.001]
  • [Cites] Hepatogastroenterology. 2001 May-Jun;48(39):614-7 [11462887.001]
  • [Cites] Jpn J Cancer Res. 2001 Aug;92(8):829-35 [11509113.001]
  • [Cites] N Engl J Med. 2001 Sep 13;345(11):784-9 [11556297.001]
  • [Cites] Gastroenterology. 2001 Oct;121(4):784-91 [11606491.001]
  • [Cites] Am J Gastroenterol. 2001 Oct;96(10):2829-38 [11693315.001]
  • [Cites] Dig Dis Sci. 2001 Nov;46(11):2440-4 [11713949.001]
  • [Cites] Lancet. 2002 Jan 5;359(9300):9-13 [11809180.001]
  • [Cites] Lancet. 2002 Jan 5;359(9300):14-22 [11809181.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] Dig Dis Sci. 2002 Jan;47(1):90-9 [11837740.001]
  • [Cites] Ann Intern Med. 2002 Feb 19;136(4):280-7 [11848725.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1999 Jan;28(1):116-9 [9890483.001]
  • [Cites] Gut. 1998 Aug;43(2):182-6 [10189841.001]
  • [Cites] Free Radic Biol Med. 1999 Mar;26(5-6):679-84 [10218657.001]
  • [Cites] Ann Intern Med. 1999 Nov 2;131(9):668-72 [10577329.001]
  • [Cites] Gastroenterology. 1954 Aug;27(2):218-20 [13183283.001]
  • [Cites] J Gastroenterol. 2004 Sep;39(9):827-30 [15565400.001]
  • [Cites] Science. 2004 Nov 26;306(5701):1568-71 [15567866.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Nov 15;20(10):1071-82 [15569109.001]
  • [Cites] Am J Surg Pathol. 2004 Dec;28(12):1560-7 [15577674.001]
  • [Cites] Cochrane Database Syst Rev. 2005;(1):CD002096 [15674892.001]
  • [Cites] Eur J Neurol. 2005 Feb;12(2):139-43 [15679702.001]
  • [Cites] Eur J Clin Invest. 2005 Mar;35(3):214-9 [15733077.001]
  • [Cites] Virchows Arch. 2005 Mar;446(3):219-24 [15742170.001]
  • [Cites] Platelets. 2005 Mar;16(2):117-9 [15823868.001]
  • [Cites] Am J Gastroenterol. 2005 May;100(5):1037-42 [15842576.001]
  • [Cites] Leuk Res. 2005 Jun;29(6):661-4 [15863206.001]
  • [Cites] Clin Cancer Res. 2005 May 1;11(9):3349-52 [15867234.001]
  • [Cites] FEMS Immunol Med Microbiol. 2005 May 1;44(2):163-9 [15866211.001]
  • [Cites] J Biol Chem. 2002 Mar 1;277(9):6775-8 [11788577.001]
  • [Cites] Mol Microbiol. 2001 Dec;42(5):1337-48 [11886563.001]
  • [Cites] Lancet Oncol. 2001 Sep;2(9):533-43 [11905707.001]
  • [Cites] BMJ. 2002 Apr 27;324(7344):1012-6 [11976244.001]
  • [Cites] Gastroenterology. 2002 May;122(5):1286-94 [11984515.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8354-9 [12060779.001]
  • [Cites] Science. 2002 Jul 26;297(5581):573-8 [12142529.001]
  • [Cites] N Engl J Med. 2002 Oct 10;347(15):1175-86 [12374879.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14428-33 [12391297.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14819-24 [12409607.001]
  • [Cites] J Natl Cancer Inst. 2002 Nov 20;94(22):1680-7 [12441323.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1793-803 [12454835.001]
  • [Cites] N Engl J Med. 1994 May 5;330(18):1267-71 [8145781.001]
  • [Cites] Ann Intern Med. 1994 Jun 15;120(12):977-81 [7741826.001]
  • [Cites] Keio J Med. 1994 Mar;43(1):1-8 [8189675.001]
  • [Cites] J Clin Pathol. 1994 May;47(5):436-9 [8027397.001]
  • [Cites] Aliment Pharmacol Ther. 1994 Aug;8(4):369-89 [7986962.001]
  • [Cites] N Engl J Med. 1995 Jan 19;332(3):139-42 [7800005.001]
  • [Cites] IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-240 [7715070.001]
  • [Cites] Arch Intern Med. 1995 May 8;155(9):922-8 [7726700.001]
  • [Cites] Lancet. 1995 Jun 17;345(8964):1525-8 [7791437.001]
  • [Cites] Gut. 1995 Jun;36(6):834-7 [7615269.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):17771-7 [7629077.001]
  • [Cites] Scand J Gastroenterol. 1995 May;30(5):401-7 [7638563.001]
  • [Cites] Aliment Pharmacol Ther. 1995;9 Suppl 2:45-51 [8547528.001]
  • [Cites] J Natl Cancer Inst. 1995 Dec 6;87(23):1777-80 [7473834.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S45-7 [8574735.001]
  • [Cites] Scand J Gastroenterol Suppl. 1995;210:70-2 [8578212.001]
  • [Cites] Gastroenterology. 1996 Apr;110(4):1244-52 [8613015.001]
  • [Cites] Am J Gastroenterol. 1996 Apr;91(4):690-4 [8677930.001]
  • [Cites] N Engl J Med. 1996 Jul 25;335(4):242-9 [8657240.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4501-7 [8890198.001]
  • [Cites] Aliment Pharmacol Ther. 1996 Oct;10(5):821-7 [8899093.001]
  • [Cites] Dig Dis Sci. 1997 Jan;42(1):103-5 [9009123.001]
  • [Cites] BMJ. 1997 Feb 22;314(7080):565-8 [9055715.001]
  • [Cites] Gut. 1997 Mar;40(3):297-301 [9135515.001]
  • [Cites] Gastroenterology. 1997 May;112(5):1442-7 [9136820.001]
  • [Cites] J Natl Cancer Inst. 1997 Jun 18;89(12):863-8 [9196252.001]
  • [Cites] Scand J Gastroenterol. 1997 Jun;32(6):617-22 [9200297.001]
  • [Cites] Am J Gastroenterol. 1997 Sep;92(9):1480-2 [9317067.001]
  • [Cites] Gastroenterology. 1997 Dec;113(6 Suppl):S67-77 [9394764.001]
  • [Cites] Helicobacter. 1996 Sep;1(3):138-44 [9398894.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Feb 1;19(3):349-58 [14984382.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17205-16 [14963045.001]
  • [Cites] BMJ. 2004 Jun 12;328(7453):1417 [15126313.001]
  • [Cites] Mol Microbiol. 2004 Jul;53(2):623-38 [15228539.001]
  • [Cites] Gut. 2004 Sep;53(9):1244-9 [15306578.001]
  • [Cites] Br J Cancer. 2004 Aug 31;91(5):929-34 [15280918.001]
  • [Cites] Hepatogastroenterology. 2004 Sep-Oct;51(59):1249-54 [15362725.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Oct 1;20(7):733-44 [15379833.001]
  • [Cites] J Natl Cancer Inst. 1976 Nov;57(5):1027-35 [1003539.001]
  • [Cites] Lancet. 1983 Jun 4;1(8336):1273-5 [6134060.001]
  • [Cites] Lancet. 1984 Jun 16;1(8390):1311-5 [6145023.001]
  • [Cites] J Biol Chem. 1984 Aug 25;259(16):10404-13 [6381484.001]
  • [Cites] Int J Cancer. 1985 Feb 15;35(2):173-7 [3871738.001]
  • [Cites] Med J Aust. 1985 Apr 15;142(8):436-9 [3982345.001]
  • [Cites] Med J Aust. 1985 Apr 15;142(8):439-44 [3982346.001]
  • [Cites] Am J Gastroenterol. 1987 Mar;82(3):200-10 [3548326.001]
  • [Cites] Lancet. 1988 Dec 24-31;2(8626-8627):1437-42 [2904568.001]
  • [Cites] Biochem Biophys Res Commun. 1989 Aug 15;162(3):1578-84 [2788416.001]
  • [Cites] Lancet. 1990 May 26;335(8700):1233-5 [1971318.001]
  • [Cites] Int J Cancer. 1990 Oct 15;46(4):608-11 [2210881.001]
  • [Cites] FEBS Lett. 1991 Apr 9;281(1-2):9-19 [1849843.001]
  • [Cites] Gastroenterology. 1991 Jun;100(6):1495-501 [2019355.001]
  • [Cites] J Exp Med. 1992 Feb 1;175(2):517-25 [1732414.001]
  • [Cites] Gut. 1992 Aug;33(8):1020-3 [1398224.001]
  • [Cites] J Gastroenterol Hepatol. 1999 Nov;14(11):1062-9 [10574132.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Jan;14(1):45-51 [10632644.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1263-8 [10655519.001]
  • [Cites] Am J Gastroenterol. 2000 Mar;95(3):659-69 [10710054.001]
  • [Cites] Gastroenterology. 1998 Sep;115(3):642-8 [9721161.001]
  • [Cites] Am J Gastroenterol. 1998 Sep;93(9):1409-15 [9732917.001]
  • [Cites] Lancet. 1998 Sep 12;352(9131):878 [9742983.001]
  • [Cites] Lancet. 1998 Sep 26;352(9133):1016-21 [9759744.001]
  • [Cites] Cancer Res. 1998 Oct 1;58(19):4255-9 [9766647.001]
  • [Cites] Dev Biol. 1998 Dec 1;204(1):124-35 [9851847.001]
  • [Cites] Keio J Med. 2002 Dec;51 Suppl 2:2-3 [12528927.001]
  • [Cites] Keio J Med. 2002 Dec;51 Suppl 2:33-7 [12528934.001]
  • [Cites] Arch Dis Child. 2003 Feb;88(2):178 [12538339.001]
  • [Cites] J Biol Chem. 2003 Feb 7;278(6):3664-70 [12446738.001]
  • [Cites] Nihon Rinsho. 2003 Jan;61(1):119-24 [12607328.001]
  • [Cites] Eur J Pediatr. 2003 Mar;162(3):177-9 [12655422.001]
  • [Cites] J Natl Cancer Inst. 2003 Apr 2;95(7):E3 [12671026.001]
  • [Cites] BMJ. 2003 Apr 5;326(7392):737 [12676842.001]
  • [Cites] J Exp Med. 2003 Apr 7;197(7):813-22 [12668646.001]
  • [Cites] Helicobacter. 2003 Jun;8(3):227-34 [12752735.001]
  • [Cites] Cell Microbiol. 2003 Jun;5(6):395-404 [12780777.001]
  • [Cites] Microbes Infect. 2003 Jul;5(8):705-13 [12814771.001]
  • [Cites] J Infect Dis. 2003 Jul 15;188(2):272-81 [12854083.001]
  • [Cites] Gastroenterology. 2003 Aug;125(2):364-71 [12891537.001]
  • [Cites] Keio J Med. 2003 Sep;52(3):163-73 [14529149.001]
  • [Cites] J Am Acad Dermatol. 2003 Nov;49(5):861-4 [14576665.001]
  • [Cites] Helicobacter. 2003 Dec;8(6):573-7 [14632670.001]
  • [Cites] Gut. 2004 Jan;53(1):12-20 [14684569.001]
  • [Cites] Gut. 2004 Jan;53(1):34-7 [14684573.001]
  • [Cites] Trends Microbiol. 2004 Jan;12(1):29-36 [14700549.001]
  • [Cites] Int J Hematol. 2003 Dec;78(5):429-31 [14704035.001]
  • [Cites] JAMA. 2004 Jan 14;291(2):187-94 [14722144.001]
  • [Cites] JAMA. 2004 Jan 14;291(2):244-5 [14722152.001]
  • [Cites] Gut. 2004 Feb;53(2):187-94 [14724148.001]
  • [Cites] N Engl J Med. 2004 Jan 15;350(3):213-5 [14724298.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 Feb;38(2):146-51 [14734875.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):4-10 [14744726.001]
  • [Cites] J Clin Invest. 2004 Feb;113(3):321-33 [14755326.001]
  • [Cites] Am J Physiol. 1992 Nov;263(5 Pt 1):G719-25 [1443147.001]
  • [Cites] N Engl J Med. 1993 Feb 4;328(5):308-12 [8419816.001]
  • [Cites] J Bacteriol. 1993 Feb;175(3):674-83 [7678592.001]
  • [Cites] Lancet. 1993 May 29;341(8857):1359-62 [8098787.001]
  • [Cites] Lancet. 1993 Aug 7;342(8867):328-31 [8101585.001]
  • [Cites] Gut. 1993 Oct;34(10):1339-43 [8244098.001]
  • [Cites] N Engl J Med. 1998 Mar 19;338(12):804-10 [9504941.001]
  • [Cites] J Gastroenterol Hepatol. 1998 May;13(5):516-20 [9641651.001]
  • [Cites] Ital J Gastroenterol Hepatol. 1997 Jun;29(3):220-7 [9646213.001]
  • [Cites] Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:25-36 [9701002.001]
  • [Cites] J Pathol. 2005 Jun;206(2):186-97 [15818572.001]
  • [Cites] Gastroenterology. 2005 May;128(5):1229-42 [15887107.001]
  • [Cites] Gastroenterology. 2005 Jun;128(7):1838-44 [15940619.001]
  • [Cites] Cancer. 2005 Aug 1;104(3):532-40 [15937928.001]
  • [Cites] Gut. 2005 Nov;54(11):1536-40 [15985559.001]
  • [Cites] Cochrane Database Syst Rev. 2005;(4):CD001961 [16235292.001]
  • [Cites] J Clin Oncol. 2005 Nov 1;23(31):8018-24 [16204012.001]
  • [Cites] Am J Gastroenterol. 2006 Feb;101(2):243-7 [16454825.001]
  • [Cites] Curr Opin Microbiol. 2006 Feb;9(1):21-7 [16406776.001]
  • [Cites] Neurology. 2006 Mar 28;66(6):938-40 [16567719.001]
  • [Cites] Antimicrob Agents Chemother. 2006 Apr;50(4):1538-40 [16569878.001]
  • [Cites] Cochrane Database Syst Rev. 2006;(2):CD003840 [16625592.001]
  • [Cites] Gastroenterology. 2006 Apr;130(5):1377-90 [16678553.001]
  • [Cites] Gastroenterology. 2006 Apr;130(5):1466-79 [16678560.001]
  • [Cites] Helicobacter. 2006 Jun;11(3):152-8 [16684262.001]
  • [Cites] Am Heart J. 2006 Jun;151(6):1215-22 [16781222.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1341-7 [16835334.001]
  • [Cites] J Gastroenterol. 2006 Jun;41(6):513-23 [16868798.001]
  • [Cites] Haematologica. 2006 Oct;91(10):1436-7 [16963398.001]
  • [Cites] Int J Hematol. 2006 Nov;84(4):291-300 [17118754.001]
  • [Cites] J Clin Microbiol. 2007 Feb;45(2):303-5 [17122023.001]
  • [Cites] Hepatogastroenterology. 2007 Apr-May;54(75):697-700 [17591044.001]
  • (PMID = 17322988.001).
  • [ISSN] 0944-1174
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal
  • [Number-of-references] 184
  • [Other-IDs] NLM/ PMC2780612
  •  go-up   go-down


29. Raz I, Gollop N, Polak-Charcon S, Schwartz B: Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Br J Nutr; 2007 Apr;97(4):725-34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The novel isolated bacterium was obtained from human faeces and grown in selective liquid intestinal microflora medium containing rumen fluid under microaerobic conditions.
  • Its probiotic properties were demonstrated by the ability of the isolate to survive high acidity and medium containing bile acids and the ability to adhere to colon cancer cells (Caco-2) in vitro.
  • Administration of E. durans ameliorated histological, clinical and biochemical scores directly related to intestinal inflammation whereas the lactic acid bacterium Lactobacillus delbrueckii was ineffective in this regard.
  • The novel isolated bacterium described in the present paper, upon further characterisation, can be developed into a useful probiotic aimed at the treatment of patients suffering from ulcerative colitis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17349085.001).
  • [ISSN] 0007-1145
  • [Journal-full-title] The British journal of nutrition
  • [ISO-abbreviation] Br. J. Nutr.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Butyrates; 9042-14-2 / Dextran Sulfate
  •  go-up   go-down


30. Bui TN, Vernière C, Jarne P, Brisse S, Guérin F, Boutry S, Gagnevin L, Pruvost O: From local surveys to global surveillance: three high-throughput genotyping methods for epidemiological monitoring of Xanthomonas citri pv. citri pathotypes. Appl Environ Microbiol; 2009 Feb;75(4):1173-84

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Analysis of the molecular epidemiology of this bacterium is hindered by a lack of molecular typing techniques suitable for surveillance and outbreak investigation.
  • The typing techniques were congruent in describing the diversity of this strain collection, suggesting that the evolution pattern of the bacterium may be clonal.
  • This technique may be useful for the global surveillance of non-epidemiologically related strains.
  • Although pathological characteristics of strains could be most often predicted from genotyping data, we report the occurrence in the Indian peninsula of strains genetically related to pathotype A* strains but with a host range similar to that of pathotype A, which makes the classification of this bacterium even more complicated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Microbes Infect. 2002 Nov;4(13):1361-7 [12443901.001]
  • [Cites] J Clin Microbiol. 2002 Nov;40(11):4072-6 [12409377.001]
  • [Cites] Genetics. 2003 Aug;164(4):1567-87 [12930761.001]
  • [Cites] J Bacteriol. 2004 Mar;186(5):1518-30 [14973027.001]
  • [Cites] Infect Genet Evol. 2004 Sep;4(3):205-13 [15450200.001]
  • [Cites] Cancer Res. 1967 Feb;27(2):209-20 [6018555.001]
  • [Cites] Mol Biol Evol. 1987 Jul;4(4):406-25 [3447015.001]
  • [Cites] J Clin Microbiol. 1988 Nov;26(11):2465-6 [3069867.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 May 15;90(10):4384-8 [8506277.001]
  • [Cites] Mol Ecol. 1994 Apr;3(2):91-9 [8019690.001]
  • [Cites] Genetics. 1995 Jan;139(1):457-62 [7705646.001]
  • [Cites] Nucleic Acids Res. 1995 Nov 11;23(21):4407-14 [7501463.001]
  • [Cites] Genetics. 1997 Apr;145(4):1219-28 [9093870.001]
  • [Cites] Mol Biol Evol. 1998 May;15(5):538-43 [9580982.001]
  • [Cites] Infect Control Hosp Epidemiol. 1998 Aug;19(8):565-9 [9758056.001]
  • [Cites] Res Microbiol. 1999 Jan-Feb;150(1):33-44 [10096132.001]
  • [Cites] J Clin Microbiol. 2005 Jan;43(1):314-20 [15634988.001]
  • [Cites] Mol Ecol. 2005 Jul;14(8):2611-20 [15969739.001]
  • [Cites] Electrophoresis. 2005 Jun;26(13):2567-82 [15937984.001]
  • [Cites] Syst Appl Microbiol. 2005 Aug;28(6):494-518 [16104350.001]
  • [Cites] J Clin Microbiol. 2005 Nov;43(11):5628-38 [16272496.001]
  • [Cites] J Clin Microbiol. 2006 Jun;44(6):1951-62 [16757584.001]
  • [Cites] Syst Appl Microbiol. 2006 Dec;29(8):690-5 [17183629.001]
  • [Cites] Appl Environ Microbiol. 2007 Mar;73(5):1612-21 [17220258.001]
  • [Cites] Int J Syst Evol Microbiol. 2007 May;57(Pt 5):893-7 [17473228.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 May 15;104(20):8472-7 [17485665.001]
  • [Cites] Mol Plant Microbe Interact. 2007 Aug;20(8):934-43 [17722697.001]
  • [Cites] Appl Environ Microbiol. 2007 Nov;73(21):6790-801 [17720825.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18427-32 [17998540.001]
  • [Cites] Phytopathology. 2008 Aug;98(8):919-25 [18943210.001]
  • [Cites] FEMS Microbiol Lett. 2008 Nov;288(1):33-9 [18771421.001]
  • [Cites] Int J Syst Evol Microbiol. 2009 Feb;59(Pt 2):306-18 [19196770.001]
  • [Cites] Bioinformatics. 2012 Oct 1;28(19):2537-9 [22820204.001]
  • [Cites] Int J Syst Evol Microbiol. 2000 Mar;50 Pt 2:665-77 [10758874.001]
  • [Cites] Genetics. 2000 Jun;155(2):945-59 [10835412.001]
  • [Cites] Annu Rev Microbiol. 2000;54:641-79 [11018140.001]
  • [Cites] Clin Microbiol Rev. 2001 Jul;14(3):547-60 [11432813.001]
  • [Cites] J Med Microbiol. 2002 Jan;51(1):7-10 [11800474.001]
  • [Cites] Mol Ecol. 2002 Feb;11(2):155-65 [11856418.001]
  • [Cites] Appl Environ Microbiol. 2002 Mar;68(3):1257-64 [11872476.001]
  • [Cites] Mol Ecol. 2002 Jan;11(1):139-51 [11903911.001]
  • [Cites] Nature. 2002 May 23;417(6887):459-63 [12024217.001]
  • [Cites] Appl Environ Microbiol. 2002 Dec;68(12):5796-803 [12450798.001]
  • (PMID = 19088309.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Bacterial
  • [Other-IDs] NLM/ PMC2643580
  •  go-up   go-down


31. Conners R, Hill DJ, Borodina E, Agnew C, Daniell SJ, Burton NM, Sessions RB, Clarke AR, Catto LE, Lammie D, Wess T, Brady RL, Virji M: The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled-coil. EMBO J; 2008 Jun 18;27(12):1779-89
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Moraxella catarrhalis is a ubiquitous human-specific bacterium commonly associated with upper and lower respiratory tract infections, including otitis media, sinusitis and chronic obstructive pulmonary disease.
  • The bacterium uses an autotransporter protein UspA1 to target an important human cellular receptor carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1).

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 2005 Mar;55(5):1515-27 [15720557.001]
  • [Cites] J Bacteriol. 1999 Jul;181(13):4026-34 [10383971.001]
  • [Cites] Infect Immun. 2000 Jun;68(6):3554-63 [10816511.001]
  • [Cites] Microbes Infect. 2000 Apr;2(5):547-59 [10865200.001]
  • [Cites] EMBO J. 2000 Nov 15;19(22):5989-99 [11080146.001]
  • [Cites] J Mol Biol. 2001 Apr 13;307(5):1427-50 [11292353.001]
  • [Cites] Blood. 2001 Sep 1;98(5):1469-79 [11520797.001]
  • [Cites] Infect Immun. 2005 Apr;73(4):2400-10 [15784586.001]
  • [Cites] Virology. 2005 May 10;335(2):276-85 [15840526.001]
  • [Cites] Biophys J. 2005 Aug;89(2):1237-50 [15923225.001]
  • [Cites] J Infect Dis. 2005 Sep 15;192(6):1029-38 [16107956.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3375-80 [16488979.001]
  • [Cites] J Mol Biol. 2006 Mar 31;357(3):890-903 [16460758.001]
  • [Cites] EMBO J. 2006 Jun 7;25(11):2297-304 [16688217.001]
  • [Cites] Trends Microbiol. 2006 Jun;14(6):264-70 [16678419.001]
  • [Cites] J Infect Dis. 2006 Aug 15;194(4):493-7 [16845633.001]
  • [Cites] Int J Biol Macromol. 2006 Aug 15;39(1-3):3-9 [16405993.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):971-9 [16929097.001]
  • [Cites] J Struct Biol. 2006 Aug;155(2):154-61 [16675268.001]
  • [Cites] Infect Immun. 2006 Nov;74(11):6163-70 [17057091.001]
  • [Cites] Cell Microbiol. 2007 Feb;9(2):329-46 [16953805.001]
  • [Cites] Cell Microbiol. 2007 Dec;9(12):2968-83 [17764466.001]
  • [Cites] Mol Microbiol. 2008 Jan;67(2):420-34 [18086185.001]
  • [Cites] Mol Microbiol. 1999 Nov;34(3):538-51 [10564495.001]
  • [Cites] FEMS Microbiol Lett. 2002 Jan 2;206(1):81-6 [11786261.001]
  • [Cites] Proteins. 2003 Feb 15;50(3):437-50 [12557186.001]
  • [Cites] Mol Microbiol. 2003 Apr;48(1):117-29 [12657049.001]
  • [Cites] EMBO J. 2004 Feb 25;23(4):701-11 [14765110.001]
  • [Cites] EMBO J. 2004 Mar 24;23(6):1257-66 [15014442.001]
  • [Cites] EMBO J. 2004 Mar 24;23(6):1245-56 [15029242.001]
  • [Cites] J Immunol. 2004 Oct 1;173(7):4598-606 [15383594.001]
  • [Cites] Proc Natl Acad Sci U S A. 1967 Jul;58(1):45-51 [5231618.001]
  • [Cites] Nature. 1981 Jan 29;289(5796):366-73 [7464906.001]
  • [Cites] Infect Immun. 1991 Jun;59(6):2051-7 [1674739.001]
  • [Cites] J Virol. 1993 Jan;67(1):1-8 [8380065.001]
  • [Cites] Nature. 1994 Sep 1;371(6492):37-43 [8072525.001]
  • [Cites] Nat Struct Biol. 1994 Nov;1(11):789-94 [7634089.001]
  • [Cites] Nat Struct Biol. 1996 May;3(5):465-9 [8612078.001]
  • [Cites] Trends Biochem Sci. 1996 Oct;21(10):375-82 [8918191.001]
  • [Cites] Mol Microbiol. 1996 Dec;22(5):929-39 [8971714.001]
  • [Cites] Nature. 1997 May 29;387(6632):527-30 [9168119.001]
  • [Cites] Structure. 1997 Jun 15;5(6):789-98 [9261070.001]
  • [Cites] Infect Immun. 1998 Jul;66(7):3113-9 [9632574.001]
  • [Cites] Semin Cancer Biol. 1999 Apr;9(2):67-81 [10202129.001]
  • [Cites] Biophys J. 1999 Jun;76(6):2879-86 [10354416.001]
  • [Cites] J Bacteriol. 2000 Mar;182(5):1364-73 [10671460.001]
  • (PMID = 18497748.001).
  • [ISSN] 1460-2075
  • [Journal-full-title] The EMBO journal
  • [ISO-abbreviation] EMBO J.
  • [Language] eng
  • [Databank-accession-numbers] PDB/ 2QIH
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BB/F007256/1; United Kingdom / Medical Research Council / / G0500367; United Kingdom / Medical Research Council / / G0501013; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adhesins, Bacterial; 0 / Antigens, CD; 0 / Bacterial Outer Membrane Proteins; 0 / CD66 antigens; 0 / Cell Adhesion Molecules; 0 / Receptors, Cell Surface; 0 / UspA protein, Moraxella catarrhalis; 0 / adhesin, Moraxella
  • [Other-IDs] NLM/ PMC2396876
  •  go-up   go-down


32. Kobayashi M, Lee H, Nakayama J, Fukuda M: Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology; 2009 May;19(5):453-61
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori is a Gram-negative bacterium that infects over 50% of the world's population.
  • This organism causes various gastric diseases such as chronic gastritis, peptic ulcer, and gastric cancer. H. pylori possesses lipopolysaccharides that share structural similarity to Lewis blood group antigens in gastric mucosa.
  • On the other hand, H. pylori colonizes gastric mucosa by utilizing adhesins that bind Lewis blood group antigen-related carbohydrates expressed on gastric epithelial cells.
  • These findings show that distinct sets of carbohydrates expressed in the stomach are closely associated with pathogenesis and prevention of H. pylori-related diseases, providing therapeutic potentialities based on specific carbohydrate modulation.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2000 Dec 1;19(23):6361-70 [11101509.001]
  • [Cites] Trends Microbiol. 2000 Dec;8(12):565-70 [11115753.001]
  • [Cites] J Autoimmun. 2001 May;16(3):241-56 [11334489.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22032-40 [11283017.001]
  • [Cites] Cancer. 1984 Jun 1;53(11):2515-24 [6424928.001]
  • [Cites] Lancet. 1984 Jun 16;1(8390):1311-5 [6145023.001]
  • [Cites] Int J Cancer. 1985 Feb 15;35(2):173-7 [3871738.001]
  • [Cites] Med J Aust. 1985 Apr 15;142(8):436-9 [3982345.001]
  • [Cites] J Immunol. 1987 Feb 1;138(3):713-9 [3543117.001]
  • [Cites] J Cell Biol. 1988 Nov;107(5):1853-62 [2460470.001]
  • [Cites] J Clin Endocrinol Metab. 1989 Apr;68(4):744-51 [2466043.001]
  • [Cites] J Rheumatol. 1990 Jan;17(1):11-7 [2313659.001]
  • [Cites] J Biol Chem. 1995 May 19;270(20):12035-47 [7538131.001]
  • [Cites] FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):271-80 [7773243.001]
  • [Cites] J Bacteriol. 1995 Sep;177(18):5327-33 [7665522.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1259-64 [8577751.001]
  • [Cites] J Bacteriol. 1996 Apr;178(7):2065-70 [8606185.001]
  • [Cites] J Pathol. 1996 Feb;178(2):122-7 [8683376.001]
  • [Cites] Int J Cancer. 1997 Feb 20;74(1):112-21 [9036879.001]
  • [Cites] Nature. 1997 Aug 7;388(6642):539-47 [9252185.001]
  • [Cites] Clin Microbiol Rev. 1997 Oct;10(4):720-41 [9336670.001]
  • [Cites] Science. 1998 Jan 16;279(5349):373-7 [9430586.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7 [9642161.001]
  • [Cites] Gastroenterology. 1998 Aug;115(2):340-7 [9679039.001]
  • [Cites] J Infect Dis. 1998 Sep;178(3):717-21 [9728540.001]
  • [Cites] Nature. 1999 Jan 14;397(6715):176-80 [9923682.001]
  • [Cites] Biophys J. 1999 Mar;76(3):1401-9 [10049322.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2001-6 [10051584.001]
  • [Cites] Cancer Res. 1999 Mar 1;59(5):1003-7 [10070955.001]
  • [Cites] Science. 1999 May 21;284(5418):1328-33 [10334982.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8991-6 [10430883.001]
  • [Cites] EMBO J. 1999 Oct 15;18(20):5517-27 [10523296.001]
  • [Cites] Acta Pathol Microbiol Scand. 1965;64:31-49 [14320675.001]
  • [Cites] Dig Dis Sci. 2004 Oct;49(10):1598-606 [15573912.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17807-12 [15591109.001]
  • [Cites] BMC Immunol. 2005;6:6 [15752429.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1579-605 [15887153.001]
  • [Cites] J Biol Chem. 2005 May 20;280(20):19695-703 [15743770.001]
  • [Cites] Glycobiology. 2006 Jan;16(1):1-10 [16118287.001]
  • [Cites] Cell. 2005 Dec 16;123(6):975-6 [16360024.001]
  • [Cites] Nat Med. 2006 Sep;12(9):1030-8 [16951684.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Nov 3;349(4):1235-41 [16978585.001]
  • [Cites] Helicobacter. 2008 Apr;13(2):81-93 [18321298.001]
  • [Cites] J Clin Invest. 2008 Jun;118(6):2325-36 [18483624.001]
  • [Cites] Glycobiology. 2008 Jul;18(7):549-58 [18458030.001]
  • [Cites] Lancet. 1990 May 26;335(8700):1233-5 [1971318.001]
  • [Cites] Arch Intern Med. 1990 Nov;150(11):2347-8 [2241444.001]
  • [Cites] Histochem J. 1991 Jan;23(1):22-8 [1718927.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10570-5 [1587837.001]
  • [Cites] J Med Microbiol. 1992 Dec;37(6):389-95 [1460658.001]
  • [Cites] Mol Microbiol. 1993 Jan;7(2):323-7 [8446034.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791-5 [8516329.001]
  • [Cites] Scand J Gastroenterol Suppl. 1993;196:3-6 [8341988.001]
  • [Cites] Gut. 1993 Dec;34(12):1672-6 [8282253.001]
  • [Cites] Gastroenterology. 1994 Mar;106(3):596-605 [8119529.001]
  • [Cites] Lancet. 1995 Mar 25;345(8952):798-9 [7891510.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12778-83 [10535999.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1316-25 [10579973.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14559-64 [10588744.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6124-31 [10626802.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1263-8 [10655519.001]
  • [Cites] J Histochem Cytochem. 2000 Mar;48(3):377-88 [10681391.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1497-500 [10688800.001]
  • [Cites] Mol Microbiol. 2000 Mar;35(6):1530-9 [10760152.001]
  • [Cites] Mol Microbiol. 2000 Jun;36(6):1187-96 [10931272.001]
  • [Cites] N Engl J Med. 2000 Oct 5;343(14):1020-34 [11018170.001]
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):559-78 [11030073.001]
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):579-92, v-vi [11030074.001]
  • [Cites] Lancet. 2008 Aug 2;372(9636):350-2 [18675670.001]
  • [Cites] Nat Immunol. 2007 Apr;8(4):409-18 [17334369.001]
  • [Cites] Am J Gastroenterol. 2007 Jul;102(7):1499-509 [17459027.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8 [18192401.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Mar;23(3):351-65 [18318820.001]
  • [Cites] Lancet. 2008 Aug 2;372(9636):392-7 [18675689.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G806-12 [18719000.001]
  • [Cites] J Exp Med. 2000 Feb 21;191(4):593-602 [10684851.001]
  • [Cites] Cell. 2001 Jun 29;105(7):957-69 [11439191.001]
  • [Cites] Infect Immun. 2001 Aug;69(8):5080-7 [11447189.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):971-7 [11535550.001]
  • [Cites] Toxicon. 2001 Nov;39(11):1757-67 [11595638.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):28-37 [11902583.001]
  • [Cites] Lancet Oncol. 2001 Sep;2(9):533-43 [11905707.001]
  • [Cites] Biochem J. 2002 May 15;364(Pt 1):191-200 [11988092.001]
  • [Cites] Science. 2002 Jul 26;297(5581):573-8 [12142529.001]
  • [Cites] J Biol Chem. 2002 Sep 13;277(37):34642-50 [12121984.001]
  • [Cites] Nat Genet. 2003 Mar;33(3):375-81 [12598897.001]
  • [Cites] J Exp Med. 2003 May 5;197(9):1153-63 [12732657.001]
  • [Cites] Science. 2003 Aug 22;301(5636):1099-102 [12934009.001]
  • [Cites] Helicobacter. 2003;8(5):521-32 [14535999.001]
  • [Cites] J Biol Chem. 2003 Nov 28;278(48):48204-9 [13129933.001]
  • [Cites] Annu Rev Immunol. 2004;22:129-56 [15032576.001]
  • [Cites] Science. 2004 Jul 23;305(5683):519-22 [15273394.001]
  • [Cites] Science. 2004 Aug 13;305(5686):1003-6 [15310903.001]
  • [Cites] Lancet. 1983 Jun 4;1(8336):1273-5 [6134060.001]
  • (PMID = 19150806.001).
  • [ISSN] 1460-2423
  • [Journal-full-title] Glycobiology
  • [ISO-abbreviation] Glycobiology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA33000; United States / NCI NIH HHS / CA / CA71932
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adhesins, Bacterial; 0 / Lipopolysaccharides; 0 / Mucin-2; 0 / O Antigens; 0 / Oligosaccharides; 0 / Polysaccharides; 0 / sialyl-2-3-(6'-sulfo)galactosyl-1-4-(fucopyranosyl-1-3)-N-acetylglucosamine; 126880-86-2 / L-Selectin
  • [Number-of-references] 100
  • [Other-IDs] NLM/ PMC2667159
  •  go-up   go-down


33. Kobayashi M, Lee H, Nakayama J, Fukuda M: Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection. Curr Drug Metab; 2009 Jan;10(1):29-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori is a Gram-negative bacterium that infects over 50% of the world's population.
  • This organism causes various gastric diseases such as chronic gastritis, peptic ulcer, and gastric cancer. H. pylori possesses lipopolysaccharide, which shares structural similarity to Lewis blood group antigens in gastric mucosa.
  • On the other hand, H. pylori colonize gastric mucosa by utilizing adhesins, which bind Lewis blood group antigen-related carbohydrates expressed on gastric epithelial cells.
  • These findings show that a battery of carbohydrates expressed in the stomach is closely associated with pathogenesis and also prevention of H. pylori-related diseases.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):579-92, v-vi [11030074.001]
  • [Cites] EMBO J. 2000 Dec 1;19(23):6361-70 [11101509.001]
  • [Cites] Trends Microbiol. 2000 Dec;8(12):565-70 [11115753.001]
  • [Cites] Aliment Pharmacol Ther. 2001 May;15(5):715-25 [11328267.001]
  • [Cites] J Autoimmun. 2001 May;16(3):241-56 [11334489.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22032-40 [11283017.001]
  • [Cites] J Clin Pathol. 2001 Jul;54(7):521-5 [11429423.001]
  • [Cites] Cell. 2001 Jun 29;105(7):957-69 [11439191.001]
  • [Cites] Infect Immun. 2001 Aug;69(8):5080-7 [11447189.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):971-7 [11535550.001]
  • [Cites] Gut. 2001 Oct;49(4):474-80 [11559642.001]
  • [Cites] Toxicon. 2001 Nov;39(11):1757-67 [11595638.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] Helicobacter. 2002 Feb;7(1):39-45 [11886472.001]
  • [Cites] Lancet Oncol. 2001 Sep;2(9):533-43 [11905707.001]
  • [Cites] J Pathol. 2002 May;197(1):37-43 [12081201.001]
  • [Cites] Science. 2002 Jul 26;297(5581):573-8 [12142529.001]
  • [Cites] J Biol Chem. 2002 Sep 13;277(37):34642-50 [12121984.001]
  • [Cites] Nat Genet. 2003 Mar;33(3):375-81 [12598897.001]
  • [Cites] Science. 2003 Aug 22;301(5636):1099-102 [12934009.001]
  • [Cites] J Biol Chem. 2003 Nov 28;278(48):48204-9 [13129933.001]
  • [Cites] Annu Rev Immunol. 2004;22:129-56 [15032576.001]
  • [Cites] Science. 2004 Jul 23;305(5683):519-22 [15273394.001]
  • [Cites] Science. 2004 Aug 13;305(5686):1003-6 [15310903.001]
  • [Cites] Lancet. 1983 Jun 4;1(8336):1273-5 [6134060.001]
  • [Cites] Cancer. 1984 Jun 1;53(11):2515-24 [6424928.001]
  • [Cites] Lancet. 1984 Jun 16;1(8390):1311-5 [6145023.001]
  • [Cites] Cell. 1984 Dec;39(2 Pt 1):295-9 [6498937.001]
  • [Cites] Int J Cancer. 1985 Feb 15;35(2):173-7 [3871738.001]
  • [Cites] Med J Aust. 1985 Apr 15;142(8):436-9 [3982345.001]
  • [Cites] J Immunol. 1987 Feb 1;138(3):713-9 [3543117.001]
  • [Cites] J Cell Biol. 1988 Nov;107(5):1853-62 [2460470.001]
  • [Cites] J Clin Endocrinol Metab. 1989 Apr;68(4):744-51 [2466043.001]
  • [Cites] J Rheumatol. 1990 Jan;17(1):11-7 [2313659.001]
  • [Cites] Arch Intern Med. 1990 Nov;150(11):2347-8 [2241444.001]
  • [Cites] Histochem J. 1991 Jan;23(1):22-8 [1718927.001]
  • [Cites] Gastroenterology. 1992 Jan;102(1):41-6 [1727779.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10570-5 [1587837.001]
  • [Cites] Gut. 1992 May;33(5):597-600 [1612473.001]
  • [Cites] J Biol Chem. 1992 Sep 25;267(27):19248-57 [1527047.001]
  • [Cites] J Med Microbiol. 1992 Dec;37(6):389-95 [1460658.001]
  • [Cites] Mol Microbiol. 1993 Jan;7(2):323-7 [8446034.001]
  • [Cites] J Infect Dis. 1993 Jul;168(1):219-21 [8515114.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791-5 [8516329.001]
  • [Cites] Scand J Gastroenterol Suppl. 1993;196:3-6 [8341988.001]
  • [Cites] Gut. 1993 Dec;34(12):1672-6 [8282253.001]
  • [Cites] Gut. 1993 Dec;34(12):1681-2 [8282255.001]
  • [Cites] Gastroenterology. 1994 Mar;106(3):596-605 [8119529.001]
  • [Cites] J Clin Microbiol. 1994 May;32(5):1238-45 [8051250.001]
  • [Cites] J Biol Chem. 1995 May 19;270(20):12035-47 [7538131.001]
  • [Cites] FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):271-80 [7773243.001]
  • [Cites] J Bacteriol. 1995 Sep;177(18):5327-33 [7665522.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1259-64 [8577751.001]
  • [Cites] J Bacteriol. 1996 Apr;178(7):2065-70 [8606185.001]
  • [Cites] Am J Surg Pathol. 1996 Oct;20(10):1161-81 [8827022.001]
  • [Cites] J Biol Chem. 1996 Dec 27;271(52):33325-34 [8969192.001]
  • [Cites] Int J Cancer. 1997 Feb 20;74(1):112-21 [9036879.001]
  • [Cites] Infect Immun. 1997 May;65(5):1962-6 [9125590.001]
  • [Cites] Nature. 1997 Aug 7;388(6642):539-47 [9252185.001]
  • [Cites] Clin Diagn Lab Immunol. 1997 Sep;4(5):540-4 [9302202.001]
  • [Cites] Science. 1998 Jan 16;279(5349):373-7 [9430586.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7 [9642161.001]
  • [Cites] J Infect Dis. 1998 Sep;178(3):717-21 [9728540.001]
  • [Cites] Nature. 1999 Jan 14;397(6715):176-80 [9923682.001]
  • [Cites] Biophys J. 1999 Mar;76(3):1401-9 [10049322.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2001-6 [10051584.001]
  • [Cites] Cancer Res. 1999 Mar 1;59(5):1003-7 [10070955.001]
  • [Cites] J Biol Chem. 1999 May 7;274(19):13048-59 [10224056.001]
  • [Cites] Science. 1999 May 21;284(5418):1328-33 [10334982.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8991-6 [10430883.001]
  • [Cites] EMBO J. 1999 Oct 15;18(20):5517-27 [10523296.001]
  • [Cites] Acta Pathol Microbiol Scand. 1965;64:31-49 [14320675.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17807-12 [15591109.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1579-605 [15887153.001]
  • [Cites] Cell. 2005 Dec 16;123(6):975-6 [16360024.001]
  • [Cites] J Histochem Cytochem. 2006 May;54(5):585-91 [16618943.001]
  • [Cites] PLoS Genet. 2006 Jul;2(7):e120 [16789826.001]
  • [Cites] Nat Med. 2006 Sep;12(9):1030-8 [16951684.001]
  • [Cites] J Biol Chem. 2006 Sep 22;281(38):27765-72 [16844692.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Nov 3;349(4):1235-41 [16978585.001]
  • [Cites] Nature. 2007 May 17;447(7142):330-3 [17507984.001]
  • [Cites] Am J Gastroenterol. 2007 Jul;102(7):1499-509 [17459027.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8 [18192401.001]
  • [Cites] J Clin Invest. 2008 Jun;118(6):2325-36 [18483624.001]
  • [Cites] Glycobiology. 2008 Jul;18(7):549-58 [18458030.001]
  • [Cites] BMC Immunol. 2005;6:6 [15752429.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12778-83 [10535999.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14559-64 [10588744.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6124-31 [10626802.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1263-8 [10655519.001]
  • [Cites] J Histochem Cytochem. 2000 Mar;48(3):377-88 [10681391.001]
  • [Cites] J Exp Med. 2000 Feb 21;191(4):593-602 [10684851.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1497-500 [10688800.001]
  • [Cites] Mol Microbiol. 2000 Jun;36(6):1187-96 [10931272.001]
  • [Cites] N Engl J Med. 2000 Oct 5;343(14):1020-34 [11018170.001]
  • [Cites] Gastroenterol Clin North Am. 2000 Sep;29(3):559-78 [11030073.001]
  • (PMID = 19149511.001).
  • [ISSN] 1389-2002
  • [Journal-full-title] Current drug metabolism
  • [ISO-abbreviation] Curr. Drug Metab.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA071932; United States / NCI NIH HHS / CA / R01 CA033000; United States / NCI NIH HHS / CA / CA33000; United States / NCI NIH HHS / CA / R01 CA033000-28; United States / NCI NIH HHS / CA / CA71932; United States / NCI NIH HHS / CA / CA033000-28; United States / NCI NIH HHS / CA / R37 CA033000; United States / NCI NIH HHS / CA / CA071932-11A2; United States / NCI NIH HHS / CA / P01 CA071932-11A2
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antigens, Surface; 0 / L-selectin counter-receptors; 0 / Membrane Proteins; 0 / Polysaccharides; EC 2.4.1.- / Glucosyltransferases; EC 2.4.1.- / Hp0421 protein, Helicobacter pylori
  • [Number-of-references] 102
  • [Other-IDs] NLM/ NIHMS97911; NLM/ PMC2666621
  •  go-up   go-down


34. Micu G, Stăniceanu F, Zurac S, Grămadă E, Bastian A, Tudose I, Mateescu BR, Voiosu R: Helicobacter pylori: pathological mechanism involved in gastric colonization. Rom J Intern Med; 2009;47(4):341-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since 1982, when Marshall and Warren highlighted the presence of H. pylori at the apical pole of the epithelial gastric cells, the medical literature has registered a cascade of subsequent researches concerning this amazing bacterium, its action on the human body and the body response.
  • The data gathered in the last period identify different virulence factors of HP, but fail to fully explain the relatively low incidence of gastric cancer in HP carriers; therefore, it is now considered that the carcinogenic potential related to HP infection in humans is due to the synergic and complementary association of the bacterial genetic equipment with diet and host response.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21179915.001).
  • [ISSN] 1220-4749
  • [Journal-full-title] Romanian journal of internal medicine = Revue roumaine de médecine interne
  • [ISO-abbreviation] Rom J Intern Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Romania
  •  go-up   go-down


35. Drott JB, Alexeyev O, Bergström P, Elgh F, Olsson J: Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiol; 2010;10:126
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The immune stimulating bacterium Propionibacterium acnes is a frequent colonizer of benign and malignant prostate tissue.
  • The secretion of cytokines is accompanied by NFkappaB related upregulation of the secreted cytokines as well as several components of the TLR2-NFkappaB signaling pathway.
  • Upon infection of prostate via the retrograde urethral route, the induced inflammatory reaction might facilitate bacterial colonization deeper in the prostate tissue where persistent inflammation may impact the development of prostate diseases as hyperplasia and/or malignancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2000 Oct;164(4):1221-8 [10992370.001]
  • [Cites] Urology. 2009 Feb;73(2):220-4 [18407335.001]
  • [Cites] J Urol. 2000 Jan;163(1):127-30 [10604329.001]
  • [Cites] J Pathol. 2000 Jul;191(3):239-44 [10878544.001]
  • [Cites] Am J Pathol. 2001 Dec;159(6):2159-65 [11733366.001]
  • [Cites] J Dermatol Sci. 2002 Aug;29(2):97-103 [12088610.001]
  • [Cites] Trends Immunol. 2002 Aug;23(8):403-8 [12133803.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):655-63 [12547723.001]
  • [Cites] Annu Rev Immunol. 2003;21:335-76 [12524386.001]
  • [Cites] J Clin Invest. 2004 May;113(10):1473-81 [15146245.001]
  • [Cites] Infect Immun. 1985 Jul;49(1):116-21 [2989178.001]
  • [Cites] J Invest Dermatol. 1991 Jul;97(1):73-9 [1711550.001]
  • [Cites] Infect Immun. 1995 Aug;63(8):3158-65 [7542639.001]
  • [Cites] Annu Rev Immunol. 2005;23:1-21 [15771564.001]
  • [Cites] J Urol. 2005 Jun;173(6):1969-74 [15879794.001]
  • [Cites] J Cell Biochem. 2005 Jun 1;95(3):497-505 [15838876.001]
  • [Cites] Dermatology. 2005;211(3):193-8 [16205063.001]
  • [Cites] Br J Dermatol. 2005 Dec;153(6):1105-13 [16307644.001]
  • [Cites] Prostate. 2006 Mar 1;66(4):386-91 [16302262.001]
  • [Cites] J Leukoc Biol. 2006 May;79(5):989-98 [16522744.001]
  • [Cites] Cancer Causes Control. 2006 Nov;17(9):1127-33 [17006718.001]
  • [Cites] Nat Rev Cancer. 2007 Apr;7(4):256-69 [17384581.001]
  • [Cites] J Cell Biol. 2007 Apr 9;177(1):7-11 [17420288.001]
  • [Cites] Urol Oncol. 2007 May-Jun;25(3):242-9 [17483023.001]
  • [Cites] Urol Oncol. 2007 May-Jun;25(3):250-9 [17483024.001]
  • [Cites] Cancer Res. 2007 Jul 15;67(14):6854-62 [17638896.001]
  • [Cites] J Med Microbiol. 2007 Aug;56(Pt 8):1025-32 [17644708.001]
  • [Cites] Urol Oncol. 2007 Sep-Oct;25(5):398-400 [17826659.001]
  • [Cites] J Clin Microbiol. 2007 Nov;45(11):3721-8 [17881550.001]
  • [Cites] Prostate. 2008 Feb 1;68(2):223-9 [18092352.001]
  • [Cites] Prostate. 2008 Feb 15;68(3):306-20 [18163428.001]
  • [Cites] J Cell Biochem. 2008 Apr 1;103(5):1344-53 [17955503.001]
  • [Cites] Carcinogenesis. 2008 Jun;29(6):1148-56 [18487223.001]
  • [Cites] Clin Cancer Res. 2008 Nov 1;14(21):6735-41 [18980965.001]
  • [Cites] J Cell Biochem. 2008 Nov 1;105(4):931-9 [18655194.001]
  • [Cites] Clin Cancer Res. 2001 Sep;7(9):2941-8 [11555613.001]
  • (PMID = 20420679.001).
  • [ISSN] 1471-2180
  • [Journal-full-title] BMC microbiology
  • [ISO-abbreviation] BMC Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines
  • [Other-IDs] NLM/ PMC2867951
  •  go-up   go-down


36. Lee YC: [Pathogenesis of Helicobacter pylori infection]. Korean J Gastroenterol; 2005 Sep;46(3):159-65
MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathogenesis of H. pylori infection is based on the long-term host to bacterial interaction and affected by the virulence factors of the bacterium, environmental and host factors (age, sex, blood type).
  • Colonization is also affected by urease and/or motility of the bacterium, presence of lipopolysaccharide (LPS) and various bacterial enzymes.
  • Host cytokine gene polymorphism would be the one explanation for host susceptibility to peptic ulcer or gastric cancer.
  • Investigation into the pathogenesis of H. pylori related diseases could provide an answer to the impact of chronic host to microbial interaction resulting human diseases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16179834.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Korea (South)
  • [Number-of-references] 35
  •  go-up   go-down


37. Pommerenke C, Müsken M, Becker T, Dötsch A, Klawonn F, Häussler S: Global genotype-phenotype correlations in Pseudomonas aeruginosa. PLoS Pathog; 2010;6(8):e1001074
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we assessed bacterial growth parameters of 4030 non-redundant PA14 transposon mutants in the pathogenic bacterium Pseudomonas aeruginosa.
  • The genome-wide simultaneous analysis of 119 distinct growth-related phenotypes uncovered a comprehensive phenome and provided evidence that most genotypes are not phenotypically isolated but rather define specific complex phenotypic clusters of genotypes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2000 Aug 31;406(6799):959-64 [10984043.001]
  • [Cites] Microbiology. 2010 Feb;156(Pt 2):431-41 [19850623.001]
  • [Cites] Nat Rev Genet. 2003 Apr;4(4):309-14 [12671661.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14339-44 [14617778.001]
  • [Cites] Nat Rev Genet. 2004 Jan;5(1):11-22 [14708012.001]
  • [Cites] Nature. 2004 May 6;429(6987):92-6 [15129285.001]
  • [Cites] Curr Opin Microbiol. 2004 Jun;7(3):296-307 [15196499.001]
  • [Cites] Nat Rev Microbiol. 2004 Nov;2(11):886-97 [15494745.001]
  • [Cites] BMC Ecol. 2006;6:1 [16412253.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2833-8 [16477005.001]
  • [Cites] Genome Biol. 2006;7(10):R90 [17038190.001]
  • [Cites] Nat Biotechnol. 2007 Mar;25(3):309-16 [17344885.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90 [17502601.001]
  • [Cites] Appl Environ Microbiol. 2007 Aug;73(15):4922-30 [17545329.001]
  • [Cites] Nat Rev Cancer. 2008 Jan;8(1):37-49 [18097463.001]
  • [Cites] Trends Genet. 2008 Mar;24(3):103-6 [18243400.001]
  • [Cites] Science. 2008 Apr 18;320(5874):362-5 [18420932.001]
  • [Cites] FEMS Microbiol Rev. 2009 Jan;33(1):191-205 [19054113.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D483-8 [18978025.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D459-63 [18988623.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Jun;53(6):2522-31 [19332674.001]
  • [Cites] Nature. 2002 Jul 25;418(6896):387-91 [12140549.001]
  • (PMID = 20865161.001).
  • [ISSN] 1553-7374
  • [Journal-full-title] PLoS pathogens
  • [ISO-abbreviation] PLoS Pathog.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2928780
  •  go-up   go-down


38. Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JR, Paton JF, van Kampen E, Knight DM, Evans AK, Rook GA, Lightman SL: Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience; 2007 May 11;146(2):756-72
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have found that peripheral immune activation with antigens derived from the nonpathogenic, saprophytic bacterium, Mycobacterium vaccae, activated a specific subset of serotonergic neurons in the interfascicular part of the dorsal raphe nucleus (DRI) of mice, as measured by quantification of c-Fos expression following intratracheal (12 h) or s.c. (6 h) administration of heat-killed, ultrasonically disrupted M. vaccae, or heat-killed, intact M. vaccae, respectively.
  • The effects of M. vaccae administration on serotonergic systems were temporally associated with reductions in immobility in the forced swim test, consistent with the hypothesis that the stimulation of mesolimbocortical serotonergic systems by peripheral immune activation alters stress-related emotional behavior.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Neurosci. 2005 Mar;8(3):365-71 [15696163.001]
  • [Cites] Behav Brain Res. 2005 May 7;160(1):125-34 [15836907.001]
  • [Cites] Brain Res. 2005 May 24;1044(2):176-89 [15885216.001]
  • [Cites] Neurosci Biobehav Rev. 2005;29(4-5):891-909 [15885777.001]
  • [Cites] Neurosci Biobehav Rev. 2005;29(4-5):829-41 [15893820.001]
  • [Cites] Neuroscience. 2005;133(4):983-97 [15916857.001]
  • [Cites] Pharmacol Biochem Behav. 2005 Jul;81(3):688-93 [15982728.001]
  • [Cites] Neuroscience. 2005;136(1):181-91 [16182451.001]
  • [Cites] Exp Neurol. 1984 Feb;83(2):302-17 [6692870.001]
  • [Cites] Rev Physiol Biochem Pharmacol. 1984;99:1-110 [6695127.001]
  • [Cites] Life Sci. 1984 May 28;34(22):2193-9 [6203006.001]
  • [Cites] Auton Neurosci. 2005 Dec 30;123(1-2):62-75 [16298172.001]
  • [Cites] J Clin Psychiatry. 2005;66 Suppl 8:22-9 [16336033.001]
  • [Cites] Stress. 2005 Dec;8(4):233-46 [16423712.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1059-64 [16418294.001]
  • [Cites] Neuroscience. 2006 Sep 29;142(1):1-20 [16887277.001]
  • [Cites] Brain Behav Immun. 2006 Nov;20(6):569-77 [16554144.001]
  • [Cites] Brain Behav Immun. 2006 Nov;20(6):517-26 [16647244.001]
  • [Cites] Auton Neurosci. 2007 Jan 30;131(1-2):77-86 [16935568.001]
  • [Cites] J Pharmacol Exp Ther. 1992 Jun;261(3):964-9 [1602402.001]
  • [Cites] J Clin Psychiatry. 1993 Jan;54 Suppl:16-9 [8093884.001]
  • [Cites] Anat Rec. 1993 May;236(1):70-85; discussion 85-6 [7685156.001]
  • [Cites] Am J Epidemiol. 1999 Nov 15;150(10):1107-16 [10568627.001]
  • [Cites] Arch Intern Med. 2000 May 22;160(10):1522-6 [10826468.001]
  • [Cites] Am J Med Genet. 2000 Apr 3;96(2):146-53 [10893486.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):853-7 [10970684.001]
  • [Cites] Auton Neurosci. 2000 Dec 20;85(1-3):60-5 [11189027.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Feb;163(2):329-34 [11179101.001]
  • [Cites] Immunology. 2001 Feb;102(2):225-33 [11260328.001]
  • [Cites] J Comp Neurol. 2001 Aug 6;436(4):430-55 [11447588.001]
  • [Cites] Neuroscience. 2001;104(4):1141-55 [11457597.001]
  • [Cites] Nat Med. 2002 Jun;8(6):625-9 [12042815.001]
  • [Cites] J Neuroendocrinol. 2002 Nov;14(11):911-23 [12421345.001]
  • [Cites] Pathobiology. 2002-2003;70(5):255-9 [12771505.001]
  • [Cites] Brain Behav Immun. 2004 May;18(3):205-13 [15050647.001]
  • [Cites] Ann Rheum Dis. 2004 Jun;63(6):718-22 [15140780.001]
  • [Cites] Ann Oncol. 2004 Jun;15(6):906-14 [15151947.001]
  • [Cites] Nat Rev Neurosci. 2004 Jun;5(6):449-61 [15152195.001]
  • [Cites] Ann N Y Acad Sci. 2004 Jun;1018:46-57 [15240351.001]
  • [Cites] Neuroscience. 2004;127(2):385-97 [15262329.001]
  • [Cites] Brain Res. 1976 Sep 3;113(3):449-86 [821589.001]
  • [Cites] Pflugers Arch. 1976 Jul 30;364(2):205-7 [986631.001]
  • [Cites] J Comp Neurol. 1980 Sep 15;193(2):467-508 [7440778.001]
  • [Cites] J Comp Neurol. 1981 Dec 20;203(4):737-43 [6173402.001]
  • [Cites] J Comp Neurol. 1982 Feb 10;205(1):63-76 [6121826.001]
  • [Cites] Neurosci Lett. 1984 Mar 23;45(2):117-22 [6728309.001]
  • [Cites] Adv Neurol. 1986;43:407-68 [2418648.001]
  • [Cites] J Immunol Methods. 1987 Apr 2;98(1):5-10 [3104476.001]
  • [Cites] Eur J Pharmacol. 1989 Jan 10;159(2):157-64 [2707305.001]
  • [Cites] Neuron. 1990 Apr;4(4):477-85 [1969743.001]
  • [Cites] Annu Rev Neurosci. 1991;14:421-51 [1903243.001]
  • [Cites] Physiol Rev. 1992 Jan;72(1):165-229 [1731370.001]
  • [Cites] J Neurophysiol. 1991 Dec;66(6):2084-94 [1812238.001]
  • [Cites] Brain Res. 1993 Oct 8;624(1-2):188-98 [8252391.001]
  • [Cites] J Neurosci. 1995 Apr;15(4):2920-34 [7536823.001]
  • [Cites] J Neurosci Res. 1995 Feb 15;40(3):407-13 [7745636.001]
  • [Cites] Neurosci Biobehav Rev. 1995 Fall;19(3):377-95 [7566740.001]
  • [Cites] Clin Chem. 1996 Jul;42(7):1086-91 [8674193.001]
  • [Cites] Pharmacol Biochem Behav. 1996 May;54(1):129-41 [8728550.001]
  • [Cites] Neuroscience. 1996 Jun;72(4):989-97 [8735224.001]
  • [Cites] Infect Immun. 1997 May;65(5):1856-62 [9125572.001]
  • [Cites] Infect Immun. 1997 Aug;65(8):3317-27 [9234793.001]
  • [Cites] Am J Physiol. 1997 Sep;273(3 Pt 2):R1147-57 [9321898.001]
  • [Cites] J Auton Nerv Syst. 1998 Jan 19;68(1-2):115-24 [9531452.001]
  • [Cites] Psychol Med. 1998 May;28(3):573-84 [9626714.001]
  • [Cites] Ann N Y Acad Sci. 1998 May 1;840:289-300 [9629257.001]
  • [Cites] Neurochem Int. 1998 Oct;33(4):287-97 [9840219.001]
  • [Cites] Brain Res. 1999 Apr 24;826(1):35-43 [10216194.001]
  • [Cites] J Pediatr Psychol. 1999 Jun;24(3):259-70 [10379141.001]
  • [Cites] Respir Physiol. 1999 Apr 1;115(2):201-14 [10385034.001]
  • [Cites] Biol Psychiatry. 2004 Dec 1;56(11):819-24 [15576057.001]
  • [Cites] J Endocrinol. 2005 Feb;184(2):393-406 [15684347.001]
  • (PMID = 17367941.001).
  • [ISSN] 0306-4522
  • [Journal-full-title] Neuroscience
  • [ISO-abbreviation] Neuroscience
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / / 068558; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Vaccines; 0 / Cytokines; 0 / Mycobacterium w vaccine; 333DO1RDJY / Serotonin
  • [Other-IDs] NLM/ PMC1868963; NLM/ UKMS271
  •  go-up   go-down


39. Das JC, Paul N: Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J Pediatr; 2007 Mar;74(3):287-90
MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The organism is associated with development of peptic ulcer diseases, lymphoproliferative disorders and gastric cancer.
  • Host and bacterial factors with interaction of environment contribute pathogenicity. H. pylori cytotoxin-associated geneA (cagA), vacuolating toxinA (vacA) and adherence factors to gastric epithelium have been linked to enhanced pathogenicity of the bacterium.
  • Host genetic polymorphism of cytokines, related legends, receptors and enzymes influence H. pylori infection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17401270.001).
  • [ISSN] 0973-7693
  • [Journal-full-title] Indian journal of pediatrics
  • [ISO-abbreviation] Indian J Pediatr
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 29
  •  go-up   go-down


40. Bhadra S, Lozano MM, Payne SM, Dudley JP: Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog; 2006 Dec;2(12):e128
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infection of Mtv-null mice with an MMTV-related retrovirus, type B leukemogenic virus, also resulted in severely reduced viral loads and failure to induce T-cell lymphomas, indicating that resistance is not dependent on expression of a superantigen (Sag) encoded by exogenous MMTV.
  • Further, Mtv-null mice were resistant to rapid mortality induced by intragastric inoculation of the Gram-negative bacterium, Vibrio cholerae, but susceptibility to Salmonella typhimurium was not significantly different from BALB/c mice.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunity. 1995 Jul;3(1):139-46 [7542547.001]
  • [Cites] J Exp Med. 1995 Nov 1;182(5):1493-504 [7595219.001]
  • [Cites] J Virol. 1996 Feb;70(2):1246-9 [8551589.001]
  • [Cites] Eur J Immunol. 1996 Jul;26(7):1595-602 [8766566.001]
  • [Cites] J Immunol. 1996 Mar 15;156(6):2112-8 [8690899.001]
  • [Cites] Adv Pharmacol. 1997;39:21-46 [9160112.001]
  • [Cites] Mol Cell Biol. 1997 Sep;17(9):5275-87 [9271405.001]
  • [Cites] J Virol. 1998 Apr;72(4):2638-46 [9525580.001]
  • [Cites] J Virol. 1998 Jun;72(6):4746-55 [9573239.001]
  • [Cites] J Immunol. 1998 Sep 1;161(5):2375-82 [9725233.001]
  • [Cites] J Virol. 2000 Oct;74(20):9431-40 [11000212.001]
  • [Cites] J Virol. 1999 Aug;73(8):6634-45 [10400761.001]
  • [Cites] J Virol. 1999 Oct;73(10):8403-10 [10482591.001]
  • [Cites] Int Immunol. 2005 Jan;17(1):1-14 [15585605.001]
  • [Cites] Infect Immun. 2005 Sep;73(9):6157-64 [16113340.001]
  • [Cites] Hum Gene Ther. 2005 Aug;16(8):913-20 [16076249.001]
  • [Cites] Blood. 2005 May 1;105(9):3655-62 [15644417.001]
  • [Cites] Cell Microbiol. 2005 Oct;7(10):1387-97 [16153239.001]
  • [Cites] J Virol. 2005 Dec;79(23):14737-47 [16282474.001]
  • [Cites] J Virol. 1999 Dec;73(12):10079-85 [10559322.001]
  • [Cites] Science. 1999 Dec 3;286(5446):1965-8 [10583962.001]
  • [Cites] J Virol. 2001 Mar;75(5):2174-84 [11160721.001]
  • [Cites] Nat Immunol. 2001 Aug;2(8):675-80 [11477402.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2281-6 [11854525.001]
  • [Cites] Infect Immun. 2002 Jul;70(7):3419-26 [12065481.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12386-90 [12218182.001]
  • [Cites] Curr Top Microbiol Immunol. 2002;270:47-61 [12467243.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):199-204 [12502785.001]
  • [Cites] J Exp Med. 2003 Jan 20;197(2):233-43 [12538662.001]
  • [Cites] J Virol. 2003 Mar;77(6):3866-70 [12610163.001]
  • [Cites] Nat Immunol. 2003 Jun;4(6):573-8 [12730691.001]
  • [Cites] J Immunol. 1979 Feb;122(2):549-54 [310843.001]
  • [Cites] Nature. 1979 Mar 29;278(5703):418-23 [221817.001]
  • [Cites] Nature. 1984 Jan 12-18;307(5947):131-6 [6318122.001]
  • [Cites] Cell. 1984 Jun;37(2):529-36 [6327073.001]
  • [Cites] Virology. 1985 Jan 15;140(1):159-72 [2981451.001]
  • [Cites] J Virol. 1987 Jan;61(1):218-20 [3023699.001]
  • [Cites] J Virol. 1987 May;61(5):1651-4 [3033291.001]
  • [Cites] J Virol. 1988 Aug;62(8):2985-93 [2839715.001]
  • [Cites] Cancer Res. 1988 Nov 15;48(22):6555-9 [2846153.001]
  • [Cites] J Virol. 1988 Dec;62(12):4644-52 [2846876.001]
  • [Cites] Cell. 1993 Aug 13;74(3):529-40 [8394220.001]
  • [Cites] J Exp Med. 1994 May 1;179(5):1457-66 [8163931.001]
  • [Cites] Infect Immun. 1994 Nov;62(11):5120-5 [7927795.001]
  • [Cites] J Immunol Methods. 1994 Dec 2;176(2):245-53 [7983382.001]
  • [Cites] Virology. 1995 Jan 10;206(1):395-402 [7831795.001]
  • [Cites] J Exp Med. 1995 May 1;181(5):1683-92 [7722447.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Dec;85(24):9655-9 [2849114.001]
  • [Cites] Immunol Today. 1991 Oct;12(10):356-61 [1659830.001]
  • [Cites] J Bacteriol. 1992 May;174(10):3270-4 [1315733.001]
  • [Cites] EMBO J. 1992 May;11(5):1901-5 [1316276.001]
  • [Cites] Cell. 1992 May 15;69(4):637-45 [1316806.001]
  • [Cites] J Exp Med. 1992 Jun 1;175(6):1623-33 [1316932.001]
  • [Cites] J Immunol. 1992 Aug 15;149(4):1242-51 [1323611.001]
  • [Cites] J Exp Med. 1993 Aug 1;178(2):737-41 [7688034.001]
  • (PMID = 17140288.001).
  • [ISSN] 1553-7374
  • [Journal-full-title] PLoS pathogens
  • [ISO-abbreviation] PLoS Pathog.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA077760; United States / NCI NIH HHS / CA / R01 CA77760
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Antibodies, Viral; 0 / Superantigens
  • [Other-IDs] NLM/ PMC1665650
  •  go-up   go-down


41. Dowling AJ, Wilkinson PA, Holden MT, Quail MA, Bentley SD, Reger J, Waterfield NR, Titball RW, Ffrench-Constant RH: Genome-wide analysis reveals loci encoding anti-macrophage factors in the human pathogen Burkholderia pseudomallei K96243. PLoS One; 2010 Dec 22;5(12):e15693
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The bacterium is endemic to tropical regions, including South East Asia and Northern Australia, where it causes melioidosis, a serious disease associated with both high mortality and antibiotic resistance. B. pseudomallei is a Gram-negative facultative intracellular pathogen that is able to replicate in macrophages.
  • We identify a total of 113 such loci scattered across both chromosomes, with positive gene clusters encoding transporters and secretion systems, enzymes/toxins, secondary metabolite, biofilm, adhesion and signal response related factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 2007 Sep;75(9):4298-304 [17576760.001]
  • [Cites] Infect Immun. 2001 Apr;69(4):2650-8 [11254631.001]
  • [Cites] Infect Immun. 2008 Jul;76(7):2991-3000 [18443088.001]
  • [Cites] PLoS Pathog. 2008 Oct;4(10):e1000178 [18927621.001]
  • [Cites] Infect Immun. 2009 Aug;77(8):3244-8 [19506016.001]
  • [Cites] Infect Immun. 2000 Sep;68(9):5377-84 [10948167.001]
  • [Cites] FEMS Microbiol Rev. 2009 Nov;33(6):1079-99 [19732156.001]
  • [Cites] Mol Microbiol. 1996 Jan;19(1):65-78 [8821937.001]
  • [Cites] PLoS One. 2009;4(12):e8094 [19956607.001]
  • [Cites] FEMS Microbiol Lett. 2003 Dec 12;229(2):265-70 [14680709.001]
  • [Cites] Bioinformatics. 2009 Jan 1;25(1):119-20 [18990721.001]
  • [Cites] Cancer Res. 1988 Sep 1;48(17):4827-33 [3409223.001]
  • [Cites] Genome Res. 2001 Oct;11(10):1725-9 [11591649.001]
  • [Cites] Infect Immun. 2006 Oct;74(10):5465-76 [16988221.001]
  • [Cites] FEMS Microbiol Lett. 1996 Mar 15;137(1):79-83 [8935661.001]
  • [Cites] Cell Prolif. 2006 Dec;39(6):599-609 [17109642.001]
  • [Cites] Microbiology. 2007 Jul;153(Pt 7):2203-11 [17600064.001]
  • [Cites] J Med Microbiol. 1997 Jul;46(7):557-63 [9236739.001]
  • [Cites] Mol Microbiol. 2005 Apr;56(1):40-53 [15773977.001]
  • [Cites] Curr Opin Infect Dis. 2002 Apr;15(2):127-32 [11964912.001]
  • [Cites] BMC Genomics. 2007;8:83 [17391530.001]
  • [Cites] Lancet. 2003 May 17;361(9370):1715-22 [12767750.001]
  • [Cites] Emerg Infect Dis. 2002 Feb;8(2):225-30 [11897082.001]
  • [Cites] J Bacteriol. 2010 Jan;192(1):155-68 [19880608.001]
  • [Cites] Arch Microbiol. 2008 Dec;190(6):623-31 [18654761.001]
  • [Cites] Curr Opin Microbiol. 2009 Feb;12(1):11-7 [19162533.001]
  • [Cites] Vaccine. 1999 Feb 26;17(7-8):802-8 [10067685.001]
  • [Cites] Cell Microbiol. 2000 Feb;2(1):49-58 [11207562.001]
  • [Cites] Adv Appl Microbiol. 2005;58C:169-183 [16543033.001]
  • [Cites] Nature. 2008 Apr 10;452(7188):755-8 [18401409.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14240-5 [15377794.001]
  • [Cites] Cell Microbiol. 2005 Oct;7(10):1447-58 [16153244.001]
  • [Cites] Mol Microbiol. 2000 Sep;37(5):1106-15 [10972829.001]
  • [Cites] J Bacteriol. 2003 Aug;185(16):4992-6 [12897019.001]
  • [Cites] Microbiology. 2004 Aug;150(Pt 8):2669-76 [15289563.001]
  • [Cites] Annu Rev Microbiol. 2010;64:495-517 [20528691.001]
  • [Cites] Microbiology. 2007 Aug;153(Pt 8):2689-99 [17660433.001]
  • [Cites] Mol Microbiol. 2002 Nov;46(3):649-59 [12410823.001]
  • (PMID = 21203527.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BB/E021328/1; United Kingdom / Biotechnology and Biological Sciences Research Council / / BB/E021182/1
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Virulence Factors
  • [Other-IDs] NLM/ PMC3008741
  •  go-up   go-down


42. Sandy M, Han A, Blunt J, Munro M, Haygood M, Butler A: Vanchrobactin and anguibactin siderophores produced by Vibrio sp. DS40M4. J Nat Prod; 2010 Jun 25;73(6):1038-43
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The marine bacterium Vibrio sp.
  • DS40M4 has been found to produce a new triscatechol amide siderophore, trivanchrobactin (1), a related new biscatecholamide compound, divanchrobactin (2), and the previously reported siderophores vanchrobactin (3) and anguibactin (4).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. L-SERINE .
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2000 Feb 18;287(5456):1245-7 [10678827.001]
  • [Cites] J Nat Prod. 2009 May 22;72(5):884-8 [19320498.001]
  • [Cites] Nature. 2001 Sep 27;413(6854):409-13 [11574885.001]
  • [Cites] Bioinformatics. 2001 Dec;17(12):1246-7 [11751242.001]
  • [Cites] J Am Chem Soc. 2002 Jan 23;124(3):378-9 [11792199.001]
  • [Cites] Syst Biol. 2002 Jun;51(3):492-508 [12079646.001]
  • [Cites] Chembiochem. 2002 Jun 3;3(6):490-504 [12325005.001]
  • [Cites] Biochemistry. 2002 Nov 12;41(45):13350-9 [12416979.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3754-9 [12651947.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3677-82 [12655053.001]
  • [Cites] J Antibiot (Tokyo). 2003 Oct;56(10):871-5 [14700282.001]
  • [Cites] Biometals. 2004 Aug;17(4):471-81 [15259369.001]
  • [Cites] Biochem Biophys Res Commun. 1970 Mar 12;38(5):989-92 [4908541.001]
  • [Cites] Biochim Biophys Acta. 1970 Aug 14;215(2):393-402 [4926450.001]
  • [Cites] Anal Biochem. 1987 Jan;160(1):47-56 [2952030.001]
  • [Cites] Cancer Res. 1988 Feb 1;48(3):589-601 [3335022.001]
  • [Cites] J Biol Chem. 1989 Feb 25;264(6):3187-93 [2914949.001]
  • [Cites] Nature. 1993 Dec 2;366(6454):455-8 [8247152.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2648-59 [9485415.001]
  • [Cites] J Nat Prod. 2004 Nov;67(11):1897-9 [15568785.001]
  • [Cites] J Bacteriol. 2005 Mar;187(6):2209-14 [15743971.001]
  • [Cites] Int J Med Microbiol. 2005 Jun;295(2):99-107 [15969470.001]
  • [Cites] J Nat Prod. 2006 Apr;69(4):621-4 [16643039.001]
  • [Cites] J Biol Inorg Chem. 2006 Jul;11(5):633-41 [16791646.001]
  • [Cites] Inorg Chem. 2006 Jul 24;45(15):6028-33 [16842010.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Sep 15;348(1):320-5 [16875672.001]
  • [Cites] Mol Microbiol. 2006 Sep;61(6):1413-27 [16889643.001]
  • [Cites] Bioinformatics. 2006 Nov 1;22(21):2688-90 [16928733.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18499-503 [17132740.001]
  • [Cites] Microbiology. 2006 Dec;152(Pt 12):3517-28 [17159203.001]
  • [Cites] Nucleic Acids Res. 2007;35(21):7188-96 [17947321.001]
  • [Cites] Microbiology. 2008 May;154(Pt 5):1400-13 [18451049.001]
  • [Cites] Nature. 2008 Aug 14;454(7206):903-6 [18704088.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D141-5 [19004872.001]
  • [Cites] Biometals. 2009 Aug;22(4):565-71 [19357970.001]
  • [Cites] J Bacteriol. 2010 Jan;192(2):426-35 [19915026.001]
  • [Cites] J Biol Chem. 2001 Mar 9;276(10):7209-17 [11112781.001]
  • (PMID = 20521785.001).
  • [ISSN] 1520-6025
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM038130-16; United States / NIGMS NIH HHS / GM / R01 GM038130; United States / NIGMS NIH HHS / GM / GM38130; United States / NIGMS NIH HHS / GM / R01 GM038130-16
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Peptides; 0 / Siderophores; 0 / divanchrobactin; 0 / trivanchrobactin; 0 / vanchrobactin; 104245-09-2 / anguibactin; 452VLY9402 / Serine; 94ZLA3W45F / Arginine
  • [Other-IDs] NLM/ NIHMS211402; NLM/ PMC3065854
  •  go-up   go-down


43. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E: Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol; 2005;59:451-85
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Type IV secretion (T4S) systems are ancestrally related to bacterial conjugation machines.
  • A recent advancement also has enabled definition of the translocation route for a DNA substrate through a T4S system of a Gram-negative bacterium.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bacteriol. 2000 May;182(10):2761-70 [10781544.001]
  • [Cites] Nature. 2000 May 18;405(6784):299-304 [10830951.001]
  • [Cites] Mol Microbiol. 2000 May;36(3):608-17 [10844650.001]
  • [Cites] J Bacteriol. 2000 Jul;182(13):3705-16 [10850985.001]
  • [Cites] J Bacteriol. 2000 Jul;182(14):3885-95 [10869063.001]
  • [Cites] J Bacteriol. 2000 Jul;182(14):4022-7 [10869081.001]
  • [Cites] DNA Cell Biol. 2000 Jun;19(6):377-82 [10882236.001]
  • [Cites] J Bacteriol. 2000 Aug;182(15):4137-45 [10894719.001]
  • [Cites] Trends Microbiol. 2000 Aug;8(8):354-60 [10920394.001]
  • [Cites] Science. 2000 Nov 3;290(5493):979-82 [11062129.001]
  • [Cites] J Bacteriol. 2000 Dec;182(23):6751-61 [11073921.001]
  • [Cites] Mol Microbiol. 2001 Jan;39(2):313-29 [11136453.001]
  • [Cites] Nature. 2001 Feb 1;409(6820):637-41 [11214325.001]
  • [Cites] Mol Cell. 2000 Dec;6(6):1461-72 [11163218.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2503-8 [11226268.001]
  • [Cites] J Bacteriol. 2001 May;183(10):3176-83 [11325947.001]
  • [Cites] J Bacteriol. 2001 Jun;183(12):3636-41 [11371528.001]
  • [Cites] J Bacteriol. 2001 Jun;183(12):3642-51 [11371529.001]
  • [Cites] J Biol Chem. 2001 May 25;276(21):17968-75 [11278718.001]
  • [Cites] Mol Microbiol. 2001 Jul;41(1):263-77 [11454218.001]
  • [Cites] Mol Microbiol. 2001 Jul;41(2):379-91 [11489125.001]
  • [Cites] J Bacteriol. 2001 Oct;183(20):5813-25 [11566978.001]
  • [Cites] J Bacteriol. 2001 Oct;183(20):5927-36 [11566992.001]
  • [Cites] Mol Microbiol. 2001 Nov;42(3):705-15 [11722736.001]
  • [Cites] Nat Genet. 2001 Dec;29(4):375-6 [11726922.001]
  • [Cites] Microbiology. 2001 Dec;147(Pt 12):3201-14 [11739753.001]
  • [Cites] J Bacteriol. 2002 Jan;184(1):327-30 [11741876.001]
  • [Cites] Trends Plant Sci. 2002 Jan;7(1):1-3 [11804814.001]
  • [Cites] Science. 2002 Jan 25;295(5555):679-82 [11809974.001]
  • [Cites] Trends Cell Biol. 2002 Mar;12(3):121-9 [11859024.001]
  • [Cites] Mol Microbiol. 2002 Mar;43(5):1359-65 [11918819.001]
  • [Cites] Mol Microbiol. 2002 Mar;43(6):1523-32 [11952902.001]
  • [Cites] J Bacteriol. 2002 May;184(10):2767-79 [11976307.001]
  • [Cites] J Bacteriol. 2002 Jun;184(11):2863-9 [12003925.001]
  • [Cites] Mol Microbiol. 2002 Jul;45(1):1-8 [12100543.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11493-500 [12177441.001]
  • [Cites] J Bacteriol. 1994 Sep;176(18):5697-703 [8083162.001]
  • [Cites] Plasmid. 1994 Sep;32(2):212-8 [7846145.001]
  • [Cites] Mol Microbiol. 1994 Nov;14(3):427-36 [7533880.001]
  • [Cites] Mol Microbiol. 1994 Nov;14(3):583-94 [7885236.001]
  • [Cites] EMBO J. 1995 Jul 3;14(13):3206-14 [7621833.001]
  • [Cites] J Bacteriol. 1995 Aug;177(16):4779-91 [7642506.001]
  • [Cites] J Bacteriol. 1995 Sep;177(17):4890-9 [7665465.001]
  • [Cites] J Bacteriol. 1996 Jun;178(11):3156-67 [8655494.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11405-10 [12177443.001]
  • [Cites] FEMS Microbiol Lett. 2003 Jun 6;223(1):1-6 [12798992.001]
  • [Cites] Res Microbiol. 2003 May;154(4):283-7 [12798233.001]
  • [Cites] Mol Microbiol. 2003 Jul;49(1):105-16 [12823814.001]
  • [Cites] Mol Microbiol. 2003 Jul;49(1):219-34 [12823823.001]
  • [Cites] FEMS Microbiol Lett. 2003 Jul 15;224(1):1-15 [12855161.001]
  • [Cites] Int J Med Microbiol. 2003 Jun;293(2-3):153-65 [12868652.001]
  • [Cites] Mol Microbiol. 2003 Sep;49(6):1699-713 [12950931.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10465-70 [12925737.001]
  • [Cites] J Mol Biol. 2003 Oct 24;333(3):657-74 [14556751.001]
  • [Cites] Trends Microbiol. 2003 Nov;11(11):527-35 [14607070.001]
  • [Cites] Cell Mol Life Sci. 2003 Nov;60(11):2371-88 [14625683.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15947-52 [14673074.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):841-6 [14715899.001]
  • [Cites] Science. 2004 Feb 27;303(5662):1358-61 [14988561.001]
  • [Cites] J Bacteriol. 2004 Mar;186(6):1606-13 [14996790.001]
  • [Cites] J Bacteriol. 2004 Mar;186(6):1658-66 [14996796.001]
  • [Cites] Mol Microbiol. 2004 Apr;52(1):81-92 [15049812.001]
  • [Cites] J Bacteriol. 2004 May;186(10):3065-77 [15126468.001]
  • [Cites] Mol Microbiol. 2004 May;52(4):1159-71 [15130132.001]
  • [Cites] Curr Pharm Des. 2004;10(13):1551-65 [15134575.001]
  • [Cites] Infect Immun. 2004 Jun;72(6):3398-409 [15155646.001]
  • [Cites] Science. 2004 May 21;304(5674):1170-3 [15155952.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):643-9 [15184891.001]
  • [Cites] Mol Microbiol. 2004 Jul;53(1):1-8 [15225298.001]
  • [Cites] J Bacteriol. 2004 Jul;186(14):4796-801 [15231811.001]
  • [Cites] J Biol Chem. 2004 Jul 9;279(28):29528-33 [15123622.001]
  • [Cites] J Bacteriol. 2004 Aug;186(16):5480-5 [15292150.001]
  • [Cites] Mol Cell Proteomics. 2004 Aug;3(8):809-19 [15133060.001]
  • [Cites] Infect Immun. 2004 Sep;72(9):5143-9 [15322008.001]
  • [Cites] J Mol Biol. 2004 Aug 20;341(4):961-77 [15328612.001]
  • [Cites] J Bacteriol. 2004 Sep;186(18):6015-24 [15342570.001]
  • [Cites] Nat Rev Cancer. 2004 Sep;4(9):688-94 [15343275.001]
  • [Cites] Nature. 2004 Sep 2;431(7004):87-92 [15343337.001]
  • [Cites] Infect Immun. 2004 Oct;72(10):5972-82 [15385501.001]
  • [Cites] J Bacteriol. 2004 Oct;186(20):6999-7006 [15466052.001]
  • [Cites] Microbiology. 2004 Oct;150(Pt 10):3507-17 [15470128.001]
  • [Cites] Mol Microbiol. 2004 Oct;54(2):561-74 [15469524.001]
  • [Cites] Annu Rev Microbiol. 2004;58:365-90 [15487942.001]
  • [Cites] Nat Immunol. 2004 Nov;5(11):1166-74 [15489856.001]
  • [Cites] J Bacteriol. 1985 Jan;161(1):402-10 [2857162.001]
  • [Cites] J Bacteriol. 1985 Jan;161(1):425-7 [2857164.001]
  • [Cites] J Bacteriol. 1987 Jan;169(1):313-23 [3025176.001]
  • [Cites] J Bacteriol. 1992 Jun;174(11):3800-6 [1350587.001]
  • [Cites] J Bacteriol. 1993 Apr;175(8):2175-83 [8096837.001]
  • [Cites] Biochim Biophys Acta. 1994 Jan 4;1183(3):417-51 [8286395.001]
  • [Cites] Cell. 1994 May 6;77(3):321-4 [8181052.001]
  • [Cites] J Bacteriol. 1994 Jun;176(12):3646-60 [8206843.001]
  • [Cites] J Bacteriol. 1994 Sep;176(17):5255-61 [8071199.001]
  • [Cites] J Biol Chem. 1999 Dec 17;274(51):36117-24 [10593894.001]
  • [Cites] J Bacteriol. 1999 Dec;181(24):7485-92 [10601205.001]
  • [Cites] J Bacteriol. 2000 Feb;182(3):758-63 [10633111.001]
  • [Cites] J Bacteriol. 2000 Mar;182(6):1541-8 [10692358.001]
  • [Cites] J Bacteriol. 2000 Mar;182(6):1564-74 [10692361.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3067-72 [10716714.001]
  • [Cites] J Bacteriol. 2000 May;182(10):2709-15 [10781537.001]
  • [Cites] J Bacteriol. 2000 Aug;182(16):4505-11 [10913084.001]
  • [Cites] J Bacteriol. 1997 May;179(10):3085-94 [9150199.001]
  • [Cites] J Bacteriol. 1997 Jun;179(11):3404-9 [9171381.001]
  • [Cites] J Bacteriol. 1997 Aug;179(16):5195-202 [9260964.001]
  • [Cites] J Bacteriol. 1997 Sep;179(18):5835-42 [9294442.001]
  • [Cites] J Bacteriol. 1998 Jan;180(2):430-4 [9440537.001]
  • [Cites] Mol Microbiol. 1998 Jan;27(2):405-14 [9484895.001]
  • [Cites] J Bacteriol. 1998 May;180(10):2711-7 [9573157.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7057-62 [9618538.001]
  • [Cites] J Bacteriol. 1998 Nov;180(22):6039-42 [9811665.001]
  • [Cites] J Bacteriol. 1998 Dec;180(24):6538-43 [9851996.001]
  • [Cites] J Biol Chem. 1999 Aug 6;274(32):22548-55 [10428832.001]
  • [Cites] J Bacteriol. 1999 Sep;181(18):5563-71 [10482495.001]
  • [Cites] J Bacteriol. 1999 Oct;181(19):6108-13 [10498725.001]
  • [Cites] Science. 2004 Nov 5;306(5698):1040-2 [15528446.001]
  • [Cites] Curr Protein Pept Sci. 2004 Oct;5(5):417-24 [15544536.001]
  • [Cites] Biochim Biophys Acta. 2004 Nov 11;1694(1-3):181-206 [15546666.001]
  • [Cites] Biochim Biophys Acta. 2004 Nov 11;1694(1-3):219-34 [15546668.001]
  • [Cites] Nat Rev Microbiol. 2004 Dec;2(12):933-45 [15550939.001]
  • [Cites] Mol Microbiol. 2004 Dec;54(5):1199-211 [15554962.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17228-33 [15569944.001]
  • [Cites] Mol Microbiol. 2005 Jan;55(1):115-24 [15612921.001]
  • [Cites] J Biol Chem. 2005 Jan 14;280(2):1392-400 [15520000.001]
  • [Cites] FEMS Microbiol Rev. 2005 Jan;29(1):65-81 [15652976.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):826-31 [15613486.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):856-61 [15642951.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):832-7 [15644442.001]
  • [Cites] Mol Microbiol. 2005 Feb;55(3):881-96 [15661011.001]
  • [Cites] Mol Microbiol. 2005 Feb;55(3):912-26 [15661013.001]
  • [Cites] EMBO J. 2005 Jan 26;24(2):428-37 [15616576.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1685-90 [15668378.001]
  • [Cites] J Bacteriol. 2005 Apr;187(7):2315-25 [15774874.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4596-601 [15764702.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4866-71 [15781869.001]
  • [Cites] Mol Microbiol. 2005 May;56(4):918-33 [15853880.001]
  • [Cites] J Bacteriol. 2005 May;187(10):3486-95 [15866936.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8156-61 [15919815.001]
  • [Cites] J Biol Chem. 2005 Jul 15;280(28):26349-59 [15901731.001]
  • [Cites] Mol Membr Biol. 2005 Jan-Apr;22(1-2):51-61 [16092524.001]
  • [Cites] Nat Rev Microbiol. 2003 Nov;1(2):137-49 [15035043.001]
  • [Cites] Mol Microbiol. 2002 Sep;45(5):1325-35 [12207700.001]
  • [Cites] Int J Med Microbiol. 2002 Sep;292(3-4):159-68 [12398207.001]
  • [Cites] J Bacteriol. 2002 Dec;184(23):6465-71 [12426333.001]
  • [Cites] Science. 2002 Dec 6;298(5600):1942-6 [12471245.001]
  • [Cites] Curr Biol. 2003 Jan 8;13(1):R16-8 [12526758.001]
  • [Cites] J Bacteriol. 2003 Feb;185(3):1045-58 [12533481.001]
  • [Cites] Nucleic Acids Res. 2003 Feb 1;31(3):860-8 [12560481.001]
  • [Cites] Curr Opin Microbiol. 2003 Feb;6(1):29-34 [12615216.001]
  • [Cites] J Struct Biol. 2003 Mar;141(3):179-88 [12648564.001]
  • [Cites] Mol Microbiol. 2003 Apr;48(2):305-21 [12675793.001]
  • [Cites] J Bacteriol. 2003 May;185(9):2867-78 [12700266.001]
  • [Cites] EMBO J. 2003 May 1;22(9):1969-80 [12727865.001]
  • [Cites] J Bacteriol. 2003 Jun;185(11):3259-69 [12754223.001]
  • [Cites] Cell Microbiol. 2003 Jun;5(6):373-83 [12780775.001]
  • [Cites] Cell Microbiol. 2003 Jun;5(6):395-404 [12780777.001]
  • [Cites] Microbiol Mol Biol Rev. 2003 Jun;67(2):277-301, table of contents [12794193.001]
  • [Cites] J Bacteriol. 1996 Jun;178(11):3168-76 [8655495.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7321-6 [8692991.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7512-7 [8755505.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8889-94 [8799123.001]
  • [Cites] J Bacteriol. 1997 Jan;179(1):78-89 [8981983.001]
  • [Cites] J Bacteriol. 1997 Jan;179(2):453-62 [8990298.001]
  • [Cites] J Bacteriol. 1997 Feb;179(3):583-91 [9006008.001]
  • [Cites] J Bacteriol. 1997 Feb;179(4):1211-8 [9023204.001]
  • (PMID = 16153176.001).
  • [ISSN] 0066-4227
  • [Journal-full-title] Annual review of microbiology
  • [ISO-abbreviation] Annu. Rev. Microbiol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM048746; United States / NIGMS NIH HHS / GM / GM48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA, Bacterial
  • [Number-of-references] 164
  • [Other-IDs] NLM/ NIHMS537355; NLM/ PMC3872966
  •  go-up   go-down


44. Dodge AG, Richman JE, Johnson G, Wackett LP: Metabolism of thioamides by Ralstonia pickettii TA. Appl Environ Microbiol; 2006 Dec;72(12):7468-76
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Information on bacterial thioamide metabolism has focused on transformation of the antituberculosis drug ethionamide and related compounds by Mycobacterium tuberculosis.
  • To study this metabolism more generally, a bacterium that grew using thioacetamide as the sole nitrogen source was isolated via enrichment culture.
  • The bacterium was identified as Ralstonia pickettii and designated strain TA.

  • COS Scholar Universe. author profiles.
  • EAWAG Biocatalysis/Biodegradation Database. protein interactions/pathways - EAWAG Biocatalysis/Biodegradation Database .
  • Hazardous Substances Data Bank. THIOACETAMIDE .
  • Hazardous Substances Data Bank. Sulfur, Elemental .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Antibiot (Tokyo). 1995 Mar;48(3):282-5 [7730167.001]
  • [Cites] Biochim Biophys Acta. 1994 Dec 15;1201(3):447-53 [7803476.001]
  • [Cites] Nat Biotechnol. 1996 Dec;14(13):1705-9 [9634856.001]
  • [Cites] Appl Environ Microbiol. 2005 Feb;71(2):876-82 [15691943.001]
  • [Cites] J Pharmacol Exp Ther. 2000 Aug;294(2):473-9 [10900221.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9677-82 [10944230.001]
  • [Cites] J Microbiol Methods. 2000 Aug;41(3):179-84 [10958962.001]
  • [Cites] J Biol Chem. 2000 Sep 8;275(36):28326-31 [10869356.001]
  • [Cites] Mol Cell Biochem. 2000 Aug;211(1-2):103-10 [11055553.001]
  • [Cites] J Biol Chem. 2002 Apr 12;277(15):12824-9 [11823459.001]
  • [Cites] Curr Pharm Biotechnol. 2002 Sep;3(3):197-225 [12164478.001]
  • [Cites] Appl Microbiol Biotechnol. 2002 Oct;60(1-2):33-44 [12382040.001]
  • [Cites] Trends Biotechnol. 2003 Apr;21(4):170-7 [12679065.001]
  • [Cites] Int J Syst Evol Microbiol. 2003 Jul;53(Pt 4):1075-80 [12892129.001]
  • [Cites] J Ind Microbiol Biotechnol. 2004 Jul;31(6):261-72 [15248088.001]
  • [Cites] Science. 2004 Sep 10;305(5690):1612-5 [15361623.001]
  • [Cites] J Pharm Pharmacol. 1967 Jan;19(1):1-9 [4382170.001]
  • [Cites] Drug Metab Dispos. 1978 Jul-Aug;6(4):379-88 [28917.001]
  • [Cites] Chem Biol Interact. 1981 Apr;35(1):25-38 [6162577.001]
  • [Cites] Cancer Res. 1981 Sep;41(9 Pt 1):3430-5 [6790164.001]
  • [Cites] Biochem Biophys Res Commun. 1981 Sep 16;102(1):389-96 [7306160.001]
  • [Cites] Biochemistry. 1982 Mar 30;21(7):1608-11 [7082637.001]
  • [Cites] Mol Pharmacol. 1983 Jan;23(1):219-27 [6408387.001]
  • [Cites] Drug Metab Dispos. 1983 May-Jun;11(3):201-5 [6135576.001]
  • [Cites] Int J Lepr Other Mycobact Dis. 1985 Dec;53(4):587-94 [3910748.001]
  • [Cites] J Inorg Biochem. 1986 Oct-Nov;28(2-3):97-105 [3806099.001]
  • [Cites] Biochem J. 1987 Jul 1;245(1):285-8 [3663153.001]
  • [Cites] J Mol Biol. 1990 Oct 5;215(3):403-10 [2231712.001]
  • [Cites] Arch Biochem Biophys. 1998 Jan 15;349(2):299-303 [9448718.001]
  • (PMID = 16997975.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ DQ908951
  • [Grant] United States / NIGMS NIH HHS / GM / T32 GM008347; United States / NIGMS NIH HHS / GM / GM08347
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S; 0 / Thioamides; 075T165X8M / Thioacetamide; 70FD1KFU70 / Sulfur; 8799VM9SXC / thiobenzamide; EC 1.13.- / Oxygenases
  • [Other-IDs] NLM/ PMC1694237
  •  go-up   go-down


45. Russell JB: The energy spilling reactions of bacteria and other organisms. J Mol Microbiol Biotechnol; 2007;13(1-3):1-11
Saccharomyces Genome Database. Saccharomyces Genome Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lactic acid bacterium, Streptococcus bovis, is an ideal bacterium for the study of energy spilling.
  • Less is known about Escherichia coli, but in this bacterium energy spilling could be mediated by a futile cycle of potassium or ammonium ions.
  • In man, energy spilling may be related to cancer, ageing, ischemia and cardiac failure.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2007 S. Karger AG, Basel.
  • (PMID = 17693707.001).
  • [ISSN] 1464-1801
  • [Journal-full-title] Journal of molecular microbiology and biotechnology
  • [ISO-abbreviation] J. Mol. Microbiol. Biotechnol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 8L70Q75FXE / Adenosine Triphosphate
  • [Number-of-references] 85
  •  go-up   go-down


46. Erwin DP, Erickson IK, Delwiche ME, Colwell FS, Strap JL, Crawford RL: Diversity of oxygenase genes from methane- and ammonia-oxidizing bacteria in the Eastern Snake River Plain aquifer. Appl Environ Microbiol; 2005 Apr;71(4):2016-25
Hazardous Substances Data Bank. Ammonia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of sequences in each archive were related to oxygenases of type II-like methanotrophs of the genus Methylocystis.
  • Sequences similar to that of the amoA gene associated with ammonia-oxidizing bacteria (AOB) most closely matched a sequence from the uncultured bacterium BS870 but showed no substantial alignment to known cultured AOB.
  • Based on these functional gene analyses, bacteria related to the type II methanotroph Methylocystis sp. were found to dominate both free-living and attached communities.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. METHANE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Environ Microbiol. 1989 Dec;55(12):3155-61 [2515801.001]
  • [Cites] J Biol Chem. 1989 May 25;264(15):8935-40 [2498321.001]
  • [Cites] Appl Environ Microbiol. 1992 Mar;58(3):953-60 [1349468.001]
  • [Cites] Biodegradation. 1990;1(1):19-29 [1368139.001]
  • [Cites] Appl Environ Microbiol. 1992 Jun;58(6):1886-93 [1377902.001]
  • [Cites] Appl Environ Microbiol. 1992 Sep;58(9):3020-6 [1444415.001]
  • [Cites] J Biol Chem. 1993 Feb 5;268(4):2719-26 [8428945.001]
  • [Cites] Appl Environ Microbiol. 1995 Jan;61(1):116-21 [7887594.001]
  • [Cites] FEMS Microbiol Lett. 1995 Oct 15;132(3):203-8 [7590173.001]
  • [Cites] J Inorg Biochem. 1995 Jun;58(4):235-44 [7500086.001]
  • [Cites] Microbiol Rev. 1996 Jun;60(2):439-71 [8801441.001]
  • [Cites] Comput Appl Biosci. 1996 Aug;12(4):357-8 [8902363.001]
  • [Cites] Appl Environ Microbiol. 1997 Feb;63(2):687-93 [9023946.001]
  • [Cites] J Biol Chem. 1998 Apr 3;273(14):7957-66 [9525893.001]
  • [Cites] Science. 1998 Oct 9;282(5387):281-4 [9765151.001]
  • [Cites] FEMS Microbiol Ecol. 2004 Jun 1;48(3):333-44 [19712303.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5261-6 [11959976.001]
  • [Cites] Appl Environ Microbiol. 1999 Nov;65(11):5066-74 [10543824.001]
  • [Cites] Appl Environ Microbiol. 1999 Dec;65(12):5198-206 [10583965.001]
  • [Cites] IARC Sci Publ. 1999;(150):315-24 [10626231.001]
  • [Cites] Arch Microbiol. 2000 May-Jun;173(5-6):325-32 [10896210.001]
  • [Cites] Appl Environ Microbiol. 2000 Dec;66(12):5259-66 [11097900.001]
  • [Cites] Appl Environ Microbiol. 2001 Jun;67(6):2799-809 [11375197.001]
  • [Cites] Appl Environ Microbiol. 2001 Sep;67(9):4177-85 [11526021.001]
  • [Cites] Biodegradation. 2001;12(2):81-103 [11710592.001]
  • [Cites] Biodegradation. 2001;12(2):105-26 [11710590.001]
  • [Cites] Appl Environ Microbiol. 2002 Apr;68(4):1569-75 [11916670.001]
  • [Cites] Environ Sci Technol. 2002 May 15;36(10):2262-8 [12038839.001]
  • [Cites] Environ Microbiol. 2002 Sep;4(9):517-24 [12220408.001]
  • [Cites] Ann N Y Acad Sci. 2002 Dec;982:177-89 [12562636.001]
  • [Cites] Genome Res. 2003 Feb;13(2):294-307 [12566408.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3820-5 [12634423.001]
  • [Cites] Genome Res. 2003 May;13(5):954-64 [12695328.001]
  • [Cites] Syst Biol. 2003 Oct;52(5):674-83 [14530134.001]
  • [Cites] Trends Biotechnol. 2003 Dec;21(12):531-5 [14624861.001]
  • [Cites] Curr Opin Microbiol. 2003 Dec;6(6):578-85 [14662353.001]
  • [Cites] Cancer Res. 1983 Mar;43(3):1145-52 [6825087.001]
  • [Cites] Ann N Y Acad Sci. 1988;534:316-42 [3389663.001]
  • [Cites] Appl Environ Microbiol. 1989 Nov;55(11):2819-26 [2624462.001]
  • (PMID = 15812034.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / R21 ES012814; United States / NIEHS NIH HHS / ES / 1R21 ES012814-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Bacterial; 7664-41-7 / Ammonia; EC 1.- / Oxidoreductases; EC 1.13.- / Oxygenases; EC 1.14.13.25 / methane monooxygenase; EC 1.7.3.- / ammonia monooxygenase; OP0UW79H66 / Methane
  • [Other-IDs] NLM/ PMC1082543
  •  go-up   go-down


47. Johnsen MG, Hansen OC, Stougaard P: Isolation, characterization and heterologous expression of a novel chitosanase from Janthinobacterium sp. strain 4239. Microb Cell Fact; 2010;9:5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: This paper describes the isolation of a chitosanase-producing, cold-active bacterium affiliated to the genus Janthinobacterium.
  • The chitosanase was related to the Glycosyl Hydrolase family 46 chitosanases with Streptomyces chitosanase as the closest related (64% amino acid sequence identity).

  • COS Scholar Universe. author profiles.
  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biosci Biotechnol Biochem. 2000 Sep;64(9):1896-902 [11055393.001]
  • [Cites] FEBS J. 2009 Feb;276(3):857-69 [19143844.001]
  • [Cites] Lett Appl Microbiol. 2002;35(1):17-21 [12081543.001]
  • [Cites] J Mol Biol. 2004 Jul 16;340(4):783-95 [15223320.001]
  • [Cites] Biochim Biophys Acta. 1980 Dec 2;603(1):13-26 [7004488.001]
  • [Cites] Methods Enzymol. 1982;87:405-26 [7176924.001]
  • [Cites] Gene. 1985;33(1):103-19 [2985470.001]
  • [Cites] Carbohydr Res. 1986 Aug 15;151:403-8 [3768901.001]
  • [Cites] Microbiol Immunol. 1989;33(4):357-67 [2505022.001]
  • [Cites] Jpn J Cancer Res. 1990 Mar;81(3):259-65 [2112529.001]
  • [Cites] Gene. 1994 Dec 30;151(1-2):131-5 [7828861.001]
  • [Cites] FEMS Microbiol Lett. 1995 Sep 15;131(3):279-88 [7557339.001]
  • [Cites] Microbiology. 1995 Oct;141 ( Pt 10):2629-35 [7582023.001]
  • [Cites] Nat Struct Biol. 1996 Feb;3(2):155-62 [8564542.001]
  • [Cites] Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 [9254694.001]
  • [Cites] Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 [9396791.001]
  • [Cites] Biochem Cell Biol. 1997;75(6):687-96 [9599657.001]
  • [Cites] Biochim Biophys Acta. 1999 Jan 11;1429(2):365-76 [9989221.001]
  • [Cites] J Biol Chem. 1999 Oct 22;274(43):30818-25 [10521473.001]
  • [Cites] Drug Deliv. 2005 Jan-Feb;12(1):41-57 [15801720.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):7904-9 [16332766.001]
  • [Cites] Biotechnol Lett. 2007 Aug;29(8):1221-5 [17563859.001]
  • [Cites] Int J Pharm. 2008 Mar 20;352(1-2):302-8 [18065172.001]
  • [Cites] Carbohydr Res. 2008 Jun 9;343(8):1316-23 [18420186.001]
  • [Cites] Biosci Biotechnol Biochem. 2008 Aug;72(8):2074-81 [18685218.001]
  • [Cites] Carbohydr Res. 2008 Oct 13;343(15):2583-8 [18722595.001]
  • [Cites] Appl Environ Microbiol. 2008 Nov;74(22):7070-2 [18806001.001]
  • [Cites] Gene. 2001 Aug 22;274(1-2):111-8 [11675003.001]
  • (PMID = 20096097.001).
  • [ISSN] 1475-2859
  • [Journal-full-title] Microbial cell factories
  • [ISO-abbreviation] Microb. Cell Fact.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Proteins; EC 3.2.1.- / Glycoside Hydrolases; EC 3.2.1.132 / chitosanase
  • [Other-IDs] NLM/ PMC2835661
  •  go-up   go-down


48. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P: New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res; 2008 May 1;146(1):149-58
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Gastric adenocarcinoma not located in the cardia still remains second only to lung cancer as the leading cause of cancer-related mortality worldwide, whereas adenocarcinoma of the cardia and gastroesophageal junction has been rapidly rising over the past two decades.
  • Gastric malignancy can be subdivided into diffuse and intestinal pathologic entities that have different epidemiological and prognostic features.
  • Various genetic and environmental factors lead to either abnormal gene overexpression or inappropriate expression of normal genes, whose products confer the malignant phenotype.
  • Oncogene overexpression, tumor suppressor loss, and defective DNA mismatch repair is associated with gastric cancer.
  • The latter leads to gastric carcinogenesis through changes related to E-cadherin-catenin complex, which plays a critical role in normal tissue architecture maintenance.
  • Mutation of any of its components results in loss of cell-cell adhesion, thereby contributing to malignancy.
  • E-cadherin/CDH1 gene germline mutations have been recognized in families with an inherited predisposition to diffuse-type malignancy.
  • This review focuses mainly on Helicobacter pylori infection involved in gastric carcinogenesis through various mechanisms, including repopulation of the stomach with bone marrow-derived stem cells that may facilitate gastric cancer progression, thereby necessitating eradication of this bacterium.


49. Krishnan N, Doster AR, Duhamel GE, Becker DF: Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress. Infect Immun; 2008 Jul;76(7):3037-44
Hazardous Substances Data Bank. (L)-PROLINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter hepaticus is a gram-negative, spiral-shaped microaerophilic bacterium associated with chronic intestinal infection leading to hepatitis and colonic and hepatic carcinomas in susceptible strains of mice.
  • In the closely related human pathogen Helicobacter pylori, L-proline is a preferred respiratory substrate and is found at significantly high levels in the gastric juice of infected patients.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bioorg Med Chem Lett. 2003 Aug 18;13(16):2703-7 [12873498.001]
  • [Cites] Infect Immun. 1998 Nov;66(11):5477-84 [9784560.001]
  • [Cites] Infect Immun. 2004 Mar;72(3):1391-6 [14977943.001]
  • [Cites] Microbiology. 2004 Apr;150(Pt 4):1055-61 [15073314.001]
  • [Cites] Infect Immun. 2004 May;72(5):2521-7 [15102759.001]
  • [Cites] Toxicol Pathol. 1998 Sep-Oct;26(5):602-11 [9789946.001]
  • [Cites] Infect Immun. 1999 Feb;67(2):740-4 [9916085.001]
  • [Cites] Curr Opin Struct Biol. 2004 Dec;14(6):663-8 [15582389.001]
  • [Cites] Helicobacter. 2004 Dec;9(6):614-21 [15610074.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3459-64 [15699356.001]
  • [Cites] Biochemistry. 2005 Jun 28;44(25):9130-9 [15966737.001]
  • [Cites] Carcinogenesis. 2005 Aug;26(8):1335-42 [15817612.001]
  • [Cites] Infect Immun. 2005 Aug;73(8):4895-904 [16041003.001]
  • [Cites] J Biol Chem. 2005 Aug 12;280(32):29346-54 [15914462.001]
  • [Cites] Infect Immun. 2005 Sep;73(9):5311-8 [16113246.001]
  • [Cites] Biochemistry. 2005 Sep 20;44(37):12297-306 [16156643.001]
  • [Cites] Inflammopharmacology. 2005;13(1-3):63-74 [16259728.001]
  • [Cites] J Biol Chem. 2006 Jan 27;281(4):2044-52 [16303758.001]
  • [Cites] J Bacteriol. 2006 Feb;188(4):1227-35 [16452403.001]
  • [Cites] Appl Environ Microbiol. 2006 Jun;72(6):4001-6 [16751508.001]
  • [Cites] Mol Microbiol. 2006 Aug;61(4):847-60 [16879643.001]
  • [Cites] Oncogene. 2006 Sep 14;25(41):5640-7 [16619034.001]
  • [Cites] Infect Immun. 2006 Dec;74(12):6839-46 [17030577.001]
  • [Cites] Clin Biochem. 2007 Jan;40(1-2):37-40 [16999949.001]
  • [Cites] Mol Cell Biochem. 2007 Jan;295(1-2):85-92 [16874462.001]
  • [Cites] FEMS Immunol Med Microbiol. 2007 Jul;50(2):177-83 [17521354.001]
  • [Cites] Free Radic Biol Med. 2008 Feb 15;44(4):671-81 [18036351.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Apr;23(4):652-9 [18005015.001]
  • [Cites] Breast Cancer Res Treat. 2008 Jul;110(2):297-307 [17879159.001]
  • [Cites] Mol Cell Biochem. 1980 Apr 18;30(2):111-27 [6991912.001]
  • [Cites] Arch Biochem Biophys. 1986 Jul;248(1):166-74 [3729412.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Apr;85(7):2036-40 [3353366.001]
  • [Cites] Gut. 1991 Aug;32(8):853-7 [1885065.001]
  • [Cites] Gut. 1993 May;34(5):599-603 [8504958.001]
  • [Cites] J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7 [8040890.001]
  • [Cites] Int J Oncol. 2000 Oct;17(4):811-8 [10995896.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13009-14 [11069295.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):1810-5 [11280728.001]
  • [Cites] Biochemistry. 2001 Apr 17;40(15):4714-21 [11294639.001]
  • [Cites] J Clin Microbiol. 2001 Jul;39(7):2598-602 [11427576.001]
  • [Cites] Amino Acids. 2001;21(2):195-200 [11665815.001]
  • [Cites] Virchows Arch. 2001 Nov;439(5):653-60 [11764386.001]
  • [Cites] Virchows Arch. 2001 Nov;439(5):661-7 [11764387.001]
  • [Cites] Virchows Arch. 2002 Jul;441(1):77-84 [12111204.001]
  • [Cites] J Biol Chem. 2003 Mar 14;278(11):9784-9 [12514185.001]
  • [Cites] J Bacteriol. 2003 Apr;185(8):2680-2 [12670994.001]
  • [Cites] J Exp Med. 2003 Apr 7;197(7):813-22 [12668646.001]
  • [Cites] Biochemistry. 2003 May 13;42(18):5469-77 [12731889.001]
  • [Cites] J Med Microbiol. 2003 Jun;52(Pt 6):461-9 [12748264.001]
  • [Cites] Infect Immun. 2003 Jul;71(7):3885-93 [12819073.001]
  • [Cites] J Clin Microbiol. 1994 May;32(5):1238-45 [8051250.001]
  • [Cites] Am J Pathol. 1994 Oct;145(4):959-68 [7943185.001]
  • [Cites] Appl Environ Microbiol. 1995 Jan;61(1):252-9 [7887605.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Apr 6;209(1):1-5 [7726821.001]
  • [Cites] J Clin Microbiol. 1995 Nov;33(11):2968-72 [8576355.001]
  • [Cites] Infect Immun. 1996 May;64(5):1548-58 [8613359.001]
  • [Cites] Infect Immun. 1996 Sep;64(9):3673-81 [8751916.001]
  • [Cites] Emerg Infect Dis. 1995 Oct-Dec;1(4):129-31 [8903182.001]
  • [Cites] Helicobacter. 1998 Jun;3(2):69-78 [9631303.001]
  • [Cites] Microbiology. 2003 Aug;149(Pt 8):2023-30 [12904542.001]
  • (PMID = 18458068.001).
  • [ISSN] 1098-5522
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM061068-07; United States / NCRR NIH HHS / RR / P20 RR-017675-02; United States / NCRR NIH HHS / RR / RR017675-067443; United States / NCRR NIH HHS / RR / P20 RR017675; United States / NCRR NIH HHS / RR / 5P-20-RR017675-03; United States / NCRR NIH HHS / RR / P20 RR017675-067443; United States / NIGMS NIH HHS / GM / R01 GM061068; United States / NIGMS NIH HHS / GM / GM061068; United States / NIGMS NIH HHS / GM / R01 GM061068-07
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Membrane Proteins; 0 / PutA protein, Bacteria; 9DLQ4CIU6V / Proline; EC 1.5.- / Oxidoreductases Acting on CH-NH Group Donors; EC 1.5.3.- / Proline Oxidase
  • [Other-IDs] NLM/ PMC2446744
  •  go-up   go-down


50. Cho EA, Lee DW, Cha YH, Lee SJ, Jung HC, Pan JG, Pyun YR: Characterization of a novel D-lyxose isomerase from Cohnella laevoribosii RI-39 sp. nov. J Bacteriol; 2007 Mar;189(5):1655-63
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A newly isolated bacterium, Cohnella laevoribosii RI-39, could grow in a defined medium with L-ribose as the sole carbon source.
  • A 21-kDa protein isomerizing L-ribose to L-ribulose, as well as D-lyxose to D-xylulose, was purified to homogeneity from this bacterium.
  • The ability of lyxA to permit E. coli cells to grow on D-lyxose and L-ribose and homology searches of other sugar-related enzymes, as well as previously described sugar isomerases, suggest that CLLI is a novel type of rare sugar isomerase.


51. Patterson MM, Rogers AB, Fox JG: Experimental Helicobacter marmotae infection in A/J mice causes enterohepatic disease. J Med Microbiol; 2010 Oct;59(Pt 10):1235-41
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because the majority of WHV-positive woodchucks with hepatic tumours were culture or PCR positive for this helicobacter, and WHV-negative woodchucks with H. marmotae had hepatitis, the bacterium may have a role in tumour promotion related to chronic inflammation.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastroenterology. 1998 Apr;114(4):755-63 [9516396.001]
  • [Cites] Infect Immun. 1997 Aug;65(8):3126-31 [9234764.001]
  • [Cites] Infect Immun. 1998 Nov;66(11):5477-84 [9784560.001]
  • [Cites] Toxicol Pathol. 1998 Sep-Oct;26(5):602-11 [9789946.001]
  • [Cites] J Clin Microbiol. 1999 Aug;37(8):2439-45 [10405381.001]
  • [Cites] Am J Pathol. 1999 Aug;155(2):571-82 [10433949.001]
  • [Cites] Comp Med. 2004 Oct;54(5):571-7 [15575372.001]
  • [Cites] World J Gastroenterol. 2007 Jan 7;13(1):104-24 [17206759.001]
  • [Cites] Infect Immun. 2008 May;76(5):1866-76 [18285497.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1027-32 [19164562.001]
  • [Cites] Infect Immun. 2009 Jun;77(6):2508-16 [19307212.001]
  • [Cites] J Clin Microbiol. 2009 Nov;47(11):3673-81 [19759229.001]
  • [Cites] Gut. 2010 Jan;59(1):88-97 [19850960.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):691-702 [12547727.001]
  • [Cites] Helicobacter. 1999 Dec;4(4):249-59 [10597395.001]
  • [Cites] J Med Microbiol. 2000 Jun;49(6):525-34 [10847206.001]
  • [Cites] J Clin Microbiol. 2001 Apr;39(4):1580-5 [11283091.001]
  • [Cites] Exp Biol Med (Maywood). 2001 May;226(5):420-8 [11393169.001]
  • [Cites] ILAR J. 2001;42(2):89-102 [11406711.001]
  • [Cites] J Am Vet Med Assoc. 1985 Apr 15;186(8):789-91 [3997638.001]
  • [Cites] Infect Immun. 2004 May;72(5):2521-7 [15102759.001]
  • [Cites] J Clin Microbiol. 2002 Jul;40(7):2513-9 [12089272.001]
  • [Cites] Vet Pathol. 1985 Jul;22(4):338-43 [2994274.001]
  • [Cites] J Clin Microbiol. 1987 May;25(5):942-3 [3584432.001]
  • [Cites] J Clin Microbiol. 1988 Jan;26(1):101-5 [3343302.001]
  • [Cites] J Clin Microbiol. 1990 May;28(5):1016-20 [2191002.001]
  • [Cites] J Wildl Dis. 1991 Apr;27(2):281-7 [2067050.001]
  • [Cites] J Clin Microbiol. 1993 Mar;31(3):569-71 [8458951.001]
  • [Cites] J Clin Microbiol. 1993 Jul;31(7):1916-7 [8349774.001]
  • [Cites] J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7 [8040890.001]
  • [Cites] J Clin Microbiol. 1995 Feb;33(2):445-54 [7536217.001]
  • [Cites] Infect Immun. 1996 May;64(5):1548-58 [8613359.001]
  • [Cites] Lab Anim Sci. 1996 Feb;46(1):15-20 [8699813.001]
  • [Cites] Infect Immun. 1996 Sep;64(9):3673-81 [8751916.001]
  • [Cites] J Clin Microbiol. 1996 Oct;34(10):2479-82 [8880504.001]
  • [Cites] Gastroenterology. 1997 Apr;112(4):1386-97 [9098027.001]
  • [Cites] Vet Pathol. 1997 May;34(3):225-9 [9163879.001]
  • [Cites] Infect Immun. 1998 Jul;66(7):3142-8 [9632578.001]
  • (PMID = 20616187.001).
  • [ISSN] 1473-5644
  • [Journal-full-title] Journal of medical microbiology
  • [ISO-abbreviation] J. Med. Microbiol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01-AI37750; United States / NIAID NIH HHS / AI / R01 AI037750; United States / NIEHS NIH HHS / ES / P30 ES002109; United States / NCRR NIH HHS / RR / T32 RR007036; United States / NCRR NIH HHS / RR / T32-RR07036
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Immunoglobulin G
  • [Other-IDs] NLM/ PMC3052501
  •  go-up   go-down


52. Biswas A, Liu YJ, Hao L, Mizoguchi A, Salzman NH, Bevins CL, Kobayashi KS: Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A; 2010 Aug 17;107(33):14739-44
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report that Nod2-deficient mice inoculated with Helicobacter hepaticus, an opportunistic pathogenic bacterium, developed granulomatous inflammation of the ileum, characterized by an increased expression of Th1-related genes and inflammatory cytokines.

  • MedlinePlus Health Information. consumer health - Crohn's Disease.
  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2008 Mar;172(3):702-13 [18258845.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15813-8 [19805227.001]
  • [Cites] Nat Rev Immunol. 2008 Jun;8(6):435-46 [18500229.001]
  • [Cites] Nat Rev Immunol. 2008 Jun;8(6):458-66 [18500230.001]
  • [Cites] Gut. 2008 Jul;57(7):903-10 [18305068.001]
  • [Cites] Inflamm Bowel Dis. 2008 Aug;14(8):1033-40 [18383179.001]
  • [Cites] Mucosal Immunol. 2008 Nov;1 Suppl 1:S5-9 [19079230.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20858-63 [19075245.001]
  • [Cites] Gut. 2009 Jun;58(6):882-3; discussion 883-4 [19433600.001]
  • [Cites] Clin Microbiol Rev. 2001 Jan;14(1):59-97 [11148003.001]
  • [Cites] Digestion. 2001;63 Suppl 1:43-7 [11173909.001]
  • [Cites] Nature. 2001 May 31;411(6837):599-603 [11385576.001]
  • [Cites] Nature. 2001 May 31;411(6837):603-6 [11385577.001]
  • [Cites] J Exp Med. 2009 Sep 28;206(10):2101-10 [19737867.001]
  • [Cites] Nat Immunol. 2009 Dec;10(12):1267-74 [19881508.001]
  • [Cites] N Engl J Med. 2009 Nov 19;361(21):2066-78 [19923578.001]
  • [Cites] Nat Immunol. 2010 Jan;11(1):76-83 [19855381.001]
  • [Cites] Am J Gastroenterol. 2010 Feb;105(2):452-9 [19904243.001]
  • [Cites] Cell Mol Life Sci. 2002 Jan;59(1):156-70 [11846026.001]
  • [Cites] Nature. 2002 Mar 14;416(6877):194-9 [11894098.001]
  • [Cites] Gut. 2002 May;50 Suppl 3:III60-4 [11953335.001]
  • [Cites] Nature. 2003 Apr 3;422(6931):522-6 [12660734.001]
  • [Cites] Gastroenterology. 2003 Jul;125(1):47-57 [12851870.001]
  • [Cites] Mol Cell Biol. 2003 Nov;23(21):7531-9 [14560001.001]
  • [Cites] Gut. 2003 Nov;52(11):1591-7 [14570728.001]
  • [Cites] Hum Mol Genet. 2004 Aug 15;13(16):1715-25 [15198989.001]
  • [Cites] Infect Immun. 1998 Nov;66(11):5157-66 [9784517.001]
  • [Cites] Gut. 2005 Jan;54(1):162-7 [15591523.001]
  • [Cites] Science. 2005 Feb 4;307(5710):731-4 [15692051.001]
  • [Cites] Science. 2005 Feb 4;307(5710):734-8 [15692052.001]
  • [Cites] Cell Microbiol. 2005 May;7(5):675-86 [15839897.001]
  • [Cites] J Biol Chem. 2005 Oct 28;280(43):35859-67 [16115863.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18129-34 [16330776.001]
  • [Cites] J Leukoc Biol. 2006 Apr;79(4):860-6 [16461743.001]
  • [Cites] Inflamm Bowel Dis. 2006 Jul;12(7):641-50 [16804402.001]
  • [Cites] J Cell Physiol. 2006 Nov;209(2):241-52 [16897777.001]
  • [Cites] Immunity. 2006 Sep;25(3):473-85 [16949315.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1072:218-32 [17057202.001]
  • [Cites] J Clin Invest. 2007 Mar;117(3):605-15 [17318261.001]
  • [Cites] Am J Gastroenterol. 2007 Jun;102(6):1259-67 [17319929.001]
  • [Cites] PLoS One. 2007;2(6):e523 [17565376.001]
  • [Cites] Nature. 2007 Jul 26;448(7152):427-34 [17653185.001]
  • [Cites] J Leukoc Biol. 2008 Jan;83(1):13-30 [17875812.001]
  • [Cites] Gastroenterology. 2008 Feb;134(2):577-94 [18242222.001]
  • [Cites] Immunity. 2008 Feb;28(2):246-57 [18261938.001]
  • [Cites] Immunity. 2008 Mar;28(3):285-7 [18341998.001]
  • (PMID = 20679225.001).
  • [ISSN] 1091-6490
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK074738-05; United States / NIDDK NIH HHS / DK / P30 DK043351; United States / NIAID NIH HHS / AI / R01 AI032738; United States / NIAID NIH HHS / AI / R01 AI081807; United States / NIAID NIH HHS / AI / AI032738; United States / NIAID NIH HHS / AI / AI050843; United States / NIDDK NIH HHS / DK / R01DK074738; United States / NIAID NIH HHS / AI / R37 AI032738; United States / NIAID NIH HHS / AI / R01 AI057757; United States / NIAID NIH HHS / AI / R01 AI057757-05; United States / NIAID NIH HHS / AI / R21 AI057757; United States / NIAID NIH HHS / AI / R01 AI050843; United States / NIAID NIH HHS / AI / AI057757; None / None / / R01 DK074738-05; United States / NIDDK NIH HHS / DK / R01 DK074738
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Card15 protein, mouse; 0 / Interleukin-1beta; 0 / Interleukin-6; 0 / Nod2 Signaling Adaptor Protein; 82115-62-6 / Interferon-gamma
  • [Other-IDs] NLM/ PMC2930434
  •  go-up   go-down


53. Ben Amara A, Ghigo E, Le Priol Y, Lépolard C, Salcedo SP, Lemichez E, Bretelle F, Capo C, Mege JL: Coxiella burnetii, the agent of Q fever, replicates within trophoblasts and induces a unique transcriptional response. PLoS One; 2010;5(12):e15315
SciCrunch. ArrayExpress: Data: Microarray .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Q fever is a zoonosis caused by Coxiella burnetii, an obligate intracellular bacterium typically found in myeloid cells.
  • This program was associated with the modulation of inflammatory responses that were shared with inflammatory agonists, such as TNF, and more specific responses involving genes related to pregnancy development, including EGR-1 and NDGR1.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Emerg Infect Dis. 2004 Jul;10(7):1264-9 [15324547.001]
  • [Cites] J Exp Med. 2003 Mar 17;197(6):687-701 [12642601.001]
  • [Cites] J Comp Pathol. 1993 Oct;109(3):295-301 [8300917.001]
  • [Cites] Clin Infect Dis. 1995 Nov;21(5):1318-21 [8589167.001]
  • [Cites] J Virol. 1997 May;71(5):3628-35 [9094636.001]
  • [Cites] Science. 1998 Aug 21;281(5380):1191-3 [9712583.001]
  • [Cites] Blood. 1999 Mar 1;93(5):1464-76 [10029572.001]
  • [Cites] Biol Reprod. 1999 Sep;61(3):681-6 [10456845.001]
  • [Cites] Lancet Infect Dis. 2005 Apr;5(4):219-26 [15792739.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2956-63 [15805299.001]
  • [Cites] Vet Res. 2005 May-Jun;36(3):327-49 [15845229.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8585-90 [15937114.001]
  • [Cites] Emerg Infect Dis. 2005 Aug;11(8):1211-7 [16102309.001]
  • [Cites] Endocr Rev. 2005 Dec;26(7):877-97 [15901666.001]
  • [Cites] Reproduction. 2006 Aug;132(2):217-32 [16885531.001]
  • [Cites] J Comp Pathol. 2006 Aug-Oct;135(2-3):108-15 [16997003.001]
  • [Cites] J Allergy Clin Immunol. 2006 Oct;118(4):858-65 [17030238.001]
  • [Cites] Vet Microbiol. 2006 Nov 26;118(1-2):101-6 [16891064.001]
  • [Cites] Eur J Immunol. 2007 Jan;37(1):24-32 [17163446.001]
  • [Cites] Cell Microbiol. 2007 Apr;9(4):829-40 [17381428.001]
  • [Cites] J Virol. 2007 May;81(9):4701-12 [17314173.001]
  • [Cites] Placenta. 2007 May-Jun;28(5-6):538-42 [16904741.001]
  • [Cites] APMIS. 2007 Apr;115(4):347-53 [17504302.001]
  • [Cites] Cell. 2007 Jun 29;129(7):1287-98 [17604718.001]
  • [Cites] Placenta. 2007 Aug-Sep;28(8-9):920-7 [17485108.001]
  • [Cites] Clin Infect Dis. 2007 Sep 1;45(5):548-55 [17682987.001]
  • [Cites] Am J Pathol. 2008 Jan;172(1):50-8 [18165264.001]
  • [Cites] Infect Immun. 2008 Apr;76(4):1558-64 [18227157.001]
  • [Cites] Eur J Immunol. 2008 Apr;38(4):1065-70 [18350541.001]
  • [Cites] Infect Immun. 2008 May;76(5):1897-907 [18316388.001]
  • [Cites] PLoS Pathog. 2008 Feb 8;4(2):e23 [18248094.001]
  • [Cites] Prenat Diagn. 2008 May;28(5):434-42 [18444225.001]
  • [Cites] PLoS Pathog. 2008 May;4(5):e1000066 [18483547.001]
  • [Cites] Hum Reprod Update. 2008 Jul-Aug;14(4):335-44 [18424427.001]
  • [Cites] J Immunol. 2008 Sep 15;181(6):3733-9 [18768823.001]
  • [Cites] Microbes Infect. 2008 Jul;10(9):1010-3 [18664389.001]
  • [Cites] Cell Microbiol. 2008 Dec;10(12):2408-15 [18783482.001]
  • [Cites] Placenta. 2009 Feb;30(2):111-23 [19027157.001]
  • [Cites] Mol Cell Endocrinol. 2009 Feb 27;299(2):178-87 [19133314.001]
  • [Cites] J Immunol. 2009 Mar 15;182(6):3735-45 [19265152.001]
  • [Cites] Placenta. 2009 Apr;30(4):313-9 [19201463.001]
  • [Cites] PLoS One. 2009;4(4):e5357 [19399182.001]
  • [Cites] Infect Immun. 2009 Jun;77(6):2474-81 [19332535.001]
  • [Cites] Reprod Biol Endocrinol. 2009;7:80 [19656380.001]
  • [Cites] Immunobiology. 2009;214(7):526-42 [19261352.001]
  • [Cites] BJOG. 2006 Feb;113(2):152-8 [16411991.001]
  • [Cites] Mol Hum Reprod. 2005 Dec;11(12):865-70 [16421220.001]
  • [Cites] J Immunol. 2006 Jun 15;176(12):7495-501 [16751396.001]
  • [Cites] J Immunol. 1999 Dec 1;163(11):6078-85 [10570297.001]
  • [Cites] J Infect Dis. 2000 Jan;181(1):188-94 [10608766.001]
  • [Cites] Placenta. 2000 Mar-Apr;21 Suppl A:S113-9 [10831135.001]
  • [Cites] Infect Immun. 2001 Jan;69(1):486-93 [11119541.001]
  • [Cites] Infect Immun. 2001 Apr;69(4):2345-52 [11254592.001]
  • [Cites] Infect Immun. 2001 Apr;69(4):2520-6 [11254615.001]
  • [Cites] J Exp Med. 2001 Jul 16;194(2):189-203 [11457894.001]
  • [Cites] J Immunol. 2002 Oct 15;169(8):4488-95 [12370385.001]
  • [Cites] J Immunol. 2002 Dec 1;169(11):6309-15 [12444137.001]
  • [Cites] Can J Vet Res. 1991 Apr;55(2):139-42 [1884293.001]
  • (PMID = 21179488.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Early Growth Response Protein 1; 0 / Egr1 protein, mouse; 0 / Interleukin-13; 0 / Interleukin-6; 0 / STAT3 Transcription Factor; 0 / Stat3 protein, mouse
  • [Other-IDs] NLM/ PMC3001886
  •  go-up   go-down


54. Liu W, Luo C, Han C, Peng S, Yang Y, Yue J, Shen X, Jiang H: A new beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Helicobacter pylori: Molecular cloning, enzymatic characterization, and structural modeling. Biochem Biophys Res Commun; 2005 Aug 12;333(4):1078-86
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori is a gram-negative pathogenic bacterium that causes peptic ulcer disease and gastric cancer, and studies of the related potent enzymes associated with this bacterium are urgent for the discovery of novel drug targets.

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15967411.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AY725427
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 4.2.1.- / Hydro-Lyases; EC 4.2.1.- / beta-hydroxyacyl-(acyl-carrier-protein)dehydrase
  •  go-up   go-down


55. Guo J, Luan P, Li ZQ: [Clinical analysis of 120 cases of malignancies with nosocomial infections]. Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul;25(7):802-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The infection-related factors, classification of the pathogens and therapeutic effect were also analyzed.
  • RESULTS: The hospital-acquired infections involved mostly patients with acute leukemia and lung cancer (70/120), occurring at the site of the respiratory tract (78.89%), oral mucosa, gastrointestinal tract, skin and abdominal cavity, etc.
  • The pathogenic bacteria causing the infections were predominately G-bacterium, which were sensitive to meropenem and imipenem/cilastatin.

  • MedlinePlus Health Information. consumer health - Childhood Leukemia.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16027072.001).
  • [ISSN] 1000-2588
  • [Journal-full-title] Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
  • [ISO-abbreviation] Di Yi Jun Yi Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


56. Voth DE, Howe D, Heinzen RA: Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages. Infect Immun; 2007 Sep;75(9):4263-71
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Coxiella burnetii, the cause of human Q fever, is an aerosol-borne, obligate intracellular bacterium that targets host alveolar mononuclear phagocytic cells during infection.
  • Apoptosis inhibition was a C. burnetii-driven process as infected cells treated with rifampin or chloramphenicol, inhibitors of bacterial RNA and protein synthesis, respectively, showed significantly reduced protection against staurosporine-induced apoptosis. C. burnetii infection affected the expression of multiple apoptosis-related genes and resulted in increased synthesis of the antiapoptotic proteins A1/Bfl-1 and c-IAP2.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Traffic. 2002 Mar;3(3):178-85 [11886588.001]
  • [Cites] J Immunol. 2006 Nov 1;177(9):6245-55 [17056554.001]
  • [Cites] J Immunol. 2002 Dec 1;169(11):6309-15 [12444137.001]
  • [Cites] J Infect Dis. 2003 Apr 1;187(7):1097-106 [12660924.001]
  • [Cites] J Clin Microbiol. 2003 May;41(5):1869-74 [12734219.001]
  • [Cites] Trends Microbiol. 2003 May;11(5):210-4 [12781523.001]
  • [Cites] Cell Microbiol. 2003 Jul;5(7):469-80 [12814437.001]
  • [Cites] Expert Opin Biol Ther. 2003 Sep;3(6):919-24 [12943451.001]
  • [Cites] Infect Immun. 2004 Apr;72(4):2075-80 [15039329.001]
  • [Cites] Mol Microbiol. 2004 Apr;52(1):81-92 [15049812.001]
  • [Cites] Apoptosis. 2004 Jul;9(4):399-413 [15192322.001]
  • [Cites] J Exp Med. 2004 Oct 4;200(7):905-16 [15452181.001]
  • [Cites] J Bacteriol. 2004 Nov;186(21):7344-52 [15489446.001]
  • [Cites] Infect Immun. 2004 Nov;72(11):6666-75 [15501800.001]
  • [Cites] Can J Microbiol. 1971 Feb;17(2):143-50 [4100953.001]
  • [Cites] J Immunol. 1976 Sep;117(3):996-1003 [986414.001]
  • [Cites] Infect Immun. 1981 Jul;33(1):258-66 [7263063.001]
  • [Cites] Infect Immun. 1983 Jun;40(3):1155-62 [6852916.001]
  • [Cites] PLoS Pathog. 2006 Nov;2(11):e115 [17121462.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18745-50 [17124169.001]
  • [Cites] Cell Microbiol. 2007 Jan;9(1):246-64 [16911566.001]
  • [Cites] Biochim Biophys Acta. 2007 Apr;1770(4):649-58 [17204371.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5121-6 [17360363.001]
  • [Cites] Cell Microbiol. 2007 Apr;9(4):829-40 [17381428.001]
  • [Cites] Cell Microbiol. 2007 Apr;9(4):891-909 [17087732.001]
  • [Cites] Infect Immun. 1984 Sep;45(3):781-3 [6432701.001]
  • [Cites] Infect Immun. 1985 Feb;47(2):366-9 [3967922.001]
  • [Cites] Infect Immun. 2000 Jan;68(1):342-51 [10603407.001]
  • [Cites] Lab Anim Sci. 1999 Dec;49(6):634-8 [10638499.001]
  • [Cites] Infect Immun. 2000 Jul;68(7):3815-21 [10858189.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):7039-45 [11598079.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):7121-9 [11598088.001]
  • [Cites] J Leukoc Biol. 2001 Nov;70(5):783-92 [11698499.001]
  • [Cites] J Gen Microbiol. 1986 May;132(5):1415-22 [3772338.001]
  • [Cites] Infect Immun. 1987 Jul;55(7):1731-3 [2439460.001]
  • [Cites] Infect Immun. 1988 Jul;56(7):1792-9 [3290107.001]
  • [Cites] FEBS Lett. 1995 Oct 30;374(2):303-8 [7589559.001]
  • [Cites] Infect Immun. 1996 Mar;64(3):796-809 [8641784.001]
  • [Cites] J Exp Med. 1998 Feb 16;187(4):487-96 [9463399.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4646-51 [9539792.001]
  • [Cites] J Exp Med. 1998 Dec 7;188(11):2127-37 [9841926.001]
  • [Cites] J Immunol. 1999 Feb 15;162(4):2259-65 [9973502.001]
  • [Cites] Trends Microbiol. 1999 Apr;7(4):149-54 [10217829.001]
  • [Cites] Clin Microbiol Rev. 1999 Oct;12(4):518-53 [10515901.001]
  • [Cites] Cell Microbiol. 2005 Jan;7(1):29-38 [15617521.001]
  • [Cites] Cell Microbiol. 2005 Jan;7(1):91-104 [15617526.001]
  • [Cites] FEMS Microbiol Rev. 2005 Jan;29(1):65-81 [15652976.001]
  • [Cites] Infect Immun. 2005 Mar;73(3):1399-403 [15731037.001]
  • [Cites] Infect Immun. 2005 Mar;73(3):1861-4 [15731089.001]
  • [Cites] Infect Immun. 2005 Apr;73(4):2469-77 [15784593.001]
  • [Cites] Cancer Biol Ther. 2005 Feb;4(2):139-63 [15725726.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8722-7 [15939879.001]
  • [Cites] Infect Immun. 2005 Dec;73(12):8089-99 [16299303.001]
  • [Cites] Curr Opin Microbiol. 2006 Feb;9(1):95-101 [16406779.001]
  • [Cites] Cell Microbiol. 2006 Mar;8(3):496-507 [16469060.001]
  • [Cites] J Bacteriol. 2006 Apr;188(7):2309-24 [16547017.001]
  • [Cites] Curr Opin Microbiol. 2006 Apr;9(2):207-17 [16529981.001]
  • [Cites] Infect Immun. 2006 Sep;74(9):5035-46 [16926395.001]
  • [Cites] J Exp Med. 2006 Sep 4;203(9):2177-89 [16940169.001]
  • [Cites] J Biol Chem. 2006 Oct 20;281(42):31495-501 [16940052.001]
  • [Cites] Cell Death Differ. 2002 May;9(5):505-12 [11973609.001]
  • (PMID = 17606599.001).
  • [ISSN] 0019-9567
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Caspase Inhibitors; EC 3.4.22.- / Caspases; H88EPA0A3N / Staurosporine
  • [Other-IDs] NLM/ PMC1951190
  •  go-up   go-down


57. Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S, Guiney DG: Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun; 2007 May;75(5):2408-14
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori is a gram-negative microaerophilic bacterium that colonizes the gastric mucosa, leading to disease conditions ranging from gastritis to cancer.
  • These observations are important in light of a recent report on IL-6 and IL-1beta playing a role in the development of H. pylori-related gastric cancer.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Immunol. 1998;70:83-243 [9755338.001]
  • [Cites] Mol Cell. 1998 Aug;2(2):253-8 [9734363.001]
  • [Cites] J Immunol. 1999 Apr 1;162(7):3749-52 [10201887.001]
  • [Cites] J Biol Chem. 1999 Jun 18;274(25):17406-9 [10364168.001]
  • [Cites] Science. 1999 Jul 30;285(5428):736-9 [10426996.001]
  • [Cites] J Immunol. 1999 Sep 1;163(5):2382-6 [10452971.001]
  • [Cites] Mol Pharmacol. 2004 Dec;66(6):1465-77 [15456896.001]
  • [Cites] J Immunol. 2005 May 1;174(9):5672-80 [15843568.001]
  • [Cites] Anticancer Res. 2005 Mar-Apr;25(2A):709-13 [15868900.001]
  • [Cites] Infect Immun. 2006 Apr;74(4):2121-7 [16552041.001]
  • [Cites] FEMS Immunol Med Microbiol. 2006 Aug;47(3):414-9 [16872378.001]
  • [Cites] Immunity. 1999 Oct;11(4):443-51 [10549626.001]
  • [Cites] J Immunol. 1999 Dec 15;163(12):6748-55 [10586073.001]
  • [Cites] J Immunol. 2000 Jul 15;165(2):1022-9 [10878379.001]
  • [Cites] Infect Immun. 2000 Aug;68(8):4802-4 [10899893.001]
  • [Cites] Eur Cytokine Netw. 2000 Jun;11(2):143-52 [10903793.001]
  • [Cites] Nature. 2000 Dec 7;408(6813):740-5 [11130078.001]
  • [Cites] Infect Immun. 2001 Jul;69(7):4382-9 [11401977.001]
  • [Cites] Immunity. 2001 Jun;14(6):661-4 [11420036.001]
  • [Cites] Pediatr Res. 2001 Sep;50(3):315-21 [11518816.001]
  • [Cites] J Med Invest. 2001 Aug;48(3-4):190-7 [11694959.001]
  • [Cites] J Biol Chem. 2001 Nov 30;276(48):44856-64 [11546774.001]
  • [Cites] Nat Rev Immunol. 2001 Nov;1(2):135-45 [11905821.001]
  • [Cites] J Immunol. 2002 Dec 15;169(12):6668-72 [12471095.001]
  • [Cites] Infect Immun. 2003 Feb;71(2):794-800 [12540559.001]
  • [Cites] J Infect Dis. 2003 Mar 1;187(5):829-36 [12599057.001]
  • [Cites] Annu Rev Immunol. 2003;21:335-76 [12524386.001]
  • [Cites] Cell Microbiol. 2003 Mar;5(3):143-53 [12614458.001]
  • [Cites] FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):1-7 [12727359.001]
  • [Cites] Eur J Immunol. 2003 May;33(5):1205-14 [12731045.001]
  • [Cites] Infect Immun. 2003 Jun;71(6):3496-502 [12761134.001]
  • [Cites] Infect Immun. 2003 Jul;71(7):4163-6 [12819109.001]
  • [Cites] Science. 2003 Aug 1;301(5633):640-3 [12855817.001]
  • [Cites] Curr Opin Immunol. 2003 Aug;15(4):396-401 [12900270.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):32552-60 [12807870.001]
  • [Cites] J Biol Chem. 2003 Oct 3;278(40):38105-8 [12893815.001]
  • [Cites] Helicobacter. 2003;8(5):495-502 [14535996.001]
  • [Cites] J Biol Chem. 2004 Jan 2;279(1):245-50 [14573621.001]
  • [Cites] Clin Exp Immunol. 2004 Jun;136(3):521-6 [15147355.001]
  • [Cites] Nat Rev Immunol. 2004 Jul;4(7):499-511 [15229469.001]
  • [Cites] J Immunol. 2004 Jul 15;173(2):1406-16 [15240737.001]
  • [Cites] Infect Immun. 2004 Nov;72(11):6446-54 [15501775.001]
  • [Cites] Gut. 1991 Dec;32(12):1473-7 [1773951.001]
  • [Cites] Infect Immun. 1997 Feb;65(2):843-6 [9009355.001]
  • [Cites] Gastroenterology. 1997 Apr;112(4):1386-97 [9098027.001]
  • [Cites] Infect Immun. 1997 Aug;65(8):3310-6 [9234792.001]
  • [Cites] Science. 1997 Nov 28;278(5343):1612-5 [9374458.001]
  • [Cites] Annu Rev Immunol. 1998;16:495-521 [9597139.001]
  • [Cites] Science. 1998 Dec 11;282(5396):2085-8 [9851930.001]
  • (PMID = 17353291.001).
  • [ISSN] 0019-9567
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / K01 CA096709; United States / NCI NIH HHS / CA / K01 CA96709
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytokines; 0 / Myd88 protein, mouse; 0 / Myeloid Differentiation Factor 88; 0 / Toll-Like Receptor 2; 0 / Toll-Like Receptor 4
  • [Other-IDs] NLM/ PMC1865764
  •  go-up   go-down


58. Jannière L, Canceill D, Suski C, Kanga S, Dalmais B, Lestini R, Monnier AF, Chapuis J, Bolotin A, Titok M, Le Chatelier E, Ehrlich SD: Genetic evidence for a link between glycolysis and DNA replication. PLoS One; 2007;2(5):e447
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The link, discovered during an analysis of suppressors of thermosensitive replication mutants in bacterium Bacillus subtilis, is very strong as some metabolic alterations fully restore viability to replication mutants in which a lethal arrest of DNA synthesis otherwise occurs at a high, restrictive, temperature.
  • It is proposed that related systems are ubiquitous.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochimie. 2006 Jan;88(1):1-10 [16225979.001]
  • [Cites] Cell. 2006 Jan 27;124(2):275-86 [16413606.001]
  • [Cites] Mol Microbiol. 2002 Jan;43(2):487-95 [11985724.001]
  • [Cites] Annu Rev Biochem. 2002;71:333-74 [12045100.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8342-7 [12060778.001]
  • [Cites] Nature. 2002 Jul 25;418(6896):387-91 [12140549.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):776-81 [12552134.001]
  • [Cites] FEMS Microbiol Rev. 2003 Jan;26(5):533-54 [12586394.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):6093-100 [12473677.001]
  • [Cites] Mol Microbiol. 2003 Mar;47(6):1709-21 [12622823.001]
  • [Cites] Microbiology. 2003 Apr;149(Pt 4):1001-10 [12686642.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4678-83 [12682299.001]
  • [Cites] Mol Cell. 2003 Apr;11(4):1009-20 [12718886.001]
  • [Cites] J Bacteriol. 2003 Jun;185(12):3583-95 [12775696.001]
  • [Cites] J Biol Chem. 2003 Jul 11;278(28):25408-16 [12738768.001]
  • [Cites] Genetics. 1979 Aug;92(4):1041-59 [391641.001]
  • [Cites] Proc Natl Acad Sci U S A. 1982 May;79(10):3340-4 [6285347.001]
  • [Cites] Genetics. 1984 Mar;106(3):365-85 [6323245.001]
  • [Cites] J Mol Biol. 1990 Mar 5;212(1):79-96 [2108251.001]
  • [Cites] J Biol Chem. 1990 Apr 25;265(12):6540-3 [2324090.001]
  • [Cites] J Bacteriol. 1990 Dec;172(12):6736-40 [2174858.001]
  • [Cites] J Mol Biol. 1991 Jun 20;219(4):605-13 [1905358.001]
  • [Cites] Cell. 1992 Apr 3;69(1):5-8 [1555241.001]
  • [Cites] Prog Biophys Mol Biol. 1993;59(2):105-235 [8426905.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 1993;44:167-203 [8434123.001]
  • [Cites] J Bacteriol. 1993 Dec;175(24):7931-7 [8253681.001